Curriculum Vitae
João Pedro Taborda Barata
Identificação
Identificação pessoal
- Nome completo
- João Pedro Taborda Barata
Nomes de citação
- Barata, João T.
- Barata, Joao T.
Identificadores de autor
- Ciência ID
- B51D-8696-3CA2
- ORCID iD
- 0000-0002-4826-8976
- Researcher Id
- D-9181-2015
- Scopus Author Id
- 7006937224
Endereços de correio eletrónico
- joao_barata@medicina.ulisboa.pt (Profissional)
Moradas
- Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina de Lisboa, Edifício Egas Moniz, P3B-35, 1649-028, Lisbon, Lisbon, Portugal (Profissional)
Websites
Domínios de atuação
- Ciências Médicas e da Saúde - Medicina Básica
Idiomas
| Idioma | Conversação | Leitura | Escrita | Compreensão | Peer-review |
|---|---|---|---|---|---|
| Português (Idioma materno) | |||||
| Inglês | Utilizador proficiente (C2) | Utilizador proficiente (C2) | Utilizador proficiente (C2) | Utilizador proficiente (C2) | Utilizador proficiente (C2) |
Formação
| Grau | Classificação | |
|---|---|---|
|
2003 - 2006
Concluído
|
n.a. (Pós-doutoramento)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Institut Pasteur Département Immunologie, França Utrecht University Medical Center, Países Baixos |
|
|
1997 - 2003
Concluído
|
n/a (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Interleukin-7—Mediated Signaling and its Role in the Biology of T-Cell Acute Lymphoblastic Leukemia: Potential Targets for
Therapeutic Intervention. " (TESE/DISSERTAÇÃO)
|
N/A |
|
1996 - 1997
Concluído
|
Ph.D. Program on Basic and Applied Biology - GABBA (Curso de doutoramento (conclusão de unidades curriculares))
Universidade do Porto, Portugal
|
|
|
1996
Concluído
|
Biology (Licenciatura)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
"Utilization of Molecular Assays (ELISA and RAPD-PCR) in the Characterization and Identification of the Potato Cyst-Nematodes
(Globodera spp.)" (TESE/DISSERTAÇÃO)
|
Percurso profissional
Ciência
| Categoria Profissional Instituição de acolhimento |
Empregador | |
|---|---|---|
| 2006 - Atual | Investigador principal (carreira) (Investigação) | Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal | ||
| 2003 - 2006 | Pós-doutorado (Investigação) | Fundação para a Ciência e a Tecnologia, Portugal |
| Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal (...) |
||
| 1997 - 2002 | Estagiário de Investigação (Investigação) | Dana Farber Cancer Institute, Estados Unidos |
| Dana Farber Cancer Institute, Estados Unidos | ||
| 1992 - 1996 | Assistente de Investigação (carreira) (Investigação) | Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal |
| Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal |
Docência no Ensino Superior
| Categoria Profissional Instituição de acolhimento |
Empregador | |
|---|---|---|
| 2020/01 - Atual | Professor Associado (Docente Universitário) | Universidade de Lisboa Faculdade de Medicina, Portugal |
| Universidade de Lisboa Faculdade de Medicina, Portugal | ||
| 2013 - 2019 | Professor Associado Convidado (Docente Universitário) | Universidade de Lisboa Faculdade de Medicina, Portugal |
| Universidade de Lisboa Faculdade de Medicina, Portugal | ||
| 2008 - 2009 | Professor Auxiliar Convidado (Docente Universitário) | Universidade de Lisboa Faculdade de Ciências, Portugal |
| Universidade de Lisboa Faculdade de Ciências, Portugal |
Outros
| Categoria Profissional Instituição de acolhimento |
Empregador | |
|---|---|---|
| 2007/07/02 - Atual | Accredited as competent for the practice of animal experimentation by the Portuguese Government accreditation agency (DGV – Direcção Geral de Veterinária), | n.a., Portugal |
| 2014 - 2018 | FCT Investigator (Consolidator – for established independent researchers, with an outstanding curriculum and proof of leadership in their research area). | Fundação para a Ciência e a Tecnologia, Portugal |
| Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal | ||
| 2006 - 2008 | Coordinator of the Flow Cytometry Unit | Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
Projetos
Bolsa
| Designação | Financiadores | |
|---|---|---|
| 2024/04/01 - Atual | ALLTogether team science : development of a preclinical testing platform to improve outcomes for drug resistant T-cell Acute
Lymphoblastic Leukemia - €500,000.00
23-FKC-09
Co-Investigador Responsável (Co-IR)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Prinses Máxima Centrum voor Kinderoncologie, Países Baixos |
European Science Foundation
Em curso
|
| 2024/01/01 - Atual | Targeted chronotherapy in T-cell acute lymphoblastic leukemia - €86,000.00
n/a
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA)
Em curso
|
| 2024/01 - Atual | Dependence of IL-7R-mediated signaling on sphingosine kinase activity in acute lymphoblastic leukemia cells as an exploitable
therapeutic vulnerability - £228,860.00
WWCR 24-0426
|
Association for International Cancer Research
Em curso
|
| 2022/04 - Atual | IL7R hijacking by lung cancer cells - € 249.921,25
PTDC/MEC-ONC/4606/2021
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Em curso
|
| 2021/09 - Atual | IL7R_LungCan - IL7R in lung cancer development, metastasis and resistance to immune checkpoint inhibitor therapy - Three-year
long grant. €999,962.00 (iMM: €458,520.00)
HR21-00761
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona 'la Caixa'
Em curso
|
| 2022/06 - 2024/05 | miRToTALL - A microRNA-regulated cell death-inducing gene therapy for T-cell Acute Lymphoblastic Title Leukemia - €150,000.00
ERC-PoC-101069429
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
European Research Council
Concluído
|
| 2021/01 - 2023/08 | CIRCAandSIGNAL - The reciprocal regulation between the circadian molecular clock and IL7/IL7R-mediated signaling in T-cell
Acute Lymphoblastic Leukemia - €50,000.00
EXPL/MEC-HEM/0571/2021
Co-Investigador Responsável (Co-IR)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2020/01 - 2021/12 | IL7RsignaTHER - Antibody-based IL-7R targeted therapies - €150,000.00
PoC-862545
Investigador responsável
Instituto de Medicina Molecular João Lobo Antunes, Portugal
|
European Research Council
Em curso
|
| 2018/10 - 2021/09 | NEUROMETS - Using genomics to identify novel targeted therapies in brain metastases - €238,740.00
EXPL/MEC-HEM/0571/2021
Co-Investigador Responsável (Co-IR)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2015/09 - 2021/08 | IL7sigNETure - IL-7/IL-7R signaling networks in health and malignancy - €1,988,125.00
CoG-648455
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
European Research Council
Em curso
|
| 2018/06 - 2021/05 | CIRCA-TO-TREAT-LEUKEMIA - Decoding the interplay between CK2, PI3K and the circadian molecular clock to better understand
the biology of, and maximize targeted treatment responses in, T-cell leukemia - €239,641.00
PTDC/MEC-HEM/31588/2017
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2016/10 - 2019/09 | Aberrant IL7R signaling in leukemogenesis: from the basics to potential therapeutics - €199,778.00
FAPESP/20015/2014
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2018/02 - 2019/02 | Selective cancer cell death using a microRNA-detector system in T-cell acute lymphoblastic leukemia - €84,287.00
n.a.
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA)
Concluído
|
| 2016/01 - 2018/12 | ReTuBi - Towards outstanding research and training in tumour biology - €999,975.00
H2020-TWINN-2015 - ReTuBi
|
European Union
Concluído
|
| 2015/01 - 2016/01 | Generating the tools to explore an idea: Does in vivo aberrant IL-7R constitutive signaling promote cancer development? -
€70,000.00
n.a.
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA)
Concluído
|
| 2012/09 - 2015/09 | Dissecting the impact of IL7R gain-of-function mutations in T-cell leukemia - €165,000.00
PTDC/SAU-ONC/122428
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2013 - 2015 | Do miRNAs and TAL1 crosstalk? New insights into the regulation and function of a major T-cell oncogene. - €125,797.00
PTDC/BIM-ONC/1548
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2011 - 2014 | Identification of novel regulators of CK2 with impact on PTEN function in leukemia - €186,127.00
PTDC/SAU-ONC/113202
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2010 - 2012 | Cell-intrinsic and microenvironmental signals intertwined: novel targets for therapeutic intervention in acute lymphoblastic
leukemia? - €190,000.00
PTDC/SAU-OBD/104816
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2010 - 2012 | Reciprocal regulation between TAL1 and miRNA expression in T-cell leukemia - €15,000.00
n.a.
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Liga Portuguesa Contra o Cancro Núcleo Regional do Sul
Concluído
|
| 2009 - 2012 | Regulation of ZAP-70 and PTEN activity and stability in chronic lymphocytic leukemia: prognostic and therapeutic implications.
- €134,000.00
PIC/IC/83193
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2009 - 2012 | Clinical implications of activation of PI3K/Akt signaling pathway in primary adult acute lymphoblastic leukemia - €134,000.00
PIC/IC/83023
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2007 - 2010 | Molecular and Functional Effects of TAL1 and LMO2 Overexpression in Normal Human Hematopoietic Stem Cells: Impact on T-cell
Leukemia - €174,800.00
PTDC/SAU-OBD/69974
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2007 - 2010 | Can TAL1 and LMO2 Effectively Trigger T-cell Acute Leukaemia? Studies on the Functional and Molecular Consequences of TAL1/LMO2
Over-expression in Normal Human Haematopoietic and T-cell progenitors - £98,329.00
n.a.
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Children with Cancer UK
Concluído
|
| 2005 - 2008 | External and Cell-Autonomous Signals in Tumorigenesis: Potential Targets for Novel Cancer Therapies - €99,935.00
POCI/SAU-OBS/58913
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2005 - 2008 | The Role of PI3K-mediated Signaling in the Biology of T-cell Acute Lymphoblastic Leukemia - €10,000.00
n.a.
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação Calouste Gulbenkian
Concluído
|
| 2005 - 2008 | The Role of Microenvironmental Factors in Leukemogenesis: Biological Implications of Interleukin-7 Signaling and Potential
for the Development of Novel Therapeutic Strategies - €30,000.00
n.a.
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Associação Portuguesa Contra a Leucecmia
Concluído
|
| 2005 - 2008 | The role of IL-7 in the homeostatic regulation of CD4+ T lymphocyte populations in humans
POCI/BIA-BCM/61079
Investigador
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
| 2001 - 2004 | TARGETING SIGNALING PATHWAYS AS THERAPY FOR HUMAN CANCER
POCTI/CBO/34914
Investigador
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
Projeto
| Designação | Financiadores | |
|---|---|---|
| 2019 - 2021 | Explore the role of CHK1 and the importance of CHK1 targeted therapy in AML - €10,000.00
n.a.
Co-Investigador Responsável (Co-IR)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Concluído
|
Outro
| Designação | Financiadores | |
|---|---|---|
| 2024/03/01 - Atual | Interleukin-7 receptor-mediated regulation of lipid metabolism as a potential target for therapeutic intervention in acute
lymphoblastic leukemia - €40,000.00
Grant 21717
Investigador responsável
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
Gilead Grants Program
Em curso
|
Produções
Publicações
| Artigo em conferência |
|
| Artigo em revista |
|
| Capítulo de livro |
|
| Recurso online |
|
Propriedade Intelectual
| Patente |
|
Atividades
Apresentação oral de trabalho
| Título da apresentação | Nome do evento Anfitrião (Local do evento) |
|
|---|---|---|
| 2024/03/22 | “Da investigação fundamental à geração de novas armas terapêuticas contra a leucemia linfoblástica aguda? [From fundamental research to the generation of new therapeutic tools against acute lymphoblastic leukemia?]”, CAML (Centro Académico de Medicina de Lisboa) Sessions - What’s new in CAML, Faculdade de Medicina, Universidade de Lisboa, 22 Março (Host: Prof. João Lacerda). This talk was given together with Rita Fragoso and Mafalda Duque, from João T. Barata’s lab. | CAML (Centro Académico de Medicina de Lisboa) Sessions - What’s new in CAML
Faculdade de Medicina, Universidade de Lisboa (Lisbon, Portugal)
|
| 2023/09/25 | “MicroRNA-Regulated Gene Therapy Cell Death-inducing System for T-ALL”, T-ALL Biology Special Interest Group, ALLTogether Consortium Annual General Meeting, University of Strathclyde Technology and Innovation Centre, Glasgow, UK, 25-27 September. | ALLTogether Consortium Annual General Meeting
University of Strathclyde Technology and Innovation Centre (Glasgow, Reino Unido)
|
| 2023/05/05 | Lecture on IL-7 in immunodeficiency and in leucemia (“Entre imunodeficiência e leucemia: as duas faces da IL-7 e do seu receptor”) | Immunology Course directed by Prof. Ana C. Sousa for undergraduate students
University of Évora (Évora, Portugal)
|
| 2023/04/20 | JT Barata participated in the round table on job perspectives for early carreer biomedical graduates [“Saídas profissionais para os estudantes da ESDH - desafios para os próximos anos”] (together with Dr. Vítor Pataco, President of Instituto Português do Desporto e Juventude, and Dra Cristina Rubianes Vieira, Presidente of Associação Portuguesa de Psicomotricidade). DIA DA ESCOLA DE SAÚDE E DESENVOLVIMENTO HUMANO, University of Évora, Portugal, 20 April. | Saídas profissionais para os estudantes da ESDH - desafios para os próximos anos
University of Évora (Évora, Portugal)
|
| 2023/03/30 | “ Gone rogue: IL7R in acute lymphoblastic leukemia”, Institute of cellular and molecular radiobiology (IRCM), French Alternative Energies and Atomic Energy Commission (CEA), Fontenais-aux-Roses, Paris, France, 30 March. (Host: Dr. Françoise Pflumio) |
Institute of cellular and molecular radiobiology (IRCM), French Alternative Energies and Atomic Energy Commission (CEA) (Paris, França)
|
| 2023/03/25 | “Twists and turns of immune cells: Lymphoid leukemia and anti-leukemia immunotherapies” | Curso de Imunologia e Imunoterapia [Immunology and Immunotherapy course]
SPFCS - Sociedade Portuguesa dos Farmacêuticos dos Cuidados da Saúde (Tomar, Portugal)
|
| 2023/02/14 | Signaling in Cancer | 24th JORTEC – Jornadas Tecnológicas, NOVA School of Sciences and Technology |
| 2023/02/14 | “Signaling in Cancer”, 24th JORTEC – Jornadas Tecnológicas, NOVA School of Sciences and Technology, Caparica, 14 February. | Jornadas Tecnológicas
NOVA School of Sciences and Technology (Lisboa, Portugal)
|
| 2023 | Sphingosine Kinases are essential positive modulators of IL7/IL-7R signaling in Acute Lymphoblastic Leukemia. M.B. Fernandes, A. Melão, T. Araújo, A. Cachucho, D.R. Adams, J. Oh, A.R.M. Almeida, F. Torta, V. Barreto, S. Pyne, T. Hla, N.J. Pyne, J.T. Barata (2023). | YoungEHA Research Meeting, European Hematology Association 2023 Hybrid Congress
European Hematology Association (Frankfurt, Alemanha)
|
| 2023 | Dependence of IL-7R-mediated signaling on sphingosine kinase activity in acute lymphoblastic leukemia, but not healthy lymphoid cells, is an exploitable therapeutic vulnerability. M.B. Fernandes, A. Melão, T. Araújo, A. Cachucho, D.R. Adams, J. Oh, A.R.M. Almeida, F. Torta, V. Barreto, S. Pyne, T. Hla, N.J. Pyne, J.T. Barata (2023). (Work was highlighted in the “Best of ASH 2023”) | The American Society of Hematology 65th Annual Meeting
American Society of Hematology (San Diego, Estados Unidos)
|
| 2023 | Characterizing the risk for IL-7R-mediated malignancy in different stages of hematopoietic development. A. Cachucho, J. Ronchi, P. Amaral, T. Araújo, M.B. Fernandes, M. Euzébio, J.L. Neto, C. Veludo, V. Martins, A.R.M. Almeida, A. Yunes, J.T. Barata (2023). Poster Presentation. | XLVIII Annual Meeting of the Portuguese Society for Immunology
Portuguese Society for Immunology (Aveiro, Portugal)
|
| 2023 | Histone deacetylase inhibition abrogates IL-7R-mediated signaling by downregulating IL7R and preventing mTORC1 activation. J. Fontela, M. Oliveira, I. Alcobia, T. Serafim, A.R. Grosso, J.T. Barata (2023). (Poster Presentation). | XLVIII Annual Meeting of the Portuguese Society for Immunology
Portuguese Society for Immunology (Aveiro, Portugal)
|
| 2023 | Sphingosine Kinases are essential positive modulators of IL7/IL-7R signaling in Acute Lymphoblastic Leukemia. M.B. Fernandes, A. Melão, T. Araújo, A. Cachucho, D.R. Adams, J. Oh, A.R.M. Almeida, F. Torta, V. Barreto, S. Pyne, T. Hla, N.J. Pyne, Barata JT (2023). (Poster Presentation) | 3rd Translational Research Conference: Acute Lymphoblastic Leukaemia
(Berlin, Alemanha)
|
| 2023 | Development of anti-IL-7Ra antibodies as a targeted therapy for T-cell Acute Lymphoblastic Leukemia. M. Duque, J. Santos, S. Andrade, D. Teixeira, M. Pajuelo, A. Parada, R. Fragoso, Barata JT (2023). (Poster Presentation). | 3rd Translational Research Conference: Acute Lymphoblastic Leukaemia
(Berlin, Alemanha)
|
| 2023 | Development of a gene therapy cell death-inducing system regulated by microRNAs for T-cell Acute Lymphoblastic Leukemia. M. Duque, J. Silva, J.T. Barata, R. Fragoso (2023). (Poster Presentation) | European Hematology Association 2023 Hybrid Congress
European Hematology Association (Frankfurt, Alemanha)
|
| 2023 | Development of anti-IL-7Ra antibodies as a targeted therapy for T-cell Acute Lymphoblastic Leukemia. M. Duque, J. Santos, S. Andrade, D. Teixeira, M. Pajuelo, A. Parada, R. Fragoso, Barata JT (2023). (Poster Presentation). | European Hematology Association 2023 Hybrid Congress
European Hematology Association (Frankfurt, Alemanha)
|
| 2023 | Development of a gene therapy cell death-inducing system regulated by microRNAs for cancer. M. Duque, J. Silva, J.T. Barata, R. Fragoso (2023). (Poster Presentation) | ESGCT 30th ANNUAL CONGRESS
(Brussels, Bélgica)
|
| 2023 | Sphingosine Kinases are essential positive modulators of IL7/IL-7R signaling in Acute Lymphoblastic Leukemia. M.B. Fernandes, A. Melão, T. Araújo, A. Cachucho, D.R. Adams, J. Oh, A.R.M. Almeida, F. Torta, V. Barreto, S. Pyne, T. Hla, N.J. Pyne, Barata JT (2023). (Poster Presentation). | 3rd Translational Research Conference: Acute Lymphoblastic Leukaemia
(Frankfurt, Alemanha)
|
| 2022/12/05 | Gone wild: IL-7 and IL-7R in T-cell leukemia | European Federation of Immunological Societies (Study Group T-cell Connect Europe) Online Immunology Lecture series |
| 2022/12/05 | “Gone wild: IL-7 and IL-7R in T-cell leukemia”, European Federation of Immunological Societies (Study Group T-cell Connect Europe) Online Immunology Lecture series, 5 December (Online meeting). | European Federation of Immunological Societies (Study Group T-cell Connect Europe) Online Immunology Lecture series
Study Group T-cell Connect Europe
|
| 2022/11/15 | UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease. E. Paisana, R. Cascão, C. Custódia, N. Qin, D. Picard, D. Pauck, T. Carvalho, P. Ruivo, C. Barreto, P. Pereira, R. Roque, D. Doutel, J. Cabeçadas, J. Pimentel, J. Miguéns, M. Remke, J.T. Barata, C.C. Faria (2022). | 6ª Conferência Anual da redeSAÚDE – Perspetivas Multidisciplinares e Saúde Global na Ulisboa
Universidade de Lisboa (Lisbon, Portugal)
|
| 2022/11/15 | “The role of HoxA9 in IL7R-mediated B-Cell Leukemogenesis”. S. Gama, M. Duque, J.T. Barata (2022). | 6ª Conferência Anual da redeSAÚDE – Perspetivas Multidisciplinares e Saúde Global na ULisboa. Lisboa
Universidade de Lisboa (Lisbon, Portugal)
|
| 2022/11/15 | Histone deacetylase inhibitors as therapeutic candidates against IL-7-responsive acute lymphoblastic leukemia. J. Fontela, M. Oliveira, J.T. Barata (2022). | 6ª Conferência Anual da redeSAÚDE – Perspetivas Multidisciplinares e Saúde Global na ULisboa. Lisboa
Universidade de Lisboa (Lisboa, Portugal)
|
| 2022/11/15 | Crosstalk between the Circadian Molecular Clock and the CK2-PI3K signaling axis in T-ALL. P.M. Amaral, C. Gonçalves Dias, B.A. Cardoso, J.T. Barata (2022). | 6ª Conferência Anual da redeSAÚDE – Perspetivas Multidisciplinares e Saúde Global na ULisboa.
Universidade de Lisboa (Lisboa, Portugal)
|
| 2022/10/04 | Interleukin-7 receptor-mediated signaling can trigger acute lymphoblastic leukemia | 63rd Advances in Biological Regulation Symposium
University of Bologna (Itália)
|
| 2022/10/04 | “Interleukin-7 receptor-mediated signaling can trigger acute lymphoblastic leukemia”, 63rd Advances in Biological Regulation Symposium, University of Bologna, Italy, 4 – 5 October. (Other speakers: Vytas Baikantis, Sarah Spiegel) | 63rd Advances in Biological Regulation Symposium
University of Bologna (Bologna, Itália)
|
| 2022/07/18 | IL-7R signaling in the genesis and potential treatment of acute lymphoblastic leukemia | AFFIMED |
| 2022/07/18 | “IL-7R signaling in the genesis and potential treatment of acute lymphoblastic leukemia”, AFFIMED, 18 July (online). (Host: Dr. Jan C. Schmollinger) | AFFIMED
Dr. Jan C. Schmollinger (Online, Alemanha)
|
| 2022/05/18 | “Cancer - Successes and Challenges”, Plenary Session 6, Encontro Ciência ’22 - Encontro com a Ciência e Tecnologia em Portugal [Science Meeting ’22], Lisboa, 18 May. | Encontro Ciência ’22 - Encontro com a Ciência e Tecnologia em Portugal
(Portugal)
|
| 2022/04/04 | “A view on how the Terry Fox award impacted our research”, VII Jornadas de Investigação em Oncologia – 25 Anos de Bolsas Terry Fox [VII Research in Oncology Meeting - 25 Years of Terry Fox Awards], Lisboa, 4 April. | VII Jornadas de Investigação em Oncologia – 25 Anos de Bolsas Terry Fox [VII Research in Oncology Meeting - 25 Years of Terry
Fox Awards]
Liga Portuguesa Contra o Cancro (Lisbon, Portugal)
|
| 2022/03/26 | “Twists and turns of immune cells: Lymphoid leukemia and anti-leukemia immunotherapies” | Curso de Imunologia e Imunoterapia [Immunology and Immunotherapy course]
SPFCS - Sociedade Portuguesa dos Farmacêuticos dos Cuidados da Saúde (Tomar, Portugal)
|
| 2022/03/04 | Gone wild: IL-7 and its receptor in leukemia development | 8th MCBiology Symposium |
| 2022/03/04 | “Gone wild: IL-7 and its receptor in leukemia development”, 8th MCBiology Symposium, 4 March (Online meeting). | 8th MCBiology Symposium
(Online, Portugal)
|
| 2022/03/02 | JT Barata participated in the session / roundtable “Tratar o cancro por tu - 4ª conferência: linfomas e leucemias [Conference on cancer for lay people: lymphomas and leukemias]”, together with Profs. Maria Gomes da Silva, Manuel Abecasis, José Carlos Machado and Manuel Sobrinho-Simões, Câmara Municipal de Lisboa [Lisbon City Hall], Portugal, 2 March. This session was broadcast by the national radio station Antena 1 to a general audience. | Conference on cancer for lay people: lymphomas and leukemias
Antena 1 (Lisbon, Portugal)
|
| 2022 | Patient-derived models of brain metastases are useful tools for preclinical evaluation of anticancer therapies. R. Cascão, C. Custódia, E. Paisana, I. Cortes-Ciriano, J.T. Barata, C.C. Faria (2022). (Poster Presentation). | Innovative cancer Science - EACR
EACR (Seville, Espanha)
|
| 2022 | UBE2C-driven leptomeningeal dissemination can be abrogated by targeting the PI3K-mTOR pathway in patients with brain metastases. E. Paisana, R. Cascão, C. Custódia, N. Qin, D. Picard, D. Pauck, T. Carvalho, P. Ruivo, C. Barreto, P. Pereira, R. Roque, D. Doutel, J. Cabeçadas, J. Pimentel, J. Miguéns, M. Remke, J.T. Barata, C.C. Faria (2022). (Poster Presentation). | 2022 Annual Conference on CNS Clinical Trials & Brain Metastases
SNO and ASCO (Toronto, Canadá)
|
| 2021/10/14 | “IL-7R signaling as a therapeutic target in acute lymphoblastic leukemia?”, II ASPIC-ASEICA International Meeting – Current Trends in Precision Medicine in Cancer, 14-15 October (online meeting). (Other speakers: Maria S. Soengas, Michael Weller, Gabri van der Pluijm, An Hendrix, Aleix Prat) | II ASPIC-ASEICA International Meeting – Current Trends in Precision Medicine in Cancer
ASPIC-ASEICA
|
| 2021/10 | “IL-7R signaling as a therapeutic target in acute lymphoblastic leukemia?” | II ASPIC-ASEICA International Meeting – Current Trends in Precision Medicine in Cancer (online meeting) |
| 2021/08/19 | Ubiquitin Conjugating Enzymes promote leptomeningeal dissemination and decrease survival in patients with brain metastatic disease. E. Paisana, R. Cascão, C. Custódia, N. Qin, D. Picard, D. Pauck, T. Carvalho, P. Ruivo, P. Pereira, R. Roque, J. Pimentel, M. Remke, J. Miguéns, J.T. Barata, C.C. Faria (Poster presentation) | SNO 3rd Annual Conference on Brain Metastases (international virtual meeting) |
| 2021/08/19 | Ubiquitin Conjugating Enzymes promote leptomeningeal dissemination and decrease survival in patients with brain metastatic disease. E. Paisana, R. Cascão, C. Custódia, N. Qin, D. Picard, D. Pauck, T. Carvalho, P. Ruivo, P. Pereira, R. Roque, J. Pimentel, M. Remke, J. Miguéns, J.T. Barata, C.C. Faria (Poster presentation) | Third Annual Conference on Brain Metastases, Virtual Conference, Toronto, Canada |
| 2021/07/08 | Bridging – A integração da investigação básica na investigação clínica em Oncologia [Bridging – Integrating basic research into Clinical research in Oncology] | 3ª Edição do Curso de Investigação em Oncologia [3rd Edition of the Course on Research in Oncology]
Núcleo de Internos e Jovens Especialistas da SPO [Group of Interns and Young Specialists of the Portuguese Society of Oncology] (Online Course)
|
| 2021/06/09 | IL7R mutational activation can initiate Ph-Like and Pax5 P80R precursor B-cell acute lymphoblastic leukemia. A. Almeida, J.L. Neto, A. Cachucho, M. Euzébio, X. Meng, R. Kim, M.B. Fernandes, B. Raposo, M.L. Oliveira, D. Ribeiro, R. Fragoso, P.P. Zenatti, T. Soares, M.R. de Matos, J. Ronchi Corrêa, M. Duque, K.G. Roberts, Z. Gu, C. Qu, S. Pyne, N.J. Pyne, V.M. Barreto, I. Bernard-Pierrot, E. Clappier, C.G. Mullighan, A.R. Grosso, J.A. Yunes, J.T. Barata | EHA 2021 - Online meeting of the European Hematology Association |
| 2021/06/09 | Checkpoint kinase 1 is overexpressed, by post-transcriptional regulation, in immature and monoblastic / monocytic acute myeloid leukemia. L.M. Sarmento, S.G. Pereira, F. Costa, A. Monteiro, J. Caldas, P. Ribeiro, J.T. Barata (Poster presentation) | EHA 2021 - Online meeting of the European Hematology Association |
| 2021/06/09 | The Role of Ubiquitin Conjugating Enzymes in Brain Metastases. E. Paisana, R. Cascão, C. Custódia, N. Qin, D. Picard, P. Pereira, R. Roque, J. Pimentel, M. Remke, J. Miguéns, J.T. Barata, C.C. Faria (Poster presentation) | EACR 2021 Congress, Innovative Cancer Science: Better Outcomes through Research, Virtual Conference |
| 2021/05/20 | Ubiquitin Conjugating Enzymes promote aggressive metastatic brain disease and decrease patients’ survival E. Paisana, R. Cascão, C. Custódia, N. Qin, D. Picard, T. Carvalho, P. Ruivo, P. Pereira, R. Roque, J. Pimentel, M. Remke, J. Miguéns, J.T. Barata, Cláudia C. Faria | 27th Porto Cancer Meeting – Stemness and metastasis: advances in research and clinical translation |
| 2021/05/20 | Diving into the dark side of IL-7 and IL-7R and their contribution to lymphoid leukemia development | XLVI Annual Meeting of The Portuguese Society of Immunology (SPI), 20-21 May (Online meeting). |
| 2021/05/20 | “Diving into the dark side of IL-7 and IL-7R and their contribution to lymphoid leukemia development”, XLVI Annual Meeting of The Portuguese Society of Immunology (SPI), 20-21 May (Online meeting). | XLVI Annual Meeting of The Portuguese Society of Immunology (SPI)
Portuguese Society of Immunology
|
| 2021/05/15 | Signal Transduction and Cancer: IL-7 and leukemia | XI Jornadas Nacionais de Ciências Biomédicas [XI National Meeting of Biomedical Sciences] (Online meeting). |
| 2021/05/15 | “Signal Transduction and Cancer: IL-7 and leukemia”, XI Jornadas Nacionais de Ciências Biomédicas [XI National Meeting of Biomedical Sciences], 15 May (Online meeting). | XI Jornadas Nacionais de Ciências Biomédicas [XI National Meeting of Biomedical Sciences] |
| 2021/05/07 | IL7R gain-of-function mutation is sufficient to initiate B-cell acute lymphoblastic leukemia in vivo with features of PAX5 P80R and Ph-like ALL. A. Almeida, J.L. Neto, A. Cachucho, M. Euzébio, X. Meng, R. Kim, M.B. Fernandes, B. Raposo, M.L. Oliveira, D. Ribeiro, R. Fragoso, P.P. Zenatti, T. Soares, M.R. de Matos, J. Ronchi Corrêa, M. Duque, K.G. Roberts, Z. Gu, C. Qu, S. Pyne, N.J. Pyne, V.M. Barreto, I. Bernard-Pierrot, E. Clappier, C.G. Mullighan, A.R. Grosso, J.A. Yunes, J.T. Barata (2021). | European School of Hematology (ESH) Translational Research E-Conference ACUTE LYMPHOBLASTIC LEUKAEMIA |
| 2021/05 | “Diving into the dark side of IL-7 and IL-7R and their contribution to lymphoid leukemia development” | XLVI Annual Meeting of The Portuguese Society of Immunology (SPI), 20-21 May (Online meeting).
(Online, Portugal)
|
| 2021/05 | “Signal Transduction and Cancer: IL-7 and leukemia”, XI Jornadas Nacionais de Ciências Biomédicas [XI National Meeting of Biomedical Sciences], 15 May (Online meeting). | XI Jornadas Nacionais de Ciências Biomédicas [XI National Meeting of Biomedical Sciences] (Online meeting).
(Online, Portugal)
|
| 2020/03 | High IL-7- IL-7Ra signals promote T-cell acute lymphoblastic leukemia in mice and humans overexpressing wild type IL-7Ra. A. Almeida, A. Silva, S. Demeyer, A. Cachucho, T. Hogan, J. Meijerink, J. Cools, A.R. Grosso, B. Seddon*, J. T. Barata*. | EACR-AACR Basic and Translational Research Conference in partnership with ASPIC: Tumor Microevironment
EACR - European Association for Cancer Research; AACR - American Association for Cancer Research; ASPIC - Associação Portuguesa
de Investigação em Cancro (Lisbon, Portugal)
|
| 2020 | Sphingosine Kinases are key effectors of IL-7-mediated leukemia expansion. M. Fernandes, A. Melão, A. Almeida, S. Pyne, N.J. Pyne, J.T. Barata* (Poster presentation) | EACR-AACR Basic and Translational Research Conference in partnership with ASPIC: Tumor Microevironment
(Lisbon, Portugal)
|
| 2019/10/19 | Overexpression of wild type IL-7Ra promotes T-cell acute lymphoblastic leukemia/lymphoma. A. Silva, A. Almeida, M. Matos, S. Demeyer, A. Cachucho, T. Hogan, Y. Li, J. Meijerink, J. Cools, A.R. Grosso, B. Seddon* and J.T. Barata* | Xth SINAL meeting on Signal Transduction
SINAL - Signal Transduction Network (Olhão, Portugal)
|
| 2019/05 | Overexpression of wild type IL-7Ra promotes T-cell acute lymphoblastic leukemia/lymphoma. A. Silva, A. Almeida, M. Matos, S. Demeyer, A. Cachucho, T. Hogan, Y. Li, J. Meijerink, J. Cools, A.R. Grosso, B. Seddon* and J.T. Barata* | SPI 45 - 45th Annual Meeting of the Portuguese Society of Immunology
SPI - Sociedade Portuguesa de Imunologia (Coimbra, Portugal)
|
| 2019/05 | Sphingosine Kinases are key effectors of IL-7R-mediated signaling, viability, growth and proliferation in T-cell Acute Lymphoblastic Leukemia. M.B. Fernandes, A. Melão, J. Matos, H. Cadilha, S. Pyne, N.J. Pyne, J.T. Barata* - Best Oral Communication | Sphingolipids in Health and Disease FEBS/SLC/iCC
Federation of European Biochemical Societies (Cascais, Portugal)
|
| 2019 | “Development of IL-7R blocking antibodies to treat T-ALL”, Session on Research, Joint iBFM Resistant Disease Committee and IntReALL 2010-2020 study group Interim Meeting, Nice, France, 15-16 November. (Other speakers: Andreas Kulozik, Pablo Menendez, Pieter Van Vlierberghe) | Joint iBFM Resistant Disease Committee and IntReALL 2010-2020 study group Interim Meeting
(Nice, França)
|
| 2019 | “IL-7R and PTEN in T-ALL”, European School of Haematology INTERNATIONAL CONFERENCE ON ACUTE LYMPHOBLASTIC LEUKAEMIA, Berlin, Germany, 17-19 May. (Other speakers: Charles Mullighan, Tariq Enver, Jean-Pierre Bourquin, Hervé Dombret) | European School of Haematology INTERNATIONAL CONFERENCE ON ACUTE LYMPHOBLASTIC LEUKAEMIA
(Berlin, Alemanha)
|
| 2019 | Participation in the round table on Cuidados de Sáude – Perspectivando o Futuro [Health Care – Picturing the Future], discussing the talks of Faustino Ferreira, Adalberto Campos Fernandes, Carlos Alberto Ferreira, Manuel Sobrinho Simões, José Santos-Victor, Henrique Bicha Castelo, Catarina Oliveira and Alexandre Castro Caldas, 25th Anniversary of Hospital SAMS, Lisbon, 9 November. | Round table on Cuidados de Sáude – Perspectivando o Futuro [Health Care – Picturing the Future]
(Lisbon, Portugal)
|
| 2019 | “Acute lymphoblastic leukemia: can basic science contribute to novel therapeutic solutions?” ASPIC CONFERENCE - Research on Pediatric Cancer: Where are we? Where are we going?, Calouste Gulbenkian Foundation, Lisbon, Portugal, 8 November. | ASPIC CONFERENCE - Research on Pediatric Cancer: Where are we? Where are we going?
(Lisbon, Portugal)
|
| 2019 | Plenary Talk “IL-7 and IL-7R: signals impacting on leukemia development”, SINAL 2019 - Xth meeting on Signal Transduction, Olhão, Portugal, 18-19 October. | SINAL 2019 - Xth meeting on Signal Transduction
(Olhão, Portugal)
|
| 2019 | Participation in the round table “PhD? Check!; Post-Doc? Check! What's next? - Canonical and Non-canonical Research”, iMM PostDoc Day - Instituto de Medicina Molecular João Lobo Antunes. 25 February. | iMM PostDoc Day
Instituto de Medicina Molecular João Lobo Antunes (Lisbon, Portugal)
|
| 2019 | “Signals from the outside, signals from within: searching for new biological insights with therapeutic potential in T-cell leukemia”, CRIG - Center for Medical Genetics, University of Ghent, Belgium, 18 September. (Host: Prof. Frank Speleman) |
CRIG - Center for Medical Genetics, University of Ghent, Belgium, 18 September. (Host: Prof. Frank Speleman) (Ghent, Bélgica)
|
| 2019 | “The ins and outs of IL-7R-mediated signaling in leukemia”, CIC - Centro de Investigación del Cáncer, University of Salamanca, Spain, 21 March. (Host: Prof. Xosé Bustelo) |
CIC - Centro de Investigación del Cáncer, University of Salamanca, Spain, 21 March. (Host: Prof. Xosé Bustelo) (Salamanca, Espanha)
|
| 2019 | “Cell-autonomous and extracellular signaling cues in leukemia development: new targets for therapeutic intervention”, Jinan University, Guangzhou, Guangdong, China, 12 January. (Host: Prof. Zhinan Yin) |
Jinan University, Guangzhou, Guangdong, China, 12 January. (Host: Prof. Zhinan Yin) (Guangzhou, China)
|
| 2019 | “Interleukin 7 and its receptor in leukemia: from basic biology to possible new therapeutics”, CICECO, Universidade de Aveiro, 16 October (Hosts: Drs. Ana C. Sousa and Mara Freire). |
CICECO, Universidade de Aveiro, 16 October (Hosts: Drs. Ana C. Sousa and Mara Freire). (Aveiro, Portugal)
|
| 2019 | Sphingosine Kinases are key effectors of IL-7R-mediated signaling, viability, growth and proliferation in T-cell Acute Lymphoblastic Leukemia. M.B. Fernandes, A. Melão, J. Matos, H. Cadilha, S. Pyne, N.J. Pyne, J.T. Barata* (Poster presentation) | Xth SINAL meeting on Signal Transduction
(Olhão, Portugal)
|
| 2019 | Overexpression of wild type IL-7Ra promotes T-cell acute lymphoblastic leukemia/lymphoma. A. Silva, A. Almeida, M. Matos, S. Demeyer, A. Cachucho, T. Hogan, Y. Li, J. Meijerink, J. Cools, A.R. Grosso, B. Seddon* and J.T. Barata* (Poster presentation) | ESID 2019 Focused Meeting - Immunodeficiencies with increased risk of cancer
(Brussels, Bélgica)
|
| 2019 | IL-7 either promotes or inhibits autophagy, depending on the stress context, to promote the viability of T-cell acute lymphoblastic leukemia cells. D. Ribeiro, I. Lopes, M. Abreu, C. Custódia, J.T. Barata* (Poster presentation) | 6th meeting of the International Society of Cancer Metabolism (ISCaM)
(Braga, Portugal)
|
| 2019 | The role of ubiquitin conjugating enzymes in brain metastases. E. Paisana, R. Cascão, C. Custódia, N. Qin, D. Picard, T. Carvalho, P. Pereira, R. Roque, J. Pimentel, M. Remke, J. Miguéns, J.T. Barata, C.C. Faria. (Poster presentation) | EACR Cancer Genomics
(Cambridge, Reino Unido)
|
| 2019 | Nrarp Displays Either Pro- or Anti-Tumoral Roles in T-Cell Acute Lymphoblastic Leukemia Depending on Notch and Wnt Signaling. M. Duque, I. Pinto, J. Gonçalves, P. Akkapeddi, M. Oliveira, R. Cabrita, A. Yunes, S. Durum, J.T. Barata, R. Fragoso (Poster presentation) | 1st ESH International Conference on Acute Lymphoblastic Leukaemia
(Berlin, Alemanha)
|
| 2019 | Preliminary characterization of IL-7/IL-7R phospho-signaling landscape. . Fragoso, M. Matos, A.R. Grosso, J.T. Barata* (Poster presentation) | 1st ESH International Conference on Acute Lymphoblastic Leukaemia
(Berlin, Alemanha)
|
| 2019 | CASZ1 is overexpressed in T-cell acute lymphoblastic leukemia and promotes cell transformation via PI3K-Akt-mTOR signaling. B.A. Cardoso, A. Gírio, R. Fragoso, L.R. Martins, A.S. Moreira, N.C. Correia, A. Bortolini, A.R. Grosso, S.F. de Almeida, J. Andres Yunes, F. Pflumio, J.T. Barata* (Poster presentation) | 1st ESH International Conference on Acute Lymphoblastic Leukaemia
(Berlin, Alemanha)
|
| 2019 | Exploring new facets of interleukin-7 receptor-mediated signaling in T-cell leukemia. A.S. Ramalho, J. Ferreira da Silva, F. Perez, J.T. Barata* (Poster presentation) | 10th AIMS Meeting
(Lisbon, Portugal)
|
| 2019 | The role of ubiquitin conjugating enzymes in brain metástases. E. Paisana, R. Cascão, C. Custódia, N. Qin, D. Picard, T. Carvalho, P. Pereira, R. Roque, J. Pimentel, M. Remke, J. Miguéns, J.T. Barata and C.C. Faria (Poster presentation) | XI Congresso Nacional da Associação Portuguesa de Neuro-Oncologia [XI National Congress of the Portuguese Association of Neuro-Oncology]
(Lisbon, Portugal)
|
| 2018/12 | IL-7 Activates a STAT5/PIM1 axis to Promote T-cell Acute Lymphoblastic Leukemia Proliferation and Viability in a Bcl-2-Independent Manner. D. Ribeiro, A. Melão, R. van Boxtel, C.I. Santos, A. Silva, M.C. Silva, B.A. Cardoso, P.J. Coffer, J.T. Barata* | The American Society of Hematology 60th Annual Meeting.
ASH - American Society of Hematology (San Diego, Estados Unidos)
|
| 2018/11 | O valor prognóstico da sobre-expressão de nucleolina em neoplasias hematológicas [The prognostic value of nucleolin overexpression in hematological neoplasias]. M.I. Pereira, A.B. Sarmento-Ribeiro, L. Ribeiro, J.T. Barata, J.-N. Moreira | Annual Meeting of the Portuguese Society of Hematology
SPH - Sociedade Portuguesa de Hematologia (Vilamoura, Portugal)
|
| 2018/09 | A phage display-generated fully human anti-IL-7Ra antibody shows anti-tumor activity against T-cell acute lymphoblastic leukemia. P. Akkapeddi, R. Fragoso, J. Hixon, S. Ramalho, M. Oliveira, T. Carvalho, A. Gloger, M. Matasci, F. Corzana, S.K. Durum, D. Neri, G.J.L. Bernardes*, J.T. Barata* | SINAL 2018 – 9th Meeting on Signal Transduction
SINAL - Signal Transduction Network (Lisboa, Portugal)
|
| 2018/09 | IL-7 Activates a STAT5/PIM1 axis to Promote T-cell Acute Lymphoblastic Leukemia Proliferation and Viability in a Bcl-2-Independent Manner. D. Ribeiro, A. Melão, R. van Boxtel, C.I. Santos, A. Silva, M.C. Silva, B.A. Cardoso, P.J. Coffer, J.T. Barata* | SINAL 2018 – 9th Meeting on Signal Transduction
SINAL - Signal Transduction Network (Li, Portugal)
|
| 2018/06 | Mutant IL-7 receptor cooperates with Myc and activated Notch to accelerate T-cell leukemogenesis in zebrafish. M.L. Oliveira, E.G. Garcia, D.M. Langenau*, J.T. Barata* | 13th International Zebrafish Conference
IZFS - International Zebrafish Society (Madison, Wisconsin, Estados Unidos)
|
| 2018/05 | CASZ1 is overexpressed in T-cell acute lymphoblastic leukemia and promotes cell transformation and tumor growth via PI3K-mTOR. B.A. Cardoso, A. Gírio, R.Fragoso, L.R. Martins, A.S. Moreira, N.C. Correia, A. Bortolini, A.R. Grosso, S.F. Almeida, J.A. Yunes, F. Pflumio, J.T. Barata* - Best Oral Communication | 3rd ASPIC International Congress
ASPIC - Associação Portuguesa de Investigação em Cancro (Lisboa, Portugal)
|
| 2018/05 | Patient-derived xenograft models of brain metastases for translational medicine. C.C. Faria, C. Custódia, E. Paisana, R. Cascão, J.T. Barata * | 3rd ASPIC International Congress
ASPIC - Associação Portuguesa de Investigação em Cancro (Lisbon, Portugal)
|
| 2018 | “IL-7R and leukemia”, Symposia on Tumour Biology: from basic biology to disease, Lisboa, 5-6 December. (Other speakers: Rong Li, Eric Sahai, Kari Alitalo, Giorgio Scita) | Symposia on Tumour Biology: from basic biology to disease,
(Lisb, Portugal)
|
| 2018 | “IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update”, Advances in Biological Regulation – 59th International Symposium on “Biological Regulation and Enzyme Activity in Normal and Neoplastic Tissues”, University of Bologna, Italy, 1-2 October. (Other speakers: Alex Toker, John York, Vytas Bankaitis, Adam Mead, Carlo Croce) | Advances in Biological Regulation – 59th International Symposium on “Biological Regulation and Enzyme Activity in Normal and
Neoplastic Tissues
(Bologna, Itália)
|
| 2018 | “João Barata’s Lab - Signaling in Cancer”, iMM Summit - Building partnerships between research and industry, 16-17 November. | iMM Summit - Building partnerships between research and industry
Instituto de Medicina Molecular João Lobo Antunes (Lisbon, Portugal)
|
| 2018 | “Good gone bad: IL-7 and IL-7R in leukemia” (Plenary talk), IV Postgrad Symposium in Biomedicine, IBIMED, University of Aveiro, 5 July. | V Postgrad Symposium in Biomedicine, IBIMED
Universidade de Aveiro (Aveiro, Portugal)
|
| 2018 | “Explorar os mecanismos básicos da leucemia para revelar novas estratégias de tratamento [Exploring the basic mechanisms of leukemia to reveal new treatment strategies]”, IX Jornadas Nacionais de Ciências Biomédicas [IX National Meeting of Biomedical Sciences], University of Algarve, Faro, 20 April. | IX Jornadas Nacionais de Ciências Biomédicas [IX National Meeting of Biomedical Sciences]
Universidade do Algarve (Faro, Portugal)
|
| 2018 | “The consequences of not being good whiskey: IL-7 in leukemogenesis”, Institut Pasteur, Paris, France, 11 Setembro. (Host: Dr. Paulo Vieira) |
Institut Pasteur, Paris, France, 11 Setembro. (Host: Dr. Paulo Vieira) (Paris, França)
|
| 2018 | “Good gone rogue: IL-7 and IL-7R in lymphoid leukemia”, Institut Curie, Paris, France, 10 September. (Host: Dr. François Radvanyi) |
Institut Curie, Paris, France, 10 September. (Host: Dr. François Radvanyi) (Pais, França)
|
| 2018 | “The problem of not being good whiskey… IL-7 and IL-7R in T-cell leukemia”, Instituto Gulbenkian de Ciência, Oeiras, 16 November (Host: Dr. Vera Martins). |
Instituto Gulbenkian de Ciência, Oeiras, 16 November (Host: Dr. Vera Martins). (Oeiras, Portugal)
|
| 2018 | “IL-7R signaling and other stories: searching for molecular targets in T cell leukemia”, Fairjourney Biologics, Porto, 7 September (Host: Dr. Maria Pajuelo). |
Fairjourney Biologics, Porto, 7 September (Host: Dr. Maria Pajuelo). (Porto, Portugal)
|
| 2018 | “Gone rogue: IL-7 and IL-7R in leukemia”, CMBR Distinguished Seminars, Center for Biomedical Research, Universidade do Algarve, Faro, 3 July (Host: Prof. Ana-Teresa Maia). |
CMBR Distinguished Seminars, Center for Biomedical Research, Universidade do Algarve, Faro, 3 July (Host: Prof. Ana-Teresa
Maia). (Faro, Portugal)
|
| 2018 | “O papel da interleucina 7 e seu receptor em leucemia linfoblástica aguda: da ciência básica a possíveis terapias? [The role of interleukin 7 and its receptor in lymphoid leukemia: from basic science to possible therapies?]”, CAML (Centro Académico de Medicina de Lisboa) Sessions - What’s new in CAML, Faculdade de Medicina, Universidade de Lisboa, 22 Março (Host: Prof. João Lacerda). |
CAML (Centro Académico de Medicina de Lisboa) Sessions - What’s new in CAML, Faculdade de Medicina, Universidade de Lisboa,
22 Março (Host: Prof. João Lacerda). (Lisbon, Portugal)
|
| 2018 | “Cancer Biology - What have we learned?”, Novartis Course “ARE WE CLOSER TO CURE LEUKEMIA? FROM TARGET TO PERSONALIZED THERAPY.” Annual Meeting of the Portuguese Society of Hematology, Vilamoura, Portugal, 15-17 November. | Annual Meeting of the Portuguese Society of Hematology
(Vilamoura, Portugal)
|
| 2018 | “Signaling in Cancer”, Advanced Course on “Fundamentals of Genetics, Development and Neoplasia”, International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 23 October. | International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS)
(Braga, Portugal)
|
| 2018 | Does mutant interleukin-7 receptor-mediated signalling occur from intracellular compartments? A.S. Ramalho, J. Ferreira da Silva, F. Perez, J.T. Barata* (Poster presentation) | Symposia on Tumour Biology: from basic biology to disease
(lisbon, Portugal)
|
| 2018 | CASZ1 is overexpressed in T-cell acute lymphoblastic leukemia and promotes cell transformation and tumor growth via PI3K-mTOR signaling. B.A. Cardoso, A. Gírio, R.Fragoso, L.R. Martins, A.S. Moreira, N.C. Correia, A. Bortolini, A.R. Grosso, S.F. Almeida, J.A. Yunes, F. Pflumio, J.T. Barata* (Poster presentation) | Symposia on Tumour Biology: from basic biology to disease
(Lisbon, Portugal)
|
| 2018 | A phage display-generated fully human anti-IL-7Ra antibody shows anti-tumor activity against T-cell acute lymphoblastic leukemia. P. Akkapeddi, R. Fragoso, J. Hixon, S. Ramalho, M. Oliveira, T. Carvalho, A. Gloger, M. Matasci, F. Corzana, S.K. Durum, D. Neri, G.J.L. Bernardes*, J.T. Barata* (Poster presentation) | The American Society of Hematology 60th Annual Meeting
(San Diego, Estados Unidos)
|
| 2018 | IL-7 either promotes or inhibits autophagy, depending on the stress context, to promote the viability of T-cell acute lymphoblastic leukemia cells. D. Ribeiro, I. Lopes, M. Abreu, C. Custódia, J.T. Barata* (Poster presentation) | The American Society of Hematology 60th Annual Meeting
(San Diego, Estados Unidos)
|
| 2018 | Mutant IL-7 receptor cooperates with Myc and activated Notch to accelerate T-cell leukemogenesis in zebrafish. M.L. Oliveira, E.G. Garcia, D.M. Langenau*, J.T. Barata* (Poster presentation) | 3rd ASPIC International Congress
(Lisbon, Portugal)
|
| 2018 | Antibody based therapy for T-cell Acute Lymphoblastic Leukemia through Targeting IL-7 receptor. P. Akkapeddi, D. Neri, G. Bernardes*, J.T. Barata* (Poster presentation) | 3rd ASPIC International Congress
(Lisbon, Portugal)
|
| 2018 | STAT5 is Essential for IL-7-Mediated Viability, Growth and Proliferation of Human T-Cell Acute Lymphoblastic Leukemia Cells. D. Ribeiro, A. Melão, R. van Boxtel, C.I. Santos, A. Silva, M.C. Silva, B.A. Cardoso, P.J. Coffer, J.T. Barata* (Poster presentation) | 3rd ASPIC International Congress
(Lisbon, Portugal)
|
| 2018 | Dual role of NRARP in Notch and Wnt signaling differentially impacts T-cell acute lymphoblastic leukemia. M. Duque, I. Pinto, J. Gonçalves, P. Akkapeddi, M.L. Oliveira, T. Carvalho, R. Cabrita, J.A. Yunes, J.T. Barata, R. Fragoso (Poster presentation) | 3rd ASPIC International Congress
(Lisbon, Portugal)
|
| 2017/06 | Involvement of CASZ1 in T-cell acute lymphoblastic leukemia. R. Fragoso, A. Gírio, B.A. Cardoso, L.R. Martins, A. Bortolini, N.C. Correia, A.R. Grosso, J.A. Yunes, F. Pflumio, J.T. Barata* | Young EHA - Research Meeting on Molecular Aspects of Hematological Disorders
EHA - European Hematology Association (Madrid, Espanha)
|
| 2017/06 | CASZ1 is overexpressed in T-cell acute lymphoblastic leukemia and promotes cell transformation via MEK/Erk and PI3K signaling. A. Gírio, B.A. Cardoso, R. Fragoso, L.R. Martins, N.C. Correia, A.R. Grosso, A. Bortolini, J.A. Yunes, F. Pflumio, J.T. Barata* | SINAL 2017 – 8th Meeting on Signal Transduction
SINAL - Signal Transduction Network (Lisb, Portugal)
|
| 2017/06 | Regulation of NOTCH and WNT signaling pathways by NRARP in T-cell acute lymphoblastic leukemia. I. Pinto, M. Duque, M. Oliveira, R. Cabrita, J.T. Barata, R. Fragoso | SINAL 2017 – 8th Meeting on Signal Transduction
SINAL - Signal Transduction Network (Li, Portugal)
|
| 2017 | “Too much of a good thing: IL-7R-mediated signaling and T-cell leukemia”, GABBA Symposium: T lymphocyte activation, i3S, Porto, Portugal, 31 March. (Other speakers: Victor Tybulewicz, Antonella Viola, Gillian Griffiths, Gottfried Baier) | GABBA Symposium: T lymphocyte activation
Instituto de Investigação e Inovação em Saúde (Porto, Portugal)
|
| 2017 | “Twists and turns of IL-7/IL-7R-mediated signaling in T-ALL”, T-ALL Workshop, Leuven, Belgium, 17-19 March. (Other speakers: Charles Mullighan, Tom Look, Adolfo Ferrando, Jon Aster, Michelle Kelliher, Cristina Lo Celso, Trang Hoang, David Langenau) | T-ALL Workshop,
(Leuven, Bélgica)
|
| 2017 | “Transdução de sinal em leucemias da linhagem linfoide: entender a biologia básica para identificar novos alvos terapêuticos [Signal transduction in lymphoid leukemias: understanding the basic biology to identify new therapeutic targets]”, Hematology Research Meeting - Translational Research in Hematology by Portuguese Labs, CIM – FMUP, Porto, 8 April. | Hematology Research Meeting - Translational Research in Hematology by Portuguese Labs
Universidade do Porto Faculdade de Medicina (Porto, Portugal)
|
| 2017 | “STAT5: a JAK of all trades in IL-7-mediated T-ALL cell survival, growth and proliferation?”, Hematology Mini-Symposium, KU Leuven, Belgium, 27 November. (Host: Prof. Kim de Keersmaecker) |
Hematology Mini-Symposium, KU Leuven, Belgium, 27 November. (Host: Prof. Kim de Keersmaecker) (Leuven, Bélgica)
|
| 2017 | “Overview of the work at João Barata’s lab”, iMM Retreat, University of Évora, 9 May. |
iMM Retreat, University of Évora, 9 May. (Évora, Portugal)
|
| 2017 | “Unraveling critical pathways to lymphoid leukemia”, i3S, Porto, 21 April. (Host: Dr. Carla Oliveira) |
i3S, Porto, 21 April. (Host: Dr. Carla Oliveira) (Porto, Portugal)
|
| 2017 | “Diving into IL-7/IL-7R signaling in health and malignancy”, iMM ERC Symposium - ERC 10 year celebration, iMM-Lisboa, Lisbon, 16 March. |
iMM ERC Symposium - ERC 10 year celebration, iMM-Lisboa, Lisbon, 16 March. (Lisbon, Portugal)
|
| 2017 | “Signaling in Cancer”, Advanced Course on “Fundamentals of Genetics, Development and Neoplasia”, International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 25 October. | International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS)
(Braga, Portugal)
|
| 2017 | “Interleukin 7-mediated signaling in T-cell leukemia”, ReTuBi Twinning network 2017 Summer School, Oceanário de Lisboa, Lisbon, Portugal, 30 May. | ReTuBi Twinning network 2017 Summer School
(Lisbon, Portugal)
|
| 2017 | Oncogenic IL-7 receptor cooperates with Myc and activated Notch to accelerate T-cell leukemogenesis in zebrafish. M.L. Oliveira, E.G. Garcia, D.M. Langenau, J.T. Barata* (Poster presentation) | ZDM10 Conference of the Zebrafish Disease Models Society
(San Diego, Estados Unidos)
|
| 2017 | Scrutinizing PHF6 regulatory networks in T-ALL and normal hematopoiesis using zebrafish. S. Loontiens, K. Durinck, I. Van de Walle, F.E. Moore, S. Vanhauwaert, E. Janssens, G. Dewyn, L. Depestel, M.L. Oliveira, J.T. Barata, D.M. Langenau, P. Van Vlierberghe, T. Taghon, F. Speleman (Poster presentation) | ZDM10 Conference of the Zebrafish Disease Models Society
(San Diego, Estados Unidos)
|
| 2017 | IL-7 Flexibly Regulates Autophagy-dependent Viability of T-cell Acute Lymphoblastic Leukemia Cells. D. Ribeiro, I. Lopes, C. Custódia, J. Silva, M. Abreu, J.T. Barata* (Poster presentation) | 22nd Congress of the European Hematology Association
(Madrid, Espanha)
|
| 2017 | Regulation of NOTCH and WNT signaling pathways by NRARP in T-cell acute lymphoblastic leukemia. I. Pinto, M.L. Oliveira, J.T. Barata, R. Fragoso (Poster presentation) | 22nd Congress of the European Hematology Association
(Madrid, Espanha)
|
| 2017 | STAT5 activation associates with high risk and poor prognosis in pediatric B-cell acute lymphoblastic leukemia. M.L. Oliveira, A.M. Gomes, L.R. Martins, J. Duarte, J.T. Barata* (Poster presentation) | SINAL 2017 – 8th Meeting on Signal Transduction
(Lisbon, Portugal)
|
| 2017 | IL-7 Flexibly Regulates Autophagy-dependent Viability of T-cell Acute Lymphoblastic Leukemia Cells. D. Ribeiro, I. Lopes, C. Custódia, J. Silva, M. Abreu, J.T. Barata* (Poster presentation) | SINAL 2017 – 8th Meeting on Signal Transduction
(Lisbon, Portugal)
|
| 2017 | IL-7 Flexibly Regulates Autophagy-dependent Viability of T-cell Acute Lymphoblastic Leukemia Cells. D. Ribeiro, I. Lopes, C. Custódia, J. Silva, M. Abreu, J.T. Barata* (Poster presentation) | T-ALL Workshop
(Leuven, Bélgica)
|
| 2017 | A Dual Role of NRARP in T-cell Acute Lymphoblastic Leukemia Pathogenesis. I. Pinto, M. Lobato, J.T. Barata, R. Fragoso (Poster presentation) | T-ALL Workshop
(Leuven, Bélgica)
|
| 2016/10 | Targeting the IL-7R Pathway in Leukemia with Jak Inhibitors and MAbs. S. Durum, J. Hixon, E. Senkevitch, S. Cramer, J.T. Barata, S. Walsh, W. Li | CYTOKINES 2016 - 4th Annual Meeting of the International Cytokine and Interferon Society (ICIS)
ICIS - International Cytokine and Interferon Society (San Francisco, Estados Unidos)
|
| 2016 | “One of many roads to sail the sea”, 1st CEDOC PhD Retreat, CEDOC, NOVA Medical School, Lisbon, 9 September. | 1st CEDOC PhD Retreat
Universidade Nova de Lisboa CEDOC CHRONIC DISEASES FCM NOVA (Lisbon, Portugal)
|
| 2016 | “Exploring the twists and turns of signaling in leukemia for therapeutic purposes”, Strathclyde University, Glasgow, UK, 22 June. (Host: Prof. Nigel Pyne) |
Strathclyde University, Glasgow, UK, 22 June. (Host: Prof. Nigel Pyne) (Glasgow, Reino Unido)
|
| 2016 | “The twists and turns of signaling in T-cell leukemia”, CEDOC, NOVA Medical School, Lisbon, 18 May (Host: Dr. Helena Soares). |
CEDOC, NOVA Medical School, Lisbon, 18 May (Host: Dr. Helena Soares). (Lisbon, Portugal)
|
| 2016 | “Signaling in Cancer”, Advanced Course on “Fundamentals of Genetics, Development and Neoplasia”, International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 27 October. | International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS)
(Braga, Portugal)
|
| 2016 | “Vias de sinalização em cancro e terapia dirigida [Signal transduction and targeted therapy]”, Curricular unit “Da clínica à biologia molecular [From the clinics to molecular biology]”, Integrated Masters in Medicine (6th year students), Instituto de Investigação em Ciências da Vida e Saúde (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 27 October. | Integrated Masters in Medicine (6th year students), Instituto de Investigação em Ciências da Vida e Saúde (ICVS)
(Braga, Portugal)
|
| 2016 | Generation and characterization of a fully human antibody against the interleukin-7 receptor, a potential target for T-ALL. . Akkapeddi, J.T. Barata*, G. Bernardes*, D. Neri* (Poster presentation) | 2nd ASPIC International Congress
(Porto, Portugal)
|
| 2016 | STAT5 activation associates with high risk and poor prognosis in pediatric B-cell acute lymphoblastic leukemia. M. Oliveira, A.M. Gomes, L.R. Martins, J. Duarte, J.T. Barata* (Poster presentation) | 2nd ASPIC International Congress
(Lisbon, Portugal)
|
| 2016 | Do IL-7Ra gain -of-function mutants signal from intracellular compartments? Implications for acute lymphoblastic leukemia. J. Ferreira da Silva, J.T. Barata* (Poster presentation) | 2nd ASPIC International Congress
(Porto, Portugal)
|
| 2016 | Tal1-regulated MIR-146b has a tumor suppressor role in T-cell acute lymphoblastic leukemia. R. Fragoso, N.C. Correia, T. Carvalho, F.J. Enguita, J.T. Barata* (Poster presentation) | 2nd ASPIC International Congress
(porto, Portugal)
|
| 2016 | A dual role of NRARP in T-cell acute lymphoblastic leukemia pathogenesis. I. Pinto, M. Lobato, R. Cabrita, J.T. Barata, R. Fragoso (Poster presentation) | 2nd ASPIC International Congress
(Porto, Portugal)
|
| 2015 | “CHK1 and replicative stress in T-cell leukemia: how a potential tumor suppressor acts as an oncogene”, Advances in Biological Regulation – 56th International Symposium on “Biological Regulation and Enzyme Activity in Normal and Neoplastic Tissues”, University of Bologna, Italy, 5-6 October. (Other speakers: Len Stephens, Maria A. de Matteis, Adolfo Saiardi, Sarah Spiegel, Pann-Gill Suh) | Advances in Biological Regulation – 56th International Symposium on “Biological Regulation and Enzyme Activity in Normal and
Neoplastic Tissues”
(Bologna, Itália)
|
| 2015 | “Signaling, Oncogenes and T-cell Leukemia”, Meeting “Cancer Epigenetics and Metabolism: Connecting the Dots”, Biocant Park, Cantanhede, Portugal, 2-3 February. (Other speakers: Paolo Sassone-Corsi, Gabriella Ficz, Maarten Van Lohuizen) | Meeting “Cancer Epigenetics and Metabolism: Connecting the Dots”
(Cantanhede, Portugal)
|
| 2015 | “A importância da via PI3Kd na Leucemia Linfocítica Crónica [The importance of PI3Kd in Chronic Lymphocytic Leukemia]”, Gilead Satellite Symposium Inovação em Hemato-Oncologia: Leucemia Linfocítica Crónica e PI3Kd, 8th APFH Week - VIII National Congress of the Portuguese Association of Clinical Pharmacists, Cascais, Portugal, 18-21 November. | Gilead Satellite Symposium Inovação em Hemato-Oncologia: Leucemia Linfocítica Crónica e PI3Kd, 8th APFH Week - VIII National
Congress of the Portuguese Association of Clinical Pharmacists
(Cascais, Portugal)
|
| 2015 | “Transdução de sinal e terapias dirigidas: Em busca de novos alvos moleculares para o tratamento de leucemias da linhagem linfoide [Signal transduction and targeted therapies: in search of novel molecular targets for the treatment of lymphoid leukemias]”, Annual Meeting of the Portuguese Society of Hematology (SPH), Figueira da Foz, Portugal, 12-14 November. | Annual Meeting of the Portuguese Society of Hematology (SPH)
(Figueira da Foz, Portugal)
|
| 2015 | “Mr Hyde exposed: interleukin 7 signaling in T-cell acute lymphoblastic leukemia”, Institute of Immunity and Transplantation, UCL, London, UK, 2 July. (Host: Dr. Ben Seddon) |
Institute of Immunity and Transplantation, UCL, London, UK, 2 July. (Host: Dr. Ben Seddon) (London, Reino Unido)
|
| 2015 | “From the outside, from within: exploring the signals essential for leukemia development”, Champalimaud Center For the Unknown, Lisbon, 22 October (Host: Prof. António Parreira). |
Champalimaud Center For the Unknown, Lisbon, 22 October (Host: Prof. António Parreira). (Lisbon, Portugal)
|
| 2015 | “Aberrant signaling in leukemia: Understanding basic biology to devise new therapies?”, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, 19 March (Host: Dr. Branca Cavaco). |
Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, 19 March (Host: Dr. Branca Cavaco). (Lisbon, Portugal)
|
| 2015 | “Signaling in Cancer”, Advanced Course on “Fundamentals of Genetics, Development and Neoplasia”, International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 13 October. | International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS)
(Braga, Portugal)
|
| 2015 | “Imunobiologia em Oncologia: Novos Alvos Terapêuticos / Terapias de Transdução de Sinal [Immunobiology in oncology: new therapeutic targets/ Signaling Therapies]”, 2º Curso APFH - Biofármacos e Imunoterapia [2nd Course from the Portuguese Association of Hospital Pharmacists - Biopharmaceuticals and Immunotherapy], Coimbra, Portugal, 26 September. | 2º Curso APFH - Biofármacos e Imunoterapia [2nd Course from the Portuguese Association of Hospital Pharmacists - Biopharmaceuticals
and Immunotherapy]
(Coimbra, Portugal)
|
| 2015 | “Autophagy in Disease I - IL-7 and Leukemia”, Advanced Course on “Autophagy in Health and Disease, conceptual and methodological advances”, School of Health Sciences, University of Minho, Braga, Portugal, 8 April. | Advanced Course on “Autophagy in Health and Disease, conceptual and methodological advances”
(Braga, Portugal)
|
| 2015 | The JAK Inhibitor Ruxolitinib Is Effective in Treating T Cell Acute Lymphoblastic Leukemia with Gain of Function Mutations in IL-7R Alpha. E. Senkevitch, J. Hixon, C. Andrews, J.T. Barata, W. Li, S. Durum (Poster presentation) | The American Society of Hematology 57th Annual Meeting
(Orlando, Estados Unidos)
|
| 2015 | Sphingosine kinases are required for IL-7-mediated signaling in T-cell acute lymphoblastic leukemia. A. Melão, J. Matos, H. Cadilha, J.T. Barata* (Poster presentation) | EHA 2015 - 20th Congress of the European Hematology Association
(Vienna, Áustria)
|
| 2015 | IL-7 activates the JAK/STAT5/PIM1 kinase axis thereby mediating viability and growth of T-cell acute lymphoblastic leukemia cells. D. Ribeiro, A. Melão, R. van Boxtel, C.I. Santos, M.C. Silva, A. Silva, B.A. Cardoso, L.F. Moita, P.J. Coffer and J.T. Barata* (Poster presentation) | EHA 2015 - 20th Congress of the European Hematology Association
(Vienna, Áustria)
|
| 2015 | MiR-146B in T-cell acute lymphoblastic leukemia: a possible tumor supressor role. N.C. Correia, R. Fragoso, V. Póvoa, F.J. Enguita, J.T. Barata* (Poster presentation) | EHA 2015 - 20th Congress of the European Hematology Association
(Vienna, Áustria)
|
| 2015 | The role of NRARP in T-cell acute lymphoblastic leukemia pathogenesis and chemotherapy sensitivity. M. Lobato, R. Cabrita, J.T. Barata, R. Fragoso (e-poster presentation) | EHA 2015 - 20th Congress of the European Hematology Association
(Vienna, Áustria)
|
| 2015 | Bone Marrow Stroma Mediated Protection of MPN cells from Ruxolitinib- and Vorinostat-Induced Apoptosis Requires MAPK-JNK and PI3K-Akt/PKB signaling pathway activation. B.A. Cardoso, H. Belo, J.T. Barata, A. Almeida (e-poster presentation) | EHA 2015 - 20th Congress of the European Hematology Association, Vienna, Austria
(Vienna, Áustria)
|
| 2014/11 | Flexible IL-7-mediated regulation of autophagy promotes T-cell acute lymphoblastic leukemia cell viability. D. Ribeiro, I. Lopes, M. Abreu, J.T. Barata* | 1st ASPIC International Congress
ASPIC - Associação Portuguesa de Investigação em Cancro (Li, Portugal)
|
| 2014/11 | A medula óssea protege células de neoplasias crónicas BCR-ABL-negativas dos efeitos citotóxicos induzidos por ruxolitinib e vorinostat [The bone marrow protects cells from chronic BCR-ABL-negative myeloproliferative neoplasias from the cytotoxic effects of Ruxolitinib and Vorinostat]. B.A. Cardoso, H. Belo, J.T. Barata, A.M. Almeida. | Annual Meeting of the Portuguese Society of Hematology
SPH - Sociedade Portuguesa de Hematologia (Évora, Portugal)
|
| 2014/09 | Sphingosine Kinase Modulates IL-7-Mediated Signaling in T-cell Acute Lymphoblastic Leukemia. J. Matos, A. Melão, J.T. Barata* | Symposium “Sphingolipids in Health and Disease”
(Porto, Portugal)
|
| 2014/05 | CK2-mediated signaling as a novel therapeutic target in chronic lymphocytic leukemia. L.R. Martins, P. Lúcio, M.C. Silva, P. Gameiro, M.G. Silva, J.T. Barata*. | SINAL 2010 – 4th National Meeting on Signal Transduction
SINAL - Signal Transdcution Network (Faro, Portugal)
|
| 2014 | “T-cell development gone wrong: cell autonomous and microenvironmental signals promoting leukemia”, SPI workshop HEMATOPOIESIS: FROM BENCH TO BEDSIDE, University of Minho, Braga, Portugal, 11 April. | SPI workshop HEMATOPOIESIS: FROM BENCH TO BEDSIDE
Universidade do Minho (Braga, Portugal)
|
| 2014 | “Na fronteira entre a Imunologia e a Oncologia: citocinas e leukemia [At the frontier between Immunology and Oncology: cytokines and leukemia]”, V MedUBI Congress, University of Beira Interior, Covilhã, Portugal, 9-10 January. | V MedUBI Congress
Universidade da Beira Interior (Covilhã, Portugal)
|
| 2014 | “Mr Hyde exposed: interleukin 7 signaling in T-cell leukemia”, Instituto Gulbenkian de Ciência, Oeiras, Portugal, 21 November (Host: Prof. Luís Moita). |
Instituto Gulbenkian de Ciência, Oeiras, Portugal, 21 November (Host: Prof. Luís Moita). (Oeiras, Portugal)
|
| 2014 | “Em busca de novos alvos moleculares para o tratamento de leukemia [Searching for new molecular targets for the treatment of leukemia]”, Clinical Sessions of the Faculty of Medicine of the University of Lisbon and Hospital de Santa Maria, Lisboa, Portugal, 6 November (Host: Prof. Maria Carmo-Fonseca). |
Clinical Sessions of the Faculty of Medicine of the University of Lisbon and Hospital de Santa Maria, Lisboa, Portugal, 6
November (Host: Prof. Maria Carmo-Fonseca). (Lisbon, Portugal)
|
| 2014 | “Aberrant signaling in leukemia: Understanding basic biology to devise new therapies?”, Neurosurgery Department of Hospital de Santa Maria, Lisboa, Portugal, 5 November (Host: Dr. Cláudia Faria). |
Neurosurgery Department of Hospital de Santa Maria, Lisboa, Portugal, 5 November (Host: Dr. Cláudia Faria). (Lisbon, Portugal)
|
| 2014 | “Ciclo celular e pontos de controlo - I: G1/S [Cell cycle & checkpoints – I (G1/S)]”, Advanced Course on “Oncologia Molecular: Biologia do Cancro e Terapias Emergentes [Molecular Oncology: Biology of Cancer and Emerging Therapies]”, IPOFG, Coimbra, Portugal, 24 October. | Advanced Course on “Oncologia Molecular: Biologia do Cancro e Terapias Emergentes [Molecular Oncology: Biology of Cancer and
Emerging Therapies]
(Coimbra, Portugal)
|
| 2014 | Bone Marrow Stroma Protects BCR-ABL-Negative Myeloproliferative Neoplasms from Ruxolitinib- and Vorinostat-Induced Apoptosis. B.A. Cardoso, H. Belo, A.I. Oliveira, O. Pereira., J.T. Barata, A. Almeida (Poster presentation) | The American Society of Hematology 56th Annual Meeting
(San Francisco, Estados Unidos)
|
| 2014 | Sphingosine Kinase is Required for IL-7-Mediated Signaling in T-cell Acute Lymphoblastic Leukemia. A. Melão*, J. Matos*, J.T. Barata* (Poster presentation) | 1st ASPIC International Congress, Lisboa
(Lisbo, Portugal)
|
| 2014 | LTßR in microenvironmental cells modulates surface lymphotoxin expression on leukemic T cells and promotes leukemogenesis. M.T. Fernandes, M.N. Ghezzo, V. Póvoa, A.R. Ribeiro, E. Dejardin, N.L. Alves, J. Ghysdael, J.T. Barata, N.R. dos Santos. (Poster presentation) | 1st ASPIC International Congress
(Lisbon, Portugal)
|
| 2014 | Prognostic significance of PI3K/Akt/mTOR pathway using phosphoflow in pediatric acute lymphoblastic leukemia–preliminary results. M.L. Oliveira, A.M. Gomes, L.R. Martins, J. Duarte, J.T. Barata* (Poster presentation) | 1st ASPIC International Congress
(Lisbon, Portugal)
|
| 2014 | Bone Marrow protects BCR-ABL-Negative Myeloproliferative Neoplasms from Ruxolitinib- and Vorinostat-Induced Apoptosis. B. A. Cardoso, H. Belo, J.T. Barata, A.M. Almeida (Poster presentation) | 1st ASPIC International Congress
(Lisbon, Portugal)
|
| 2014 | Evaluation of tumor cells’ biomechanical properties for assessing the chemotherapy efficacy of anticancer peptides. D. Gaspar, J.M. Freire, T.R. Pacheco, J.T. Barata, M.A.R.B. Castanho (Poster presentation) | 1st ASPIC International Congress
(Lisbon, Portugal)
|
| 2014 | Sphingosine Kinase-1 Modulates IL-7-Mediated Signaling in T-cell Acute Lymphoblastic Leukemia. J. Matos, A. Melão, J.T. Barata* (Poster presentation) | SPI workshop HEMATOPOIESIS: FROM BENCH TO BEDSIDE
(Braga, Portugal)
|
| 2013/12 | CHK1 is essential for the growth and survival of T-cell acute lymphoblastic leukemia. L.M. Sarmento, V. Povoa, R. Nascimento, G. Real, C. Moita, I. Antunes, L. Martins, P.M. Alves, M. Parkhouse, L. Moita, J. Meijerink, J.T. Barata* | SINAL 2013 – 7th National Meeting on Cell Signalling,
SINAL - Signal Transduction Network (Aveiro, Portugal)
|
| 2013/12 | Lymphotoxin-beta Receptor Signalling in Microenvironmental Cells Supports T-Cell Leukemogenesis. M.T. Fernandes, M.N. Ghezzo, V. Póvoa, A.R. Ribeiro, N.L. Alves, J.T. Barata, N.R. dos Santos. | SINAL 2013 – 7th National Meeting on Cell Signalling,
SINAL - Signal Transduction Network (Aveiro, Portugal)
|
| 2013/10 | PHARMACOLOGIC INTERVENTION OF CASEIN KINASE 2 (CK2)-MEDIATED PRO-SURVIVAL AND PROLIFERATIVE SIGNALING ON T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL). Y. Perera, A. Melao, J. Miranda, S.E. Perea, J.T. Barata* | Meeting of the Latin-American Association of Pharmacology, Asociación Latinoamericana de Farmacología
(Havana, Cuba)
|
| 2013 | “IL-7 and T-cell Leukemia: How Interleukins can Shape Cancer Behaviour”, 3rd Global Cancer Genomics Consortium Symposium, Lisbon, Portugal, 18-20 August. (Other speakers: Clifford Hudis, Carlos Caldas, Rakesh Kumar, Maria Carmo-Fonseca, Bruno Silva-Santos) | 3rd Global Cancer Genomics Consortium Symposium
(Lisbon, Portugal)
|
| 2013 | “Too much of a good thing: IL-7 and IL-7R in T-cell leukemia”, 3rd International Symposium on Translational Oncology, Barretos, SP, Brazil, 29-30 August. (Other speakers: Chris Meijer, Eduardo Franco) | 3rd International Symposium on Translational Oncology
(Barretos, Brasil)
|
| 2013 | “The role of IL7R in childhood T-cell acute lymphoblastic leukemia”, European Human Genetics Conference 2013, Paris, France, 8-11 June. (Other speakers: Ian Tomlinson, Lorraine O’Driscoll, Alain Fischer, Jean-Laurent Casanova) | European Human Genetics Conference
(Paris, França)
|
| 2013 | “Signals from the outside, signals from within: IL-7 and IL-7R in acute T-cell leukemia”, 8th Annual Helsinki Biomedical Graduate Program Symposium, Biomedicum Helsinki, Finland, 16-17 May. (Other speakers: Johanna Ivaska, Peter Krammer, Valerie Weaver, Raphael Kopan) | 8th Annual Helsinki Biomedical Graduate Program Symposium
(Helsinki, Finlândia)
|
| 2013 | IL-7 and IL-7R-mediated signaling in T-ALL”, Second ESH-EHA Scientific Workshop on T-cell Acute Lymphoblastic Leukemia, Lisbon, Portugal, 22-24 March. (Other speakers: Charles Mullighan, Jacques van Dongen, Ianis Aifantis, Tom Look, Jan Cools, Jon Aster) | Second ESH-EHA Scientific Workshop on T-cell Acute Lymphoblastic Leukemia
(Lisbon, Portugal)
|
| 2013 | “Good things gone bad: IL-7 and IL-7R in T-cell leukemia”, XXXIX Annual Meeting of The Portuguese Society of Immunology, Coimbra, Portugal, 13-15 November. | XXXIX Annual Meeting of The Portuguese Society of Immunology
(Coimbra, Portugal)
|
| 2013 | “O lado obscuro da lua: IL-7 e IL-7R em leucemia de células T [The dark side of the moon: IL-7 and IL-7R in T-cell leukemia]”, IV Science and Medicine Meeting, University of Minho, Braga, Portugal, 20 April. | IV Science and Medicine Meeting
Universidade do Minho (Braga, Portugal)
|
| 2013 | “Signaling in Cancer and Leukemia”, Masters in Biomedical Sciences, University of Algarve, Faro, Portugal, 24 April. | Masters in Biomedical Sciences
(Faro, Portugal)
|
| 2013 | “Signaling in Cancer”, Advanced Course on “Fundamentals of Genetics, Development and Neoplasia”, 5th Edition, International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 15 October. | Advanced Course on “Fundamentals of Genetics, Development and Neoplasia”, 5th Edition, International Postgraduate Programme,
Instituto de Investigação em Ciências da Vida e Saúde (ICVS)
(Braga, Portugal)
|
| 2013 | “Basic Concepts on Signaling in Cancer”, Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Portugal, 26 February. | Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC)
(Coimbra, Portugal)
|
| 2013 | “Signaling in Cancer”, Advanced Course on “Fundamentals of Genetics, Development and Neoplasia”, 4th Edition, International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 21 January. | Advanced Course on “Fundamentals of Genetics, Development and Neoplasia”, 4th Edition, International Postgraduate Programme,
Instituto de Investigação em Ciências da Vida e Saúde (ICVS)
(Braga, Portugal)
|
| 2013 | CK2 Activity Regulates IL-7 Pro-Oncogenic Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia. A. Melão, A. Gírio, J.T. Barata* (Poster presentation) | 3rd Global Cancer Genomics Consortium Symposium
(Lisbo, Portugal)
|
| 2013 | CHK1 is essential for the growth and survival of T-cell acute lymphoblastic leukemia cells. L.M. Sarmento, V. Póvoa, R. Nascimento, G. Real, I. Antunes, L.R. Martins, J. Meijerink, J.T. Barata* (Poster presentation) | 3rd Global Cancer Genomics Consortium Symposium
(Lisbon, Portugal)
|
| 2013 | IL-7 Activates the JAK/STAT5/PIM1 Kinase Axis Thereby Mediating Viability and Growth of T-Cell Acute Lymphoblastic Leukemia Cells.D. Ribeiro, A. Melão, R. van Boxtel, C.I. Santos, M.C. Silva, A. Silva, B.A. Cardoso, L.F. Moita, P.J. Coffer, J.T. Barata* (Poster presentation) | 3rd Global Cancer Genomics Consortium Symposium
(Lisbon, Portugal)
|
| 2013 | Anticancer activity and selectivity of the human neutrophil peptide-1 towards solid and hematological tumor cells. D. Gaspar, T.R.D. Pacheco, J.T. Barata, M.A.R.B. Castanho (Poster presentation) | EMBO Young Scientists’s Forum on Life Sciences
(Lisbon, Portugal)
|
| 2013 | Novel TAL1 targets beyond protein coding genes: identification of TAL1-regulated microRNA genes in T-cell acute lymphoblastic leukemia. N.C. Correia, F.J. Enguita, F. Speleman, J.T. Barata* (Poster presentation) | RNA 2013 – The 18th Annual Meeting of the RNA Society
(Davos, Suiça)
|
| 2013 | CK2 Basal Activity Regulates IL-7-Mediated JAK/STAT and PI3K/Akt Pathway Activation and Pro-Survival Effects in T-Cell Acute Lymphoblastic Leukemia Cells. A. Melão, A. Gírio, J.T. Barata* (Poster presentation) | Second ESH-EHA Scientific Workshop on T-cell Acute Lymphoblastic Leukemia
(Lisbon, Portugal)
|
| 2013 | IL-7-Mediated Viability and Growth of T-Cell Acute Lymphoblastic Leukemia Cells Relies on a JAK/STAT5/PIM1 Kinase Axis. D. Ribeiro, A. Melão, R. van Boxtel, C.I. Santos, M.C. Silva, A. Silva, B.A. Cardoso, L.F. Moita, P.J. Coffer, J.T. Barata* (Poster presentation) | Second ESH-EHA Scientific Workshop on T-cell Acute Lymphoblastic Leukemia
(Lisbon, Portugal)
|
| 2013 | Identification of TAL1-regulated microRNA genes in T-cell acute lymphoblastic leukemia. N.C. Correia, F. Speleman, F.J. Enguita, J.T. Barata* (Poster presentation) | Second ESH-EHA Scientific Workshop on T-cell Acute Lymphoblastic Leukemia
(Lisbon, Portugal)
|
| 2012/12 | The Role of IL7R in the Induction and Maintenance of T-Cell Leukemia/Lymphoma in Vivo. A. Silva, J.T. Barata*, B. Seddon*. | The American Society of Hematology 54th Annual Meeting,
ASH - American Society for Hematology (Atlanta, Estados Unidos)
|
| 2012/11 | Targeting Chronic Lymphocytic Leukemia Cells’ Viability Using CX-4945, a Clinical-Stage CK2-Specific Inhibitor. L.R. Martins, P. Lúcio, A. Melao, B.A. Cardoso, R. Stansfield, D. Drygin, M.G. Silva, J.T. Barata* | XXXVIII Annual Meeting of the Portuguese Society of Immunology
SPI - Sociedade Portuguesa de Imunologia (Porto, Portugal)
|
| 2012/11 | Targeting Chronic Lymphocytic Leukemia Cell Viability Using CX-4945, A Clinical-Stage CK2-specific Inhibitor. L.R. Martins, P. Lúcio, A. Melão, B.A. Cardoso, R. Stansfield, Denis Drygin, M.G. Silva, J.T. Barata* | Annual Meeting of the Portuguese Society of Hematology,
SPH - Sociedade Portuguesa de Hematologia (Porto, Portugal)
|
| 2012 | “From the environment, from within: IL-7R-mediated signaling in T-cell leukemia”, One Day Symposium sponsored by EACR, Eng. António de Almeida Foundation, Porto, Portugal, 29 October. (Other speakers: Julio Celis, Carlos Caldas, Miguel Godinho Ferreira) | One Day Symposium sponsored by EACR
(Porto, Portugal)
|
| 2012 | “IL-7R-mediated signaling in T-cell leukemia”, Advances in Biological Regulation – 53rd International Symposium on “Biological Regulation and Enzyme Activity in Normal and Neoplastic Tissues”, University of Bologna, Italy, 17-18 September. (Other speakers: Tim Hunt, Nullin Divecha, Per-Olof Berggren, Ralph Bradshaw, Vytas Bankaitis) | Advances in Biological Regulation – 53rd International Symposium on “Biological Regulation and Enzyme Activity in Normal and
Neoplastic Tissues”
(Bologna, Itália)
|
| 2012 | “IL-7R and PI3K/mTOR signaling in T-cell leukemia”, XXI Porto Cancer Meeting (International Conference on Metabolism and Cancer – from Etiopathogenesis to Therapy), Porto, Portugal, 19-20 April. (Other speakers: John Blenis, Luca Scorrano, Evangelos Michelakis, Jacques Pouysségur) | XXI Porto Cancer Meeting (International Conference on Metabolism and Cancer – from Etiopathogenesis to Therapy)
(Porto, Portugal)
|
| 2012 | “Targeting aberrant signaling in T-cell acute lymphoblastic leukemia”, International Meeting Biotecnología Habana 2012 – Medical Applications of Biotechnology, Havana International Conference Center, Havana, Cuba, 5-8 March. (Other speakers: Peter Agre, Peter Roepstorff) | International Meeting Biotecnología Habana 2012 – Medical Applications of Biotechnology
(Havana, Cuba)
|
| 2012 | “Genetic lesions and posttranslational alterations promoting T-cell acute lymphoblastic leukemia”, 16th Annual Meeting of the Portuguese Society of Human Genetics, Porto, Portugal, 22-24 November. | 16th Annual Meeting of the Portuguese Society of Human Genetics
(Porto, Portugal)
|
| 2012 | “IL-7/IL-7R signaling in T-cell leukemia: Dr Jekyll or Mr Hyde?”, Institut de Radiobiologie Cellulaire et Moléculaire (IRCM), Direction des Sciences du Vivant - CEA, Fontenaix-au-Roses, France, 29 November. (Host: Prof. Françoise Pflumio) |
Institut de Radiobiologie Cellulaire et Moléculaire (IRCM), Direction des Sciences du Vivant - CEA, Fontenaix-au-Roses, France,
29 November. (Host: Prof. Françoise Pflumio) (Fontenaix-au-Roses, França)
|
| 2012 | “The dark side of the moon: IL-7 and IL-7R signaling in T-cell leukemia”, VIB Center for the Biology of Disease, KU Leuven, Belgium, 22 October. (Host: Prof. Jan Cools) |
VIB Center for the Biology of Disease, KU Leuven, Belgium, 22 October. (Host: Prof. Jan Cools) (Leuven, Bélgica)
|
| 2012 | “Mr Hyde revealed: IL-7/IL-7R signaling in T-cell leukemia”, Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Portugal, 28 February (Host: Prof. João Nuno Moreira). |
Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Portugal, 28 February (Host: Prof. João Nuno Moreira). (Coimbra, Portugal)
|
| 2012 | “Citocinas [Cytokines]”, Workshop on “Imunoterapia do Cancro: da Investigação Básica à Aplicação Clínica [Immunotherapy of Cancer: From Basic Research to Clinical Application]”, Center for Evidence-based Medical Studies (CEMBE), Faculty of Medicine of Lisbon University, Lisbon, Portugal, 24 March. | “Imunoterapia do Cancro: da Investigação Básica à Aplicação Clínica [Immunotherapy of Cancer: From Basic Research to Clinical
Application]”, Center for Evidence-based Medical Studies (CEMBE)
(Lisbon, Portugal)
|
| 2012 | “Basic Concepts on Signaling in Cancer”, Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Portugal, 28 February. | Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC)
(Coimbra, Portugal)
|
| 2012 | CK2 Basal Activity Regulates IL-7-Mediated JAK/STAT and PI3K/Akt Pathway Activation and Pro-Survival Effects in T-Cell Acute Lymphoblastic Leukemia Cells. A. Melão, A. Gírio, J.T. Barata* (Poster presentation) | The American Society of Hematology 54th Annual Meeting
(Atlanta, Estados Unidos)
|
| 2012 | STAT5 Activation Is Mandatory for IL-7-Mediated Viability and Growth of T-cell Acute Lymphoblastic Leukemia Cells. D. Ribeiro, A. Silva, B.A. Cardoso, J.T. Barata* (Poster presentation) | The American Society of Hematology 54th Annual Meeting
(Atlanta, Estados Unidos)
|
| 2012 | In Vitro and in Vivo Targeting of Chronic Lymphocytic Leukemia Using CX-4945, a Clinical-Stage CK2-Specific Inhibitor. L.R. Martins, P. Lúcio, A. Melao, B.A. Cardoso, R. Stansfield, D. Drygin, M.G. Silva, J.T. Barata* (Poster presentation) | The American Society of Hematology 54th Annual Meeting
(Atlanta, Estados Unidos)
|
| 2012 | CK2 Activity Regulates Signaling, Survival and Proliferation Mediated by IL-7 in T-cell Acute Lymphoblastic Leukemia Cells. A. Melão, M. Spit, A. Gírio, J.T. Barata* (Poster presentation) | XXXVIII Annual Meeting of the Portuguese Society of Immunology
(Porto, Portugal)
|
| 2012 | STAT5 Activation Is Mandatory for IL-7-Mediated Viability and Growth of T-cell Acute Lymphoblastic Leukemia Cells. D. Ribeiro, C.I. Santos, M.C. Silva, A. Silva, B.A. Cardoso, L.F. Moita, J.T. Barata* (Poster presentation) | XXXVIII Annual Meeting of the Portuguese Society of Immunology
(Porto, Portugal)
|
| 2012 | Differential Regulation of Basal and IL-7-induced PI3K/Akt/mTOR and Jak/STAT5 Signaling Distinguishes Pediatric from Adult ALL. A.M. Gomes, M. Soares, P. Ribeiro, J. Caldas, A.L. Caetano, A.B. Sousa, J.F. Lacerda, J.T. Barata* (Poster presentation) | XXXVIII Annual Meeting of the Portuguese Society of Immunology
(Porto, Portugal)
|
| 2012 | CK2 Activity Regulates Signaling, Survival and Proliferation Mediated by IL-7 in T-Cell Acute Lymphoblastic Leukemia Cells. A. Melão, M. Spit, A. Gírio, J.T. Barata* (Poster presentation) | One Day Symposium sponsored by EACR
(Porto, Portugal)
|
| 2012 | STAT5 is Essential for IL-7-Mediated Viability, Cell Growth and Proliferation of Human T-Cell Acute Lymphoblastic Leukemia Cells. D. Ribeiro, C.I. Santos, M.C. Silva, A. Silva, B.A. Cardoso, L.F. Moita, J.T. Barata* (Poster presentation) | One Day Symposium sponsored by EACR
(Porto, Portugal)
|
| 2012 | In Vitro and in Vivo Targeting of Chronic Lymphocytic Leukemia Using CX-4945, a Clinical-Stage CK2-Specific Inhibitor. L.R. Martins, P. Lúcio, A. Melao, B.A. Cardoso, R. Stansfield, D. Drygin, M.G. Silva, J.T. Barata* (Poster presentation) | One Day Symposium sponsored by EACR
(Porto, Portugal)
|
| 2012 | Evidence for reciprocal regulation between TAL1 and miRNAs in T-cell acute lymphoblastic leukemia. N. Correia, M. Malumbres, F. Speleman, F. Enguita, J.T. Barata* (Poster presentation) | One Day Symposium sponsored by EACR
(Porto, Portugal)
|
| 2012 | Differential Regulation of Basal and IL-7-induced PI3K/Akt/mTOR and Jak/STAT5 Signaling Distinguishes Pediatric from Adult ALL. A.M. Gomes, M. Soares, P. Ribeiro, J. Caldas, A.L. Caetano, A.B. Sousa, J.F. Lacerda, J.T. Barata* (Poster presentation) | One Day Symposium sponsored by EACR
(Porto, Portugal)
|
| 2012 | CK2 activity is mandatory for IL-7-mediated pro-survival signaling in T-cell acute lymphoblastic leukemia cells. A. Melão, A. Gírio, M. Spit, J.T. Barata* (Poster presentation) | SINAL 2012 – 6th National Meeting on Cell Signaling
(Braga, Portugal)
|
| 2012 | Evidence for reciprocal regulation between TAL1 and miRNAs in T-cell acute lymphoblastic leukemia. N. Correia, M. Malumbres, F. Enguita, J.T. Barata* (Poster presentation) | RNA 2012 Meeting
(Lisbon, Portugal)
|
| 2011 | “Signals from the outside, signals from within: finding new molecular therapeutic targets in T-cell leukemia”, International-attended, Istanbul Technical University 5th National Molecular Biology and Genetics Student Congress, Istanbul, Turkey, 19-22 August. (Other speakers: Pam Silver, Stefan Jentsch, Oscar Fernandez-Capetillo) | International-attended, Istanbul Technical University 5th National Molecular Biology and Genetics Student Congress
(Istambul, Turquia)
|
| 2011 | “Transdução de sinal em leucemia: novos alvos moleculares – futuras terapias? [Signal Transduction in Leukemia: New Molecular Targets – Future Therapies?]”, Scientific Meeting “Ciência e Ensino – 100 anos da FMUL [Science and Teaching – 100 Years of FMUL]” (Celebrations of the 100th Anniversary of the Faculty of Medicine of Lisbon University), Faculty of Medicine, University of Lisbon, 6-7 May. | Scientific Meeting “Ciência e Ensino – 100 anos da FMUL [Science and Teaching – 100 Years of FMUL]” (Celebrations of the 100th
Anniversary of the Faculty of Medicine of Lisbon University)
Universidade de Lisboa Faculdade de Medicina (Lisbon, Portugal)
|
| 2011 | “Leucemia e transdução de sinal: as células tumorais também ouvem [Leukemia and signal transduction: cancer cells can also listen]”, 1o Encontro de Biologia Molecular em Saúde [1st Meeting on Molecular Biology in Health], Escola Superior de Saúde Egas Moniz, Caparica, Portugal, 18-19 March. | 1o Encontro de Biologia Molecular em Saúde [1st Meeting on Molecular Biology in Health]
Escola Superior de Saúde Egas Moniz (Caparica, Portugal)
|
| 2011 | “Mr Hyde revealed: IL-7/IL-7R signaling in acute T-cell leukemia”, Department of Cell Signalling and Immunology, College of Life Sciences, University of Dundee, Dundee, UK, 20 September (Host: Dr. Nick Leslie). |
Department of Cell Signalling and Immunology, College of Life Sciences, University of Dundee, Dundee, UK, 20 September (Host:
Dr. Nick Leslie). (Dundee, Reino Unido)
|
| 2011 | “Signal Transduction Aberrations in Cancer” and “’Novel’ Concepts in Cancer Signal Transduction”, Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 21 February. | Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC)
(Coimbra, Portugal)
|
| 2011 | BAFF-R and TACI expression in Common Variable Immunodeficiency – insights into receptor dynamics. R.R. Barbosa, S.L. Silva, S.P. Silva, A.C. Melo, C. Pereira-Santos, J.T. Barata, A.E. Sousa (Poster presentation) | XXXVII Annual Meeting of the Portuguese Society of Immunology
(Oeiras, Portugal)
|
| 2011 | STAT5 Activation is Required for IL-7-mediated Viability and Growth of Human Leukemia T-cells. D. Ribeiro, C.I. Santos, M.C. Silva, A. Silva, L. Vinagre, B.A. Cardoso, L.F. Moita, J.T. Barata* (Poster presentation) | SINAL 2011 – 5th Annual Meeting on Cell Signalling
(Coimbra, Portugal)
|
| 2011 | Inhibition of PI3K sensitizes T-ALL cells to chemotherapy. Targeting PI3K/mTOR Signaling in Cancer. A.B. Silveira, P. Leal, B.A. Cardoso, B. Nogueira, R.A. Yunes, S.R. Brandalise, N.I.T. Zanchin, J.T. Barata, J.A. Yunes (Poster presentation) | Targeting PI3K/mTOR Signaling in Cancer AACR Special Conference
(San Francisco, Estados Unidos)
|
| 2010/12 | The oncogene TAL1/SCL is downregulated by Histone Deacetylase inhibitors in human T-cell leukemia. B.A. Cardoso, S. de Almeida, A. Larangeira, M. Carmo-Fonseca, J.A. Yunes, P.J. Coffer, J.T. Barata*. | XVII National Congress of Biochemistry
SPB - Sociedade Portuguesa de Bioquímica (Porto, Portugal)
|
| 2010/09 | CK2 as a novel therapeutic target in chronic lymphocytic leukemia. L.R. Martins, P. Lúcio, M.C. Silva, P. Gameiro, M.G. Silva, J.T. Barata* | 6th International Conference on Protein Kinase CK2
(Cologne, Alemanha)
|
| 2010/05 | CK2 is overexpressed in B-cell chronic lymphocytic leukemia cells and promotes leukemia cell viability. L.R. Martins, M.C. Silva, P. Gameiro, M.G. Silva, P. Lúcio, J.T. Barata*. - Roche Best Oral Presentation to M.C. Silva | XI Technical Congress of Patho-anatomy
(Évora, Portugal)
|
| 2010 | “The Impact of PTEN Regulation by CK2 on PI3K-Dependent Signaling and Leukemia Cell Survival”, Advances in Enzyme Regulation – 51st International Symposium on “Regulation of Enzyme Activity and Synthesis in Normal and Neoplastic Tissues”, University of Bologna, Italy, 4-5 October. (Other speakers: Philip W. Majerus, Len Stephens) | Advances in Enzyme Regulation – 51st International Symposium on “Regulation of Enzyme Activity and Synthesis in Normal and
Neoplastic Tissues”
(Bologna, Itália)
|
| 2010 | “T-ALL signals: translating posttranslational alterations into therapy?”, European Hematology Association and European School of Haematology Joint Scientific Workshop “T-cell Acute Lymphoblastic Leukemia (T-ALL) Meets Normal T-cell Development”, Mandelieu, France, 7-9 May. (Other speakers: Harald von Boehmer, Warren Pear, Juan-Carlos Zúñiga-Pflücker, Adolfo Ferrando, Jacques Ghysdael, Hans-Guido Wendel) | European Hematology Association and European School of Haematology Joint Scientific Workshop “T-cell Acute Lymphoblastic Leukemia
(T-ALL) Meets Normal T-cell Development”
(Mandelieu, França)
|
| 2010 | “Novel molecular therapeutic targets in leukemia”, Encontro com a Ciência e a Tecnologia em Portugal 2010, Lisbon, Portugal, 4-7 July. | Encontro com a Ciência e a Tecnologia em Portugal 2010
(lisbon, Portugal)
|
| 2010 | “The ins and outs of T-cell leukemia: CK2, PTEN-PI3K and IL-7”, Centro de Biomedicina Molecular e Estrutural (CBME), University of Algarve, Faro, Portugal, 10 December (Host: Dr. Nuno Rodrigues dos Santos). |
Centro de Biomedicina Molecular e Estrutural (CBME), University of Algarve, Faro, Portugal, 10 December (Host: Dr. Nuno Rodrigues
dos Santos). (Faro, Portugal)
|
| 2010 | “The ins and outs of T-cell leukemia signaling: PTEN, PI3K/Akt and IL-7”, Instituto de Investigação em Ciências da Vida e Saúde (ICVS), University of Minho, Braga, Portugal, 13 October (Host: Prof. Fátima Baltazar). |
Instituto de Investigação em Ciências da Vida e Saúde (ICVS), University of Minho, Braga, Portugal, 13 October (Host: Prof.
Fátima Baltazar). (Braga, Portugal)
|
| 2010 | “PTEN non-deleting posttranslational inactivation in human T-cell leukemia”, Instituto Gulbenkian de Ciência, Oeiras, Portugal, 24 September. (Host: Dr. Jocelyne Demengeot). |
Instituto Gulbenkian de Ciência, Oeiras, Portugal, 24 September. (Host: Dr. Jocelyne Demengeot). (Oeiras, Portugal)
|
| 2010 | “Signal Transduction in Cancer”, Masters in Biomedical Sciences, University of Algarve, Faro, Portugal, 10 December. | Masters in Biomedical Sciences,
(Faro, Portugal)
|
| 2010 | “Cell signaling: overview” and “Cell signaling: PI3K”, Advanced Course on “Fundamentals of Genetics, Development and Neoplasia”, International Postgraduate Programme, Instituto de Investigação em Ciências da Vida e Saúde (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 14 October. | Advanced Course on “Fundamentals of Genetics, Development and Neoplasia”, International Postgraduate Programme, Instituto
de Investigação em Ciências da Vida e Saúde (ICVS)
(Braga, Portugal)
|
| 2010 | “Signal Transduction Aberrations in Cancer” and “’Novel’ Concepts in Cancer Signal Transduction”, Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 9 March. | Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC)
(Coimbra, Portugal)
|
| 2010 | Identification of three novel TAL1 target genes with potential relevance in T-cell acute lymphoblastic leukemia. A. Gírio, N. Correia, A.R. Grosso, B.A. Cardoso, J.T. Barata* (Poster presentation) | SINAL 2010 – 4th National Meeting on Signal Transduction
(Faro, Portugal)
|
| 2010 | TAL1/SCL is downregulated upon histone deacetylase inhibition in human T-cell leukemia. B.A. Cardoso, S. Almeida, P.J. Coffer, J.T. Barata* (Poster presentation) | SINAL 2010 – 4th National Meeting on Signal Transduction
(Faro, Portugal)
|
| 2010 | Inhibition of PI3K sensitizes T-ALL cells to prednisolone and methotrexate. A.B. Silveira, B. Nogueira, B.A. Cardoso, P. Leal, R.A. Yunes, J.T. Barata, N.I.T. Zanchin, J.A. Yunes (Poster presentation) | European Hematology Association and European School of Haematology Joint Scientific Workshop “T-cell Acute Lymphoblastic Leukemia
(T-ALL) Meets Normal T-cell Development”
(Mandelieu, França)
|
| 2009/12 | Targeting CK2 Overexpression as a Novel Therapeutic Tool in Chronic Lymphocytic Leukemia. L.R. Martins, P. Lúcio, P. Gameiro, M.G. Silva, J.T. Barata*. | The American Society of Hematology 51st Annual Meeting
ASH - American Society of Hematology (New Orleans, Estados Unidos)
|
| 2009/05 | Crosstalk between PI3K-Akt/PKB pathway and Intracellular Reactive Oxygen Species is Essential for IL-7-mediated Viability of Leukemia T-cells. A. Silva, A. Girio, I. Cebola, C. Santos, F. Antunes, J.T. Barata*. | SINAL 2009 – 3rd National Meeting on Signal Transduction
SINAL - Signal Transduction Network (Aveiro, Portugal)
|
| 2009 | “Does IL-7/IL-7R-mediated signaling promote human T-cell leukemia?”, SINAL 2009 – 3rd National Meeting on Signal Transduction, University of Aveiro, Portugal, 29-30 May. | SINAL 2009 – 3rd National Meeting on Signal Transduction
(Aveiro, Portugal)
|
| 2009 | Plenary session: “Beyond the gene: PTEN inactivation in human T cell leukemia”, XI Meeting of Sociedade Ibérica de Citometria (Iberian Society of Cytometry), Covilhã, Portugal, 7-9 May. | XI Meeting of Sociedade Ibérica de Citometria (Iberian Society of Cytometry)
(Covilhã, Portugal)
|
| 2009 | “Inactivation of PTEN in primary T-cell acute leukemia: beyond the canons”, WKZ – Wilhelmina Children’s Hospital, University Medical Center, Utrecht, The Netherlands, 16 April. (Host: Prof. Paul Coffer). |
WKZ – Wilhelmina Children’s Hospital, University Medical Center, Utrecht, The Netherlands, 16 April. (Host: Prof. Paul Coffer). (Utrecht, Países Baixos)
|
| 2009 | “PTEN inactivation in primary T-cell acute leukemia: more than the canons”, Max Delbruck Center for Molecular Medicine, Berlin, Germany, 9 February. (Hosts: Dr. Jan Schmollinger and Prof. Thomas Blankenstein). |
Max Delbruck Center for Molecular Medicine, Berlin, Germany, 9 February. (Hosts: Dr. Jan Schmollinger and Prof. Thomas Blankenstein). (Berlin, Alemanha)
|
| 2009 | “Signal Transduction Aberrations in Cancer” and “’Novel’ Concepts in Cancer Signal Transduction”, Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, March 17. | Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC)
(Coimbra, Portugal)
|
| 2009 | IL-7 accelerates human T-cell leukemia progression in vivo. Cytokine. A. Silva, B. Seddon, J.T. Barata* (Poster presentation) | Tri-Society Annual Conference, Cellular and Cytokine Interactions in Health and Disease
(Lisbon, Portugal)
|
| 2009 | Molecular signatures of tumors susceptible or resistant to ¿¿ T cell-mediated cytotoxicity. D.V. Correia, T. Lança, A.R. Grosso, J.T. Barata, A.Q. Gomes, B. Silva-Santos (Poster presentation) | XXXV Annual Meeting of the Portuguese Society of Immunology
(Lisbon, Portugal)
|
| 2009 | HDAC inhibitors in T-ALL: is TAL1 important? B.A. Cardoso, P.J. Coffer, J.T. Barata* (Poster presentation) | SINAL 2009 – 3rd National Meeting on Signal Transduction
(Aveiro, Portugal)
|
| 2009 | Crosstalk between PI3K-Akt/PKB pathway and Intracellular Reactive Oxygen Species is Essential for IL-7-mediated Viability of Leukemia T-cells. A. Silva, I. Cebola, C. Santos, A. Girio, F. Antunes, J.T. Barata* (Poster presentation) | Keystone Symposium on PI 3-Kinase Signaling in Disease (Z3)
(Olympic Valley, Estados Unidos)
|
| 2008/11 | PTEN Non-deletional Posttranslational Inactivation and PI3K/Akt Pathway Hyperactivation Sustain Primary T-Cell Acute Lymphoblastic Leukemia. A. Silva, J.A. Yunes, B.A. Cardoso, L.R. Martins, P.Y. Jotta, M. Abecasis, A.E. Nowill, N.R. Leslie, A.A. Cardoso, J.T. Barata*. | I Workshop DIFHEMAT “From Lymphoid Differentiation to Cancer”
(Madrid, Espanha)
|
| 2008/10 | Chasing the IL-7 receptor: Regulation of interleukin 7 receptor ¿ internalization, recycling and degradation by IL-7. C.M.O. Henriques, J. Rino, R.J. Nibbs, G.J. Graham, J.T. Barata*. | XXXIV Annual Meeting of the Portuguese Society of Immunology
SPI - Sociedade Portuguesa de Imunologia (Porto, Portugal)
|
| 2008/05 | Regulation of IL-7Ra internalization, recycling and degradation by IL-7. C.M.O. Henriques, J. Rino, R.J. Nibbs, G.J. Graham, J.T. Barata*. | SINAL 2008 – 2nd National Meeting of Signal Transduction
SINAL - Signal Transdcution Network (Porto, Portugal)
|
| 2008 | “Cancro – Perspectivas futuras na terapêutica [Cancer – Future perspectives in therapeutics”, Satellite Conference “Doenças do Século XXI [XXI Century Diseases]”, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal, 30 October. |
Universidade de Lisboa Faculdade de Farmácia (Lis, Portugal)
|
| 2008 | “Biologia do Cancro – PTEN e as mil e uma maneiras de inactivar um suppressor tumoral [Cancer Biology – PTEN and the one thousand plus one ways of inactivating a tumor suppressor]”, Conference “Genética Molecular – Genes que ditam o nosso quotidiano [Molecular Genetics – Genes that dictate our daily life], Lusófona University, Lisbon, Portugal, 6 June. | Conference “Genética Molecular – Genes que ditam o nosso quotidiano [Molecular Genetics – Genes that dictate our daily life]
Universidade Lusófona (Lisbon, Portugal)
|
| 2008 | “B-cell ontogeny and response to antigenic stimuli – implications for the pathogenesis of chronic lymphocytic leukemia”, Reunião sobre linfomas indolentes [Meeting on indolent lymphomas], Sociedade Portuguesa de Hematologia (Portuguese Hematology Society), Cascais, Portugal, 20 September. | Reunião sobre linfomas indolentes [Meeting on indolent lymphomas], Sociedade Portuguesa de Hematologia (Portuguese Hematology
Society)
Sociedade Portuguesa de Hematologia (Portuguese Hematology Society) (Cascais, Portugal)
|
| 2008 | “Flow Cytometry Applications”, Sixth Flow Cytometry Workshop, Flow Cytometry Unit, IMM, Lisbon, Portugal, 2 April. | Sixth Flow Cytometry Workshop
(Lisbon, Portugal)
|
| 2008 | “Signal Transduction Aberrations in Cancer” and “’Novel’ Concepts in Cancer Signal Transduction”, Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, March 10. | Advanced Course on Oncobiology, BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC)
(Coimbra, Portugal)
|
| 2008 | Cholesterol Promotes Acute Leukemia Progression through Systemic but Selective Endothelial Cell Activation. T. Carvalho, R. Fragoso, A.L. Gomes, C. Casalou, L. Martins, J. Barata and S. Dias (Poster presentation) | The American Society of Hematology 50th Annual Meeting
(San Francisco, Estados Unidos)
|
| 2008 | Chasing” the IL-7 receptor: Regulation of interleukin 7 receptor a internalization, recycling and degradation by IL-7. C.M.O. Henriques, J. Rino, R.J. Nibbs, G.J. Graham, J.T. Barata* (Poster presentation) | British Society for Immunlogy Congress 2008
(Glasgow, Reino Unido)
|
| 2008 | Cholesterol-Enriched Diet Promotes Leukemia Engraftment and Progression. R. Fragoso, T. Carvalho, A. Gomes, L. Martins, J. Barata, S. Dias (Poster presentation) | European Hematology Association - EHA 13th Congress
(Copenhagen, Dinamarca)
|
| 2008 | PI3K-Akt signaling pathway is essential for IL-7-mediated proliferation of positively selected human thymocytes, but not for IL-7-dependent viability or differentiation towards CD8+ lineage. L.R. Martins, L. Bicheiro, J.T. Barata* (Poster presentation) | SINAL 2008 – 2nd National Meeting of Signal Transduction
(Porto, Portugal)
|
| 2008 | Interleukin-4 Stimulates Proliferation and Growth of T-Cell Acute Lymphoblastic Leukemia Cells by Activating mTOR Signaling. B.A. Cardoso, L.R. Martins, C. Santos, L.M. Nadler, V.A. Boussiotis, A.A. Cardoso, J.T. Barata* (Poster presentation) | SINAL 2008 – 2nd National Meeting of Signal Transduction
(Porto, Portugal)
|
| 2008 | Posttranslational non-deletional inactivation of PTEN and consequent hyperactivation of PI3K/Akt pathway contribute to primary T-cell leukemia. A. Silva, J.A. Yunes, B.A. Cardoso, L.R. Martins, P.Y. Jotta, M. Abecasis, A.E. Nowill, N.R. Leslie, A.A. Cardoso, J.T. Barata* (Poster presentation) | SINAL 2008 – 2nd National Meeting of Signal Transduction
(Porto, Portugal)
|
| 2007/11 | IL-7 and IL-7R promote T-cell leukemogenesis in vivo. A. Silva, E. Buentke, B. Seddon*, J.T. Barata* | XXXIII Annual Meeting of the Portuguese Society of Immunology
SPI - Sociedade Portuguesa de Imunologia (Lisbon, Portugal)
|
| 2007 | “Leukemia Cells and the Bone Marrow Endothelium”, Vascular Wall and Endothelium Workshop, IMM, Lisbon, Portugal, 14 September. | Vascular Wall and Endothelium Workshop
Instituto de Medicina Molecular João Lobo Antunes (Lisbon, Portugal)
|
| 2007 | “External and cell-autonomous signals in T-cell leukemia”, SINAL – 1st National Meeting on Signal Transduction, Lisbon, 23 March. | SINAL – 1st National Meeting on Signal Transduction
(Lisbon, Portugal)
|
| 2007 | “PTEN, PI3K and IL-7: the ins and outs of T-cell acute leukemia”, IBMC (Institute of Molecular and Cellular Biology), University of Porto, Portugal, 16 November. (Host: Prof. Fernando Arosa). |
IBMC (Institute of Molecular and Cellular Biology), University of Porto, Portugal, 16 November. (Host: Prof. Fernando Arosa). (Porto, Portugal)
|
| 2007 | “Apoptosis in the Immune System”, for the Biochemistry of Cell Death Course run by Prof. Cecilia Rodrigues in the Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal, 9 May. | Biochemistry of Cell Death Course
Universidade de Lisboa Faculdade de Farmácia (Lisbon, Portugal)
|
| 2007 | “Cell Population Analysis by Flow Cytometry”, Introduction to Light Microscopy Course 2007, IMM, Lisbon, 11-13 January. | Introduction to Light Microscopy Course 2007
(Lisbon, Portugal)
|
| 2007 | Posttranslational non-deletional inactivation of PTEN and consequent hyperactivation of PI3K/Akt pathway regulate the viability of primary T-cell leukemias. A. Silva, J.A. Yunes, B.A. Cardoso, L.R. Martins, P.Y. Jotta, M. Abecasis, A.E. Nowill, N.R. Leslie, A.A. Cardoso, J.T. Barata* (Poster presentation) | British Assossiation for Cancer Research Meeting on "Cancer Signalling and Novel Cancer Therapeutics"
(London, Reino Unido)
|
| 2007 | Effects of IL-7 on the late stages of human thymocyte development. L.R. Martins, L. Bicheiro, J.T. Barata* (Poster presentation) | XXXIII Annual Meeting of the Portuguese Society of Immunology
(Lisbon, Portugal)
|
| 2007 | STAT activation contributes to IL-7-mediated growth, viability and cell cycle progression of T-cell acute lymphoblastic leukemia cells. C. Santos, L. Vinagre, A. Silva, B.A. Cardoso, L.R. Martins, A.A. Cardoso, J.T. Barata* (Poster presentation) | XXXIII Annual Meeting of the Portuguese Society of Immunology
(Lisbon, Portugal)
|
| 2007 | Molecular mechanisms of activation of human ¿¿ T cells by non-peptidic phosphoantigens. D. Correia, F. D’Orey, B.A. Cardoso, J.T. Barata, B. Silva-Santos (Poster presentations) | XXXIII Annual Meeting of the Portuguese Society of Immunology
(Lisbon, Portugal)
|
| 2007 | Human naïve CD4+CD45RA+CD31+ recent thymic emigrants can be maintained by IL-7. R. Azevedo, M.V.D. Soares, J.T. Barata, A.E. Sousa (Poster presentation) | XXXIII Annual Meeting of the Portuguese Society of Immunology
(Lisbon, Portugal)
|
| 2007 | TAL1 and LMO2 in T-cell Acute Lymphoblastic Leukemia: Origin or consequence? B.A. Cardoso, J. Gonçalves, J.T. Barata* (Poster presentation) | SINAL – 1st National Meeting on Signal Transduction
(Lisbon, Portugal)
|
| 2007 | Regulation of Motility and Migration of Leukemia T-Cells by IL-7-Mediated Signaling. C.M.O. Henriques, J.T. Barata* (Poster presentation) | SINAL – 1st National Meeting on Signal Transduction
(Lisbon, Portugal)
|
| 2007 | Determining the role of IL-7 in the induction and maintenance of leukaemia in an inducible IL-7R transgenic mouse model. A. Silva, E. Buentke, J.T. Barata, B. Seddon (Poster presentation) | Keystone Symposium on ‘Jaks, Stats and Immunity
(Steamboat Springs, Estados Unidos)
|
| 2006/12 | PTEN Inactivation Plays A Key Role In Primary T-Cell Acute Lymphoblastic Leukemia Maintenance. A. Silva, J.A. Yunes, P. Jotta, M. Abecasis, A.A. Cardoso, J.T. Barata*. | XV National Congress of Biochemistry
SPB - Sociedade Portuguesa de Bioquímica (Aveiro, Portugal)
|
| 2006/05 | Upregulation of Reactive Oxygen Species is Essential for IL-7-mediated Viability of Leukemia T-cells. A. Silva, J.T. Barata*. | II Workshop on Clinical Biochemistry
(Porto, Portugal)
|
| 2006/05 | Up-regulation of Intracellular Reactive Oxygen Species is Essential for IL-7-mediated Viability of Leukemia T-cells. A. Silva, J.T. Barata* | II National Symposium on Cytokines
(Coimbra, Portugal)
|
| 2006 | “Interleukin-7, PI3K and PTEN in Primary T-Cell Acute Lymphoblastic Leukemia”, Symposium on “Regulation of Protein Synthesis and Intracellular Signaling Mechanisms” (3 July), XXXV Annual Meeting of The Brazilian Society of Biochemistry and Molecular Biology (SBBq), Águas de Lindóia, SP, Brazil, 1-4 July. | Symposium on “Regulation of Protein Synthesis and Intracellular Signaling Mechanisms”
(Águas de Lindóia, Brasil)
|
| 2006 | “Microenvironmental and cell-autonomous signals in leukemia: IL-7, PI3K and T-ALL”, Barts and The London School of Medicine, London, UK, 7 September. (Host: Dr. Georges Vassaux). |
Barts and The London School of Medicine, London, UK, 7 September. (Host: Dr. Georges Vassaux). (London, Reino Unido)
|
| 2006 | “PI3K and IL-7: In and Out of Acute T-cell Leukemia”, National Laboratory of Light “Sincroton”, Campinas, SP, Brazil, 30 June. (Host: Prof. Nilson Zanchin). |
National Laboratory of Light “Sincroton”, Campinas, SP, Brazil, 30 June. (Host: Prof. Nilson Zanchin). (Campinas, Brasil)
|
| 2006 | Interplay between PI3K pathway and intracellular ROS is essential for IL-7-mediated viability of leukaemia T-cells. A. Silva, I. Cebola, J.T. Barata* (Poster presentation) | Genes and Cancer Meeting 2006
(Coventry, Reino Unido)
|
| 2006 | IL-7-mediated Viability of Acute Lymphoblastic Leukemia T-cells is Modulated by Intracellular Reactive Oxygen Species. A. Silva, I. Cebola, J.T. Barata* (Poster presentation) | Sixth ESH - UT MD Anderson Cancer Center Interdisciplinary Euroconference on Mechanisms of Cell Death and Disease: Advances
in Therapeutic Intervention and Drug Development
(Cascais, Portugal)
|
| 2006 | A expressão do gene SLIT-1 nas leucemias agudas é restrita às Leucemias Linfoides Agudas de linhagem T [The expression of the gene SLIT-1 in acute leukemias is restricted to acute lymphoid leukemias of T-cell lineage]. P.Y. Jotta, P.R. Oblessuc, B. Cardoso, J.T. Barata, S.R. Brandalise, A.A. Cardoso, J.A. Yunes (Poster presentation) | 52nd Brazilian Congress of Genetics
(Foz do Iguaçu, Brasil)
|
| 2006 | PTEN Inactivation Plays A Key Role In Primary T-Cell Acute Lymphoblastic Leukemia Maintenance. A. Silva, J.A. Yunes, P. Jotta, A.A. Cardoso, J.T. Barata* (Poster presentation) | II Workshop on Clinical Biochemistry
(Porto, Portugal)
|
| 2006 | PTEN Inactivation and PI3K-Akt/PKB Constitutive Overactivation in Primary T-Cell Acute Lymphoblastic Leukemia. A. Silva, J.A. Yunes, A.A. Cardoso, J.T. Barata* (Poster presentation) | First ESH - AACR Conference on Molecular Basis for Targeted Therapy for Leukaemia
(Cascais, Portugal)
|
| 2005 | “Interleucinas na Leucemia de Células T [Interleukins in T-cell Leukemia]”, II Scientific Symposium – Immunology, MedUBI, University of Beira Interior, Covilhã, Portugal, 12 May. | II Scientific Symposium – Immunology
Universidade da Beira Interior (Covilhã, Portugal)
|
| 2005 | “External Signals in Leukemogenesis: IL-7 and Human T-cell Leukemia”, Department of Immunology, University Medical Center, Utrecht, The Netherlands, 28 June. (Host: Prof. Paul Coffer). |
Department of Immunology, University Medical Center, Utrecht, The Netherlands, 28 June. (Host: Prof. Paul Coffer). (Utrecht, Países Baixos)
|
| 2005 | “IL-7-Mediated Signals in T-cell Acute Lymphoblastic Leukemia”, NIMR (National Institute for Medical Research), Mill Hill, London, UK, 17 March. (Host: Dr. Benedict Seddon). |
NIMR (National Institute for Medical Research), Mill Hill, London, UK, 17 March. (Host: Dr. Benedict Seddon). (London, Reino Unido)
|
| 2005 | “External Signals in Leukemogenesis: Can IL-7 Play a Role in T-cell Leukemia?”, Instituto Português de Oncologia Francisco Gentil – IPOFG (Portuguese Institute of Oncology Francisco Gentil), Lisbon, Portugal, 8 May. (Host: Dr. Sérgio Dias). |
Instituto Português de Oncologia Francisco Gentil – IPOFG (Portuguese Institute of Oncology Francisco Gentil), Lisbon, Portugal,
8 May. (Host: Dr. Sérgio Dias). (Lisbon, Portugal)
|
| 2005 | “The Role of IL-7 in Acute T-cell Leukemia”, for the Immunology Course run by Prof. Maria Margarida Telhada in the Faculty of Sciences, University of Lisbon, Portugal, 9 May. | Immunology Course run by Prof. Maria Margarida Telhada
Universidade de Lisboa Faculdade de Ciências (Lisbon, Portugal)
|
| 2005 | “Vias de sinalização aberrantes em cancro [Aberrant signal transduction pathways in cancer]”(together with Dr. Sara Vieira), Cancer Molecular and Cellular Biology Course: Introduction to the Molecular and Cellular Mechanisms of Cancer, IPOFG, Lisbon, Portugal, 2-4 March. | Cancer Molecular and Cellular Biology Course: Introduction to the Molecular and Cellular Mechanisms of Cancer
Instituto Português de Oncologia de Lisboa - Francisco Gentil (Lisbon, Portugal)
|
| 2005 | Constitutive over-activation of PI3K-AKT/PKB pathway in primary T-cell acute lymphoblastic leukemia. A. Silva, A.A. Cardoso, J.T. Barata* (Poster presentation) | EMBO/FEBS Advanced Lecture Course: Molecular Mechanisms in Signal Transduction and Cancer
(Spetses, Grécia)
|
| 2004/12 | Murine IL-7 mimics the functional and molecular effects of human IL-7 on normal and malignant human T cells. J.T. Barata, A. Silva, A.A. Cardoso. | XIV National Congress of Biochemistry
SPB - Sociedade Portuguesa de Bioquímica (Vilamoura, Portugal)
|
| 2004/12 | mTOR as Therapeutic Target for T-Cell Leukemia: Synergism with Conventional Cytotoxic Drugs and Signaling Inhibitors. A. Batista, J.T. Barata, L.F. Costa, S.E. Sallan, N. Carlesso, L.M. Nadler, A.A. Cardoso. | The American Society of Hematology 46th Annual Meeting
ASH - American Society of Hematology (San Diego, Estados Unidos)
|
| 2004 | “IL-7 Signaling in the Biology of T-cell Acute Leukemia”, IBMC (Institute of Molecular and Cellular Biology), University of Porto, Portugal, 7 June. (Host: Prof. Alexandre do Carmo). |
IBMC (Institute of Molecular and Cellular Biology), University of Porto, Portugal, 7 June. (Host: Prof. Alexandre do Carmo). (Porto, Portugal)
|
| 2004 | “Interleukin-7-mediated signaling in the biology of T-cell acute lymphoblastic leukemia”, IGC (Institute Gulbenkian of Science), Oeiras, Portugal, 20 February. (Host: Prof. Leonor Parreira) |
IGC (Institute Gulbenkian of Science), Oeiras, Portugal, 20 February. (Host: Prof. Leonor Parreira) (Oeiras, Portugal)
|
| 2004 | Crosstalk between Breast Cancer Cells and Bone Marrow Endothelium Require the Engagement of PI3K/Akt Signaling. J.G. Brandao, J.T. Barata, R. Nunes, L.M. Nadler, A.A. Cardoso (Poster presentation) | The American Society of Hematology 46th Annual Meeting
(San Diego, Estados Unidos)
|
| 2003 | An IL-7-Dependent Human Leukemia T-Cell Line as a Valuable Tool for Drug Discovery in T-ALL. J.T. Barata, V.A. Boussiotis, J.A. Yunes, A.A. Ferrando, L. Moreau, J.P. Veiga, S.E. Sallan, A.T. Look, L.M. Nadler, A.A. Cardoso (Poster presentation) | .The American Society of Hematology 45th Annual Meeting
(San Diego, Estados Unidos)
|
| 2002/12 | PI3K/PKB(Akt) is the dominant pathway regulating interleukin-7 mediated survival, activation and cell cycle progression of T-cell acute lymphoblastic leukemia (T-ALL) cells. J.T. Barata, A.A. Cardoso, J.G. Brandão, L.M. Nadler, V.A. Boussiotis. | The American Society of Hematology 44th Annual Meeting
ASH - American Society of Hematology (Philadelphia, Estados Unidos)
|
| 2002 | PI-3K/Akt(PKB) pathway is critical for interleukin-7-mediated survival, activation and cell cycle progression of T-cell acute lymphoblastic leukemia (T-ALL) cells. J.T. Barata, A.A. Cardoso, J.G. Brandão, L.M. Nadler, V.A. Boussiotis (Poster presentation) | 31st Annual Meeting of The International Society for Experimental Hematology
(Montreal, Canadá)
|
| 2001 | “Cytokine-mediated signal transduction”, Module of Molecular Immunology from the Program on Basic and Applied Biology (GABBA), IBMC, University of Porto, Portugal. | Module of Molecular Immunology from the Program on Basic and Applied Biology (GABBA)
Universidade do Porto Instituto de Biologia Molecular e Celular (Porto, Portugal)
|
| 2001 | IL-7 promotes viability and cell cycle progression of T cell acute lymphoblastic leukemia (T-ALL) cells through p27kip1 downregulation: relative contribution of Jak/Stat, PI3K/Akt and MAPK pathways. J.T. Barata, A.A. Cardoso, L.M. Nadler, V.A. Boussiotis (Poster presentation) | 27th Meeting of the Federation of European Biochemical Societies
(Lisbon, Portugal)
|
| 2000/12 | Downregulation of p27kip1 by IL-7 is mandatory for induction of bcl-2, promotion of viability and cell cycle progression in T cell acute lymphoblastic leukemia cells. J.T. Barata, A.A. Cardoso, S.E. Sallan, L.M. Nadler, V.A. Boussiotis. | The American Society of Hematology 42nd Annual Meeting
ASH - American Society of Hematology (San Francisco, Portugal)
|
| 2000/11 | Interleukin-7 promotes cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells through downregulation of p27kip1. J.T. Barata, A.A. Cardoso, L.M. Nadler, V.A. Boussiotis. | XXVI Annual Meeting of the Portuguese Society of Immunology
SPI - Sociedade Portuguesa de Imunologia (Porto, Portugal)
|
| 2000 | Tumor/Bone Marrow Dynamic Reciprocity: Intimate Interactions With Endothelium May Confer Selective Advantage to Breast Cancer Cells. R.A. Nunes, J.P. Veiga, J.T. Barata, L.M. Nadler, A.A. Cardoso (Poster presentation) | 23rd Annual San Antonio Breast Cancer Symposium
(San Antonio, Estados Unidos)
|
| 2000 | Molecular control of clonal expansion in T-ALL by IL-4 and IL-7. J.T. Barata, A.A. Cardoso, J. Donovan, L.M. Nadler, V.A. Boussiotis (Poster presentation) | Signaling 2000 Keystone Symposium on Molecular & Cellular Biology
(Keystone, Estados Unidos)
|
| 1999/12 | Peroxisome proliferator-activated receptor-y (PPARy) expression by bone marrow endothelium reveals a potential target for therapeutic intervention in acute lymphoblastic leukemia. J.P. Veiga, T.D. Keenan, J.T. Barata, S.E. Sallan, L.M. Nadler, A.A. Cardoso. | The American Society of Hematology 41st Annual Meeting
ASH - American Society of Hematology (New Orleans, Portugal)
|
| 1999 | Identification of molecular targets regulating growth of childhood T cell leukemia by IL-4 and IL-7. J.T. Barata, A.A. Cardoso, J. Donovan, L.M. Nadler, V.A. Boussiotis (Poster presentation) | The American Society of Hematology 41st Annual Meeting
(New Orleans, Estados Unidos)
|
| 1994/09 | Plant-parasitic nematodes associated with fig trees in Portugal. I.M. de O. Abrantes, M.S.N. de A. Santos, J.P.T. Barata & N. Vovlas. | 9th Congress of the Mediterranean Phytopathological Union
(Kusadasi, Turquia)
|
| 1993/12 | Nemátodes-das-galhas-radiculares, Meloidogyne spp., parasitas da figueira (Ficus carica L.) em Portugal. [Root-knot nematodes, Meloidogyne spp., parasites of Fig Tree (Ficus carica L.) in Portugal]. I.M. de O. Abrantes, J.P.T. Barata, M.S.N. de A. Santos & Z.M.C. de A. Trindade. | 2nd Meeting of Portuguese Phytopathologists
(Coimbra, Portugal)
|
Orientação
| Título / Tema Papel desempenhado |
Curso (Tipo) Instituição / Organização |
|
|---|---|---|
| 2024/08 - Atual | Marta B. Fernandes - Post-doctoral researcher
Orientador
|
|
| 2024/01/01 - Atual | Tatiana Araújo - PhD Student
Orientador
|
|
| 2023 - Atual | Maria Silva - MSc Student
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2021 - Atual | Mafalda Duque - PhD student (Supervisor: Dr. Rita Fragoso)
Coorientador
|
|
| 2021 - Atual | Miguel Martins - MSc student (Supervisor: Dr Joaquin Duarte)
Coorientador de Miguel Martins
|
|
| 2020 - Atual | Ana Cachucho - PhD Student
Orientador
|
|
| 2019 - Atual | Carlos Custódia - PhD student (Supervisor: Dr. Cláudia Faria, IMM/FMUL)
Coorientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2017 - Atual | Luís Monteiro - PhD student
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2013 - Atual | Rita Fragoso - Staff Scientist
Orientador
|
(Staff Scientist) (Outra)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2010 - Atual | “The role of CK2 in IL-7-mediated signaling in T-cell leukemia” - Maureen Spit (Supervisor) - Minor research project
Orientador
|
Universiteit Utrecht, Países Baixos
|
| 2005 - Atual | Supervisor of numerous students/technicians (BI - “bolseiros de Investigação”) integrated into the different funded research
projects that I have been leading. Given our policy of stimulating young students with interest and potential to follow a
scientific research career, also have been supervising numerous short-term interns throughout the years.
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2024/05 - 2024/07 | João Xavier de Carvalho (USA, Summer Internship)
Orientador
|
|
| 2022 - 2024 | Joana Cavaco - MSc Student (Supervisor: Dr. Rita Fragoso, iMM)
Coorientador
|
|
| 2018 - 2024 | Marta B. Fernandes - PhD student
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2017 - 2024 | Eunice Paisana - PhD student (Supervisor: Dr. Cláudia Faria, IMM/FMUL)
Coorientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2023/01 - 2023/09 | Alessia de Stefano, PhD student (Italy). Trained in the lab for 9 months (January-September) as part of her PhD project, supervised
by Prof. Matilde Y. Follo (University of Bologna, Italy).
Coorientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2023/05 - 2023/07 | Lena Schobloch (Germany, spring internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2022 - 2023 | Pedro Rosado - MSc Student
Orientador
|
|
| 2022 - 2023 | Hélio Crespo - Post-Doctoral Researcher
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2021 - 2023 | João Fontela - MSc student
Orientador de João Fontela
|
|
| 2021 - 2023 | Sara Gama - MSc student
Orientador
|
|
| 2021 - 2023 | Patrícia Amaral - MSc student
Orientador
|
|
| 2018 - 2023 | Rita Cascão - Senior Post-Doctoral Researcher
Coorientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2014 - 2023 | Cláudia Faria - Senior Researcher
Orientador
|
(Senior Researcher)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2015 - 2022/12/22 | Mariana L. Oliveira - PhD student
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2022/08 - 2022/08 | Germano Vicente (Portugal, Maria de Sousa GABBA summer internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2022 - 2022 | Maria-Eva Zimzik (Germany, SCORE summer internship for medical students)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2022 - 2022 | Audrey Mansilha (France, autumn internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2021 - 2022 | Oncogenic Transcription Factors in T-cell Acute Lymphoblastic Leukemia: a review and identification of a novel player – CASZ1”,
Integrated MSc in Medicine, Faculty of Medicine, Lisbon University.
Orientador de Francisco Alexandrino
|
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2020 - 2022 | Susana Moleirinho - Post-Doctoral Researcher
Orientador
|
|
| 2020 - 2022 | Tatiana Araújo - MSc student
Orientador
|
|
| 2020 - 2021 | Rita Alexandra Nunes Rodrigues, Project # 20210010: “CK2, PI3K-AKT pathway & the Circadian Molecular Clock: decoding the molecular
interactions network”. GAPIC program for medical students (Programa Educação Pela Ciência), Faculty of Medicine of Lisbon
University.
Orientador
|
|
| 2020 - 2021 | Juliana Ronchi, PhD student (Brazil). Trained in the lab for more than 1 year as part of her PhD project, sponsored by FAPESP
(Brazil), within a collaboration with the lab of Dr. J. Andres Yunes (Centro Infantil Boldrini, Campinas, SP, Brazil), PhD
thesis supervisor.
Coorientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2020 - 2021 | Rita Alexandra Nunes Rodrigues, Project # 20210010: “CK2, PI3K-AKT pathway & the Circadian Molecular Clock: decoding the molecular
interactions network”. GAPIC program for medical students (Programa Educação Pela Ciência), Faculty of Medicine of Lisbon
University.
Orientador
|
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2019 - 2021 | João Neto - Post-Doctoral Researcher
Orientador
|
|
| 2019 - 2021 | Clara Dias - Post-Doctoral Researcher
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2019 - 2021 | "The impact of IL-7 on metabolic reprogramming in T-cell acute lymphoblastic leukemia”, for the MSc in Biotechnology, Wien
University, Austria
Orientador de Brian Ringhofer
|
|
| 2017 - 2021 | Daniel Ribeiro - Post-Doctoral Researcher
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2016 - 2021 | Bruno Cardoso - Senior Post-Doctoral Researcher
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2010/10 - 2020/12 | Alice Melão - PhD Student
Orientador de Alice Melão
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2017 - 2020 | Sara Rocha - PhD student (Supervisor: Dr. Carla Oliveira, IPATIMUP)
Coorientador
|
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
|
| 2016 - 2020 | Sara Rocha - PhD Student (Supervisor: Dr. Carla Oliveira, IPATIMUP)
Coorientador
|
|
| 2019 - 2019 | Hannah Taylor (USA, winter internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2018 - 2019 | Francisco Alexandrino, Project #20190012. GAPIC program for medical students (Programa Educação Pela Ciência), Faculty of
Medicine of Lisbon University.
Orientador
|
|
| 2018 - 2019 | Francisco Alexandrino, Project #20190012. GAPIC program for medical students (Programa Educação Pela Ciência), Faculty of
Medicine of Lisbon University.
Orientador
|
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2015 - 2019 | Afonso Almeida - Senior Post-Doctoral Researcher
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2015 - 2019 | Mafalda Ramos Matos - PhD Student (Supervisor: Prof. Sérgio Almeida, IMM/FMUL)
Coorientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2014 - 2019 | Padma Akkapeddi - PhD Student (joint supervision with Dr. Gonçalo Bernardes)
Coorientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2018 - 2018 | Veronika Waas (Germany, summer internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2018 - 2018 | Françoise Sanderse (Belgium, summer internship within collaborative work with Ghent University - group of Prof. Pieter Van
Vlierberghe)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2017 - 2018 | Gonçalo Lopes Martins Pereira, Project #20180017. GAPIC program for medical students (Programa Educação Pela Ciência), Faculty
of Medicine of Lisbon University.
Orientador
|
|
| 2017 - 2018 | Gonçalo Lopes Martins Pereira, Project #20180017. GAPIC program for medical students (Programa Educação Pela Ciência), Faculty
of Medicine of Lisbon University.
Orientador
|
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2015 - 2018 | Teresa Serafim - Lab Manager/Post-Doctoral Researcher
Orientador
|
(Lab Manager/Post-Doctoral Researcher)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2013 - 2018 | Isabel Alcobia - Staff Scientist
Orientador
|
(Staff Scientist)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2017 - 2017 | Nina Fraticelli Guzman (USA, summer internship)
Orientador
|
|
| 2017 - 2017 | Nina Fraticelli Guzman (USA, summer internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2016 - 2017 | Andreia Amaral - Post-Doctoral Researcher
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2016 - 2017 | “The role of NRARP in the pathogenesis of T-cell Acute Lymphoblastic Leukemia” - Inês Pinto - Msc. student (Supervisor: Dr.
Rita Fragoso IMM).
Coorientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal |
| 2015 - 2016 | Raquel Linheiro - Post-Doctoral Researcher
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2012 - 2016 | Daniel Ribeiro - PhD Student
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2009 - 2016 | Leonor M. Sarmento - Senior Post-Doctoral Researcher
Orientador
|
(Senior Post-Doctoral Researcher)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2015 - 2015 | Nádia Correia - Post-Doctoral Researcher
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2015 - 2015 | Yolanda Afonso (Portugal, spring internship)
Orientador
|
|
| 2015 - 2015 | Yolanda Afonso (Portugal, spring internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2014 - 2015 | Hugo Filipe Loureiro Cadilha. Project #20150037. GAPIC program for medical students (Programa Educação Pela Ciência), Faculty
of Medicine of Lisbon University.
Orientador
|
|
| 2014 - 2015 | Hugo Filipe Loureiro Cadilha. Project #20150037. GAPIC program for medical students (Programa Educação Pela Ciência), Faculty
of Medicine of Lisbon University.
Orientador
|
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2009 - 2015 | Nádia Correia - PhD Student
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2014 - 2014 | Rita Cabrita (Portugal, summer internship)
Orientador
|
|
| 2014 - 2014 | Inês Pinto (Portugal, summer intership)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2014 - 2014 | Rita Cabrita (Portugal, summer internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2012 - 2014 | Leila Martins - Post-Doctoral Researcher
Orientador
|
(Post-Doctoral Researcher)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2013 - 2013 | Yasser Perea - Visiting Post-Doctoral Researcher
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2013 - 2013 | Ana Bolhaqueiro (Portugal, spring internship)
Orientador
|
|
| 2013 - 2013 | Joana Ferreira (Portugal, summer internship)
Orientador
|
|
| 2013 - 2013 | Josep Sampedro Soler (Spain, summer internship)
Orientador
|
|
| 2013 - 2013 | Josep Sampedro Soler (Spain, summer internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2013 - 2013 | Joana Ferreira (Portugal, summer internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2013 - 2013 | Ana Bolhaqueiro (Portugal, spring internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2012 - 2013 | João Tavanez - Post-Doctoral Researcher
Orientador
|
(Post-Doctoral Researcher)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2012 - 2013 | Maria Inês Felizardo Lopes. Project #20130007/PEC/BG. GAPIC program for medical students (Programa Educação Pela Ciência),
Faculty of Medicine of Lisbon University.
Orientador
|
|
| 2012 - 2013 | Maria Inês Felizardo Lopes. Project #20130007/PEC/BG. GAPIC program for medical students (Programa Educação Pela Ciência),
Faculty of Medicine of Lisbon University.
Orientador
|
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2007 - 2013 | Ana Gírio - Post-Doctoral Researcher
Orientador
|
(Post-Doctoral Researcher)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2012 - 2012 | Susana Santos (Portugal, summer internship)
Orientador
|
|
| 2012 - 2012 | Susana Santos (Portugal, summer internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2011 - 2012 | Marta Cancella de Abreu. Project #20120030. GAPIC program for medical students (Programa Educação Pela Ciência), Faculty of
Medicine of Lisbon University.
Orientador
|
|
| 2011 - 2012 | Marta Cancella de Abreu. Project #20120030. GAPIC program for medical students (Programa Educação Pela Ciência), Faculty of
Medicine of Lisbon University.
Orientador
|
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2009 - 2012 | Inês Antunes - Post-Doctoral Researcher
Orientador
|
Post-Doctoral Researcher
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2008 - 2012 | Leila Martins - PhD Student
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2011 - 2011 | Nuno Guerra (Portugal, summer internship)
Orientador
|
|
| 2011 - 2011 | Ahmed Bahaeldin Abdelaal (Egipt, high school student; summer internship)
Orientador
|
|
| 2011 - 2011 | Michael Svaton (Chec Republic, SCORE summer internship estágio for medical students)
Orientador
|
|
| 2011 - 2011 | Michael Svaton (Chec Republic, SCORE summer internship for medical students)
Orientador
|
|
| 2011 - 2011 | Ahmed Bahaeldin Abdelaal (Egipt, high school student; summer internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2011 - 2011 | Nuno Guerra (Portugal, summer internship)
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2006 - 2011 | Bruno Cardoso - PhD Student
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2006 - 2010 | Ana Silva - PhD Student
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2006 - 2010 | Catarina Henriques - PhD Student
Orientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2009 - 2009 | “The role of PTEN, CK2 and the PI3K/Akt pathway in B cell acute lymphoblastic leukemia (B-ALL)” - Marie Tazreiter
Orientador
|
Universität Wien, Áustria
|
| 2003 - 2005 | Collaborated in the supervision of two PhD students, Joana Brandão and Ana Batista in the Tumor Biology Unit, Institute of
Molecular Medicine, Faculty of Medicine of Lisbon University, Portugal.
Coorientador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 1998 - 2001 | Lab work supervision of several undergraduate students in short-term research projects performed at the Department of Adult
Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Coorientador
|
Dana Farber Cancer Institute, Estados Unidos
|
Organização de evento
| Nome do evento Tipo de evento (Tipo de participação) |
Instituição / Organização | |
|---|---|---|
| 2018/09/21 - 2018/09/22 | Organizer (with Peter Jordan and Duarte Barral), and co-Chair of Session 4 (with Alexandre do Carmo), SINAL 2018 – 9th Meeting
on Signal Transduction, Teatro Thalia, Lisbon, Portugal, 21-22 September. (2018/09/21 - 2018/09/22)
Congresso (Coorganizador)
|
|
| 2017/06/22 - 2017/06/22 | Organizer (with Iñaki Martin-Subero and Juan Bueren), YoungEHA Research Meeting on Molecular Aspects of Hematological Disorders,
Madrid, Spain, 22 June. (2017/06/22 - 2017/06/22)
Conferência (Membro da Comissão Organizadora)
|
|
| 2017/06/01 - 2017/06/02 | Organizer (with Peter Jordan, Duarte Barral and François Radvanyi), and co-Chair of Session 2 (with Alexandre do Carmo), SINAL
2017 – 8th Meeting on Signal Transduction, Pavilhão do Conhecimento, Lisbon, Portugal, 1-2 June. (2017/06/01 - 2017/06/02)
Congresso (Coorganizador)
|
|
| 2017/05/29 - 2017/05/31 | Organizer (with François Radvanyi), ReTuBi Twinning network 2017 Summer School, Oceanário de Lisboa, Lisbon, Portugal, 29-31
May. (2017/05/29 - 2017/05/31)
Congresso (Coorganizador)
|
|
| 2010/04 - 2010/05 | Organizer, Cancer Course for the IMM International PhD Program, IMM, Lisbon, Portugal, 19-21 April and 17-18 May. (2010/04 - 2010/05)
Oficina (workshop) (Membro da Comissão Organizadora)
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 2009/04/27 - 2009/04/30 | Organizer, Cancer Course for the IMM International PhD Program, IMM, Lisbon, Portugal, 27-30 April. (2009)
Oficina (workshop) (Presidente da Comissão Organizadora)
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 2008/02/19 - 2008/02/22 | Organizer, Fifth Flow Cytometry Workshop, Flow Cytometry Unit, IMM, Lisbon, Portugal, 19-22 February. (2008)
Oficina (workshop) (Presidente da Comissão Organizadora)
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 2007/11/14 - 2007/11/16 | Member of the local organizing committee at IMM, XXXIII Annual Meeting of the Portuguese Society of Immunology, Lisbon, Portugal,
14-16 November. (2007)
Congresso (Membro da Comissão Organizadora)
|
Sociedade Portuguesa de Imunologia, Portugal |
| 2007/03/23 - 2007/03/23 | Organizer, SINAL – 1st National Meeting on Signal Transduction, IMM/FML, Lisbon, Portugal, 23 March (Together with Peter Jordan). (2007)
Conferência (Coorganizador)
|
|
| 2007/02 - 2007/02 | Organizer, Third and Fourth Flow Cytometry Workshops, Flow Cytometry Unit, IMM, Lisbon, Portugal, 29 January – 1 February
and 14-16 February. (2007)
Oficina (workshop) (Presidente da Comissão Organizadora)
|
|
| 2006/05/15 - 2006/05/19 | Co-organizer, Second Flow Cytometry Workshop, Flow Cytometry Unit, IMM, Lisbon, Portugal, 15-19 May. (2006)
Oficina (workshop) (Coorganizador)
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 2005 - 2006 | Organizer of the Monday International Seminars of IMM (Together with António Jacinto, Maria Mota and Maria Soares). (2005 - 2006)
Seminário (Coorganizador)
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 2005 - 2005 | Organizer of the inter-departmental informal seminars (“Cake seminars”) and the Friday External Seminars of IMM (Together
with António Jacinto, Maria Mota and Maria Soares). (2005)
Seminário (Coorganizador)
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 1999/11/20 - 1999/11/21 | Organization collaborator, Portugal: Strategic Options in a European Context, Minda de Gunzburg Center for European Studies, Harvard University, Cambridge, MA, USA, 20-21 November. (1999) | |
| 1995/07/16 - 1995/07/28 | Member of the Organizing Committee, Course on Quality Management, University of Coimbra, Portugal, 16-28 July. (1995 - 1995)
Oficina (workshop) (Membro da Comissão Organizadora)
|
|
| 1993/12/02 - 1993/12/03 | Organization collaborator, 2nd Meeting of Portuguese Phytopathologists, University of Coimbra, Coimbra, Portugal, 2-3 December. (1993 - 1993)
Encontro (Membro da Comissão Organizadora)
|
|
| 1992/04/11 - 1992/04/17 | Organization collaborator, 21st International Nematology Symposium, European Society of Nematologists (ESN), Albufeira, Portugal,
11-17 April. (1992 - 1992)
Simpósio (Coorganizador)
|
Participação em evento
| Descrição da atividade Tipo de evento |
Nome do evento Instituição / Organização |
|
|---|---|---|
| 2022/09/29 - Atual | Co-moderator (together with Luisa Lopes) of the morning session, iMM Post-Doc Day, Lisbon, Portugal, 29 September. |
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2021/03 - Atual | Online Meeting Functional Precision Medicine in Blood Cancer, Comprehensive Cancer Center Zürich, 25-26 March. | |
| 2023/12/09 - 2023/12/12 | Chair of Session 603. Lymphoid Oncogenesis – basic. Mechanisms of acute lymphoblastic leukemia development and progression.
65th ASH Annual Meeting, San Diego, CA, USA, 9-12 December.
Conferência
|
65th ASH Annual Meeting |
| 2022/10/04 - 2022/10/05 | Chair of Session XI: Leukaemia and Lymphoma, 63rd Advances in Biological Regulation Symposium, University of Bologna | |
| 2022/06/30 - 2022/07/01 | Co-chair of the EACR and ASEICA plenary lectures, 5th ASPIC International Congress, Porto, Portugal, 30 June - 1 July | |
| 2021/03/25 - 2021/03/26 | Online Meeting Functional Precision Medicine in Blood Cancer, Comprehensive Cancer Center Zürich, 25-26 March.
Conferência
|
Online Meeting Functional Precision Medicine in Blood Cancer
Comprehensive Cancer Center Zürich, Suiça
|
| 2019/05/20 - 2019/05/20 | “Sinalização em cancro: travões, reviravoltas, música e um pouco de literatura na procura de novos tratamentos [Signaling
in cancer: breaks, turns, music and a little bit of literature while seeking for new treatments]”, Pint of Science Festival,
Lisboa, Portugal, 20 May.
Mesa-redonda
|
|
| 2018/02/02 - 2018/02/02 | “ABC do cancro (e um pouco de investigação) em 60 minutos [ABC of cancer (and a little bit of research) in 60 minutes]”, High
School Colégio Rainha D. Leonor, Caldas da Rainha, Portugal, 2 February.
Mesa-redonda
|
|
| 2018 - 2018 | Entry Level Bioinformatics, Gulbenkian Training Programme in Bioinformatics, Instituto Gulbenkian de Ciência, 19-23 February.
Oficina (workshop)
|
Instituto Gulbenkian de Ciência, Portugal
|
| 2017/06/22 - 2017/06/25 | Chair, Basic-Science-in-Focus session on: Mouse models of acute leukemia (Sunday, 25 June), 22nd Congress of the European
Hematology Association, Madrid, Spain, 22-25 June.
Congresso
|
European Hematology Association, Países Baixos
|
| 2016/06/01 - 2016/06/03 | Co-Chair (with Karine Serre), Immunotherapies (2 June) and Cancer Immunotherapy (3 June) Sessions, XLII Annual Meeting of
the Portuguese Society of Immunology, Oeiras, 1-3 June.
Congresso
|
Sociedade Portuguesa de Imunologia, Portugal
|
| 2015/02/25 - 2015/02/25 | “Em busca de novas terapias para o cancro [A quest for new therapies against cancer]”, Maria Amália Vaz de Carvalho High School,
Lisboa, Portugal, 26 February.
Mesa-redonda
|
|
| 2014 - 2014 | EHA-SWG Scientific Meeting on “New molecular insights in emerging therapeutic strategies in Acute Lymphoblastic Leukemia (ALL)”,
28 February - 2 March.
Encontro
|
|
| 2013/03/22 - 2013/03/24 | Co-Chair (with Jon Aster), Session II; and co-chair (with Jan Cools), Session V; Second ESH-EHA Scientific Workshop on T-cell
Acute Lymphoblastic Leukemia, Lisbon, Portugal, 22-24 March.
Conferência
|
|
| 2012/04/19 - 2012/04/20 | Co-Chair (with John Blenis), Session I (mTOR and Cancer), XXI Porto Cancer Meeting (on Metabolism and Cancer – from Etiopathogenesis
to Therapy), Porto, Portugal, 19-20 April.
Conferência
|
|
| 2012/03/05 - 2012/03/08 | Co-Chair (with Silvio Perea), Cancer Biology and Treatment session, International Meeting Biotecnología Habana 2012 – Medical
Applications of Biotechnology, Havana International Conference Center, Havana, Cuba, 5-8 March.
Congresso
|
|
| 2012 - 2012 | The Fourth Champalimaud Cancer Symposium – Early Cancer Detection and Treatment, Lisbon, Portugal, 15 June.
Simpósio
|
|
| 2011 - 2011 | Thymus@Porto Workshop, IBMC, Porto, Portugal, 14 October.
Oficina (workshop)
|
|
| 2011 - 2011 | Champalimaud Cancer Research Symposium 2011, Lisbon, Portugal, 14-15 January.
Simpósio
|
|
| 2009/05/29 - 2009/05/30 | Co-Chair, Day 2 session, SINAL 2009 – 3rd National Meeting on Signal Transduction, University of Aveiro, Portugal, 29-30 May.
Congresso
|
SINAL 2009 – 3rd National Meeting on Signal Transduction |
| 2009 - 2009 | I National Forum of R&D in Health, National Institute of Health Ricardo Jorge, Lisbon, Portugal, 4 September.
Mesa-redonda
|
|
| 2009 - 2009 | Champalimaud Cancer Research Symposium, Lisbon, Portugal, 20 May
Simpósio
|
|
| 2006/12/15 - 2006/12/19 | Chair, Session VII: Angiogenesis/Medicine, First Annual Meeting of Gulbenkian Students, Instituto Gulbenkian de Ciência, Oeiras,
Portugal, 15-19 December.
Encontro
|
Instituto Gulbenkian de Ciência, Portugal
|
| 2006 - 2006 | Practical Module on “Accomodation, Manipulation and Interventions on Small Laboratory Animals – Rats and mice” of the 1st
Course on “Laboratory animal science experimentation”, SPCAL (Portuguese Society for Laboratory Animal Sciences), Instituto
Gulbenkian de Ciência, Oeiras, Portugal, 26 and 27 June (12 hours) – Total course: 45 hours.
Outro
|
|
| 2006 - 2006 | 6th International ELMI Meeting and Workshop on Advanced Light Microscopy, Ofir, Portugal, 30 May – 2 June.
Oficina (workshop)
|
|
| 2006 - 2006 | International Course on Toxicology “Smart Toxicology: Subcellular Targets of Anti-cancer Therapy”, Center for Neurosciences
and Cell Biology, University of Coimbra, Portugal, 22-24 March.
Oficina (workshop)
|
|
| 2006 - 2006 | Biostatistics module of the 1st Course on “Laboratory animal science experimentation”, SPCAL, Faculty of Pharmacy, University
of Coimbra, Coimbra, Portugal, 10 and 17 February (10 hours).
Outro
|
|
| 2005 - 2005 | Workshop on the Mechanisms of T-cell recognition and activation, Instituto de Biologia Molecular e Celular – IBMC (Institute
of Molecular and Cellular Biology), University of Porto, Portugal, 28 November.
Oficina (workshop)
|
|
| 2005 - 2005 | Cancer Research Forum, Luso, Portugal, 18 November.
Mesa-redonda
|
|
| 2005 - 2005 | Theoretical module of the 1st Course on “Laboratory animal science experimentation”, SPCAL, Faculty of Pharmacy, University
of Coimbra, Coimbra, Portugal, 17-19 October (23 hours).
Outro
|
|
| 2004 - 2004 | Chair, 1st session on Immunology, Joint Meeting of Graduate Programmes on Biosciences, Hotel Vila Galé, Porto, Portugal, 16-20
December.
Encontro
|
Joint Meeting of Graduate Programmes on Biosciences |
| 2004 - 2004 | GABBA Mini-Symposium on Lymphocyte Biology “Complexity and Plasticity of Lymphocyte Differentiation”, IBMC, University of
Porto, Portugal, 15 December.
Simpósio
|
|
| 2004 - 2004 | Theoretical part of the course on Microarrays: Principles and Applications in Medicine, School of Health Sciences, University
of Minho, Braga, Portugal, 24-25 May.
Outro
|
|
| 2004 - 2004 | Workshop on Gene Expression and Cellular Responses, IBMC, University of Porto, Portugal, 16 January.
Oficina (workshop)
|
|
| 2003/12/18 - 2003/12/19 | Co-chair, Day 2 Session 2, GABBA Annual Scientific Meeting, IPATIMUP, Porto, Portugal, 18-19 December.
Encontro
|
GABBA Annual Scientific Meeting |
| 2003 - 2003 | Workshop ‘The Immunological Synapse’, IBMC, University of Porto, Portugal, 16 May.
Oficina (workshop)
|
|
| 2000 - 2000 | EMBO Practical Course on Lentiviral Vectors For Gene Transfer (supervised by Prof. Luigi Naldini), Institute for Cancer Research
and Treatment, University of Turin, Italy, 25-30 September.
Oficina (workshop)
|
|
| 1998 - 1998 | Investing in the Future: Industry/University Collaborations, Portuguese-American Post-graduate Society Forum, MIT Sloan School
of Management, Cambridge, MA, USA, 24 October.
Mesa-redonda
|
|
| 1997 - 1997 | Molecular and Cellular Components of the Immune System, European Network of Immunology Institutes, Les Embiez, France, 21-25
May.
Simpósio
|
|
| 1997 - 1997 | Advanced International Course on Regulatory Mechanisms Involved in Cell Ageing and Death, IBMC, University of Porto, Portugal,
12-20 May.
Outro
|
|
| 1997 - 1997 | Advanced International Course on Oncobiology: Cell Migration and Cell Invasiveness in Oncobiology, IPATIMUP, University of
Porto, Portugal, 14-24 April.
Outro
|
|
| 1996 - 1996 | Course: From Biosystems to Bioprocess Engineering - An Interdisciplinary Challenge, Board of European Students of Technology,
Rome, Italy, 8-20 September.
Outro
|
|
| 1994 - 1994 | Life Cycle Assessment Course, Board of European Students of Technology, Göteborg, Sweden, 15-26 August.
Outro
|
|
| 1993 - 1994 | Scientific Illustration Course, Portuguese Biologists Association, Coimbra, Portugal, 3 December – 15 January.
Outro
|
Júri de grau académico
| Tema Tipo de participação |
Nome do candidato (Tipo de grau) Instituição / Organização |
|
|---|---|---|
| 2024/06/03 | ''Exploring New Crossroads on IL-7R-mediated Signaling in Lymphoid Development and Acute Lymphoblastic Leukemia''
Orientador
|
Marta B. Fernandes (Doutoramento) |
| 2024/01/12 | ''UBE2C promotes leptomeningeal dissemination and can be therapeutically targeted''
Orientador
|
Eunice Paisana (Doutoramento) |
| 2023/12/20 | “Study of the impact of the IL-7R on non-small cell lung cancer”.
Orientador
|
Pedro Lino Rosado (Mestrado)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
| 2023/12/07 | “Targeting cancer-related proteins: Rational design of covalent inhibitors and degraders for TEC kinases and serine hydrolases”
Arguente
|
Bárbara Sousa (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2023/12/05 | “The involvement of DIS3L2 in nonsense-mediated mRNA decay and its functional networks in cancer”
Arguente principal
|
Juan García-Moreno (Doutoramento)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
| 2023/11/03 | “The T cell surface glycoprotein CD6 as an inhibitory receptor and as target for immunomodulation”
Arguente principal
|
Sónia Henriques (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2023/10/23 | “Multiple Roles of PLC¿1 in Mediating Target Therapy Resistance Across Different Tumor Types”
Arguente
|
Raquel Duarte (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2023/09/29 | “High systemic cholesterol and IFN-¿ response in breast cancer cells”
Presidente do júri
|
Daniela Botinas (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2023/09/22 | “Emerging roles of the critical oncogenic molecule Cadherin-3 in glioblastoma”
Arguente principal
|
Eduarda Martins (Doutoramento)
Universidade do Minho, Portugal
|
| 2023/06/27 | “Characterizing the role of the Circadian Molecular Clock in T-ALL”
Orientador
|
Patrícia Amaral (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2023/06/19 | “Molecular and Functional Characterization of Neutrophils in Psoriasis”
Arguente principal
|
Carolina Rodrigues de Souza (Outro)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
| 2023/05/24 | “Histone Deacetylase Inhibitors as therapeutic candidates against IL-7-responsive Acute Lymphoblastic Leukemia”
Orientador
|
João Fontela (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2023/05/10 | “Dynamics and functions of N-glycans in T cell development”
Arguente principal
|
Manuel Vicente (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2023/04/14 | “Regulatory T cell depletion unleashes an IFN¿+ ¿d T cell response in the tumour microenvironment”
Presidente do júri
|
André Vaz Pinto Santos (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2023/03/09 | Molecular Insights on Acute Lymphoblastic Leukemia Development and Suppression | Telmo Catarino (Doutoramento) |
| 2023/03/09 | “Molecular Insights on Acute Lymphoblastic Leukemia Development and Suppression”
Arguente principal
|
Telmo Catarino (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2023/01/26 | Exploring the role of HoxA9 in IL7R-mediated B-Cell Leukemogenesis
Orientador
|
Sara Gama (Mestrado) |
| 2023/01/26 | “Exploring the role of HoxA9 in IL7R-mediated B-Cell Leukemogenesis”
Orientador
|
Sara Gama (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2022/12/22 | Studying the impact of interleukin-7 receptor on T-cell leukemia using zebrafish models: from basic biology to therapeutics
Orientador
|
Mariana Oliveira (Doutoramento) |
| 2022/12/22 | “Studying the impact of interleukin-7 receptor on T-cell leukemia using zebrafish models: from basic biology to therapeutics”
Orientador
|
Mariana Oliveira (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2022/12/14 | Genotyping tumor DNA for precision oncology | Catarina Silveira (Doutoramento) |
| 2022/12/14 | “Genotyping tumor DNA for precision oncology”
Arguente
|
Catarina Silveira (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2022/07/15 | Tumor infiltrating lymphocytes and PD-1/PD-L1 expression in primary tumors and bone metastases from solid cancers | Joaquim Brito (Mestrado) |
| 2022/07/15 | “Tumor infiltrating lymphocytes and PD-1/PD-L1 expression in primary tumors and bone metastases from solid cancers”
Presidente do júri
|
Joaquim Brito (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2022/04/07 | The role of MYH10 in IL-7R-driven B-cell Acute Lymphoblastic Leukemia - Tatiana Araújo (Supervisor)
Orientador
|
Tatiana Araújo (Mestrado)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2022/04/07 | “The role of MYH10 in IL-7R-driven B-cell Acute Lymphoblastic Leukemia”
Orientador
|
Tatiana Araújo (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
| 2021/09/10 | The anti-oncogenic role of stromal p53 in colorectal cancer
Presidente do júri
|
Sofia Martins (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/09/10 | “The anti-oncogenic role of stromal p53 in colorectal cancer”
Presidente do júri
|
Sofia Martins (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/07/16 | Cell Competition as a Basal Cell Carcinoma Progression Mechanism and the Potential Therapeutic Effect of Ikaros
Presidente do júri
|
Joana Jesus (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/07/16 | “Cell Competition as a Basal Cell Carcinoma Progression Mechanism and the Potential Therapeutic Effect of Ikaros”
Presidente do júri
|
Joana Jesus (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/07/14 | A relação entre a leucemia linfoblástica aguda e crianças com síndrome de Down.
Presidente do júri
|
Catarina Santos (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/07/14 | Leucemia Linfoblástica Aguda: uso de protocolos pediátricos em adolescentes e adultos jovens.
Presidente do júri
|
Helena Boavida (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/07/14 | “Leucemia Linfoblástica Aguda: uso de protocolos pediátricos em adolescentes e adultos jovens”
Presidente do júri
|
Helena Boavida (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/07/14 | “A relação entre a leucemia linfoblástica aguda e crianças com síndrome de Down”
Presidente do júri
|
Catarina Santos (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/06/17 | Tradução independente de cap da proteína humana up-frameshift 1 (UPF1) e cancro.
Presidente do júri
|
Neuza Bacalhau (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/06/17 | “Tradução independente de cap da proteína humana up-frameshift 1 (UPF1) e cancro”
Presidente do júri
|
Neuza Bacalhau (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/06/15 | Impact of the human Golgi anti-apoptotic protein (hGAAP/TMBIM4) in Glioblastoma progression.
Presidente do júri
|
Marta Martins (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/06/15 | “Impact of the human Golgi anti-apoptotic protein (hGAAP/TMBIM4) in Glioblastoma progression”
Presidente do júri
|
Marta Martins (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/05/14 | Functional and Metabolic Characterization of Antitumour Macrophages.
Presidente do júri
|
Afonso Mota (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021/05/14 | “Functional and Metabolic Characterization of Antitumour Macrophages”
Presidente do júri
|
Afonso Mota (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2020 | Regulation of T Cell Fitness and Functions in Tumour Responses - Sofia Mensurado Santos
Vogal
|
Sofia Mensurado Santos (Doutoramento) |
| 2020 | Exploring the role of IL-7, CK2, and SphK in T-cell acute lymphoblastic leukemia - Alice Melão (Supervisor)
Orientador
|
Alice Melão (Doutoramento) |
| 2019 | "Cooperation between IL-7R signaling and HOXA9 in leukemogenesis" - Beatriz Raposo (Supervisor)
Orientador
|
Beatriz Raposo (Mestrado)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
| 2019 | “Deciphering complete cancer transcriptomes from bulk to single cell level”. - Karen Verboom
Arguente principal
|
Karen Verboom (Doutoramento)
Universiteit Gent, Bélgica
|
| 2019 | “ Identification of APOBEC-associated frequent mutations & characterization of FGFR3-driven signaling pathways in bladder
cancer” - Mingjun Shi
Arguente principal
|
Mingjun Shi (Doutoramento)
Université Paris-Saclay, França
|
| 2019 | “Identification of novel potential therapeutic targets for T-cell acute lymphoblastic leukemia” - Catarina Fernandes
Arguente principal
|
Catarina Fernandes - Msc. student (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2019 | “Exploring new facets of interleukin-7 receptor-mediated signaling in T-cell leukemia” - Ana Sofia Ramalho (Supervisor)
Orientador
|
Ana Sofia Ramalho - Msc. student (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2019 | “Antibody-based therapy for T-cell acute lymphoblastic leukemia: Targeting the IL-7 receptor” - Padma Akkapeddi (Supervisor)
Orientador
|
Padma Akkapeddi (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2019 | Impact of metabolic resources and infiltrating immune cells on protective responses against solid tumors
Vogal
|
Neidy Rodrigues (Doutoramento) |
| 2018 | “Modulation of the haematopoietic stem cell niche by photo-triggerable nanoparticles” - Emanuel Quartin Costa
Arguente principal
|
Emanuel Quartin Costa (Doutoramento)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
| 2018 | “Study of the impact of IL7R gain-of-function mutation on in vivo leukemogenesis” - Tiago Soares (Supervisor)
Orientador
|
Tiago Soares - Msc. student (Mestrado)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade do Algarve - Campus de Gambelas, Portugal |
| 2018 | “Co-transcriptional quality control of mRNA biogenesis: impact for human genetic diseases” - Rita Vaz Drago
Arguente
|
Rita Vaz Drago (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2017 | “How the RPL10 R98S mutation translates T-Cell acute lymphoblastic leukemia” - Tiziana Girardi
Arguente principal
|
Tiziana Girardi (Doutoramento)
Katholieke Universiteit Leuven Centrum voor Biomedische Ethiek en Recht, Bélgica
|
| 2017 | “Therapeutic targeting of CNS hemangioblastomas in VHL disease” - Ana Marguerita Metelo
Arguente
|
Ana Marguerita Metelo (Doutoramento)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
|
| 2017 | “The functional crosstalk of proteolytic systems and metabolism in acute myeloid leukemia” - Ângela Fernandes
Arguente
|
Ângela Fernandes (Doutoramento)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
|
| 2017 | “Molecular mechanisms controlling the survival and differentiation of human ¿d thymocytes” - Sérgio Ribeiro
Arguente
|
Sérgio Ribeiro (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2017 | “Role of PLC¿1 in the resistance mechanism to anti-EGFR therapy in metastatic colorectal cancer” - Raquel Duarte
Arguente principal
|
Raquel Duarte (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2016 | “Dissecting the Cellular and Molecular Mechanisms of IL-7-mediated Leukemia T- cell Survival, Proliferation and Cell Growth”
- Daniel Ribeiro (Supervisor)
Orientador
|
Daniel Ribeiro (Doutoramento)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal |
| 2016 | “The role of Myogenic Regulatory Factors in Rhabdomyosarcoma: insights from zebrafish and beyond” - Inês Tenente
Arguente principal
|
Inês Tenente (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2015 | “Does hyperglycemia impact the crosstalk between AML cells and BM stroma? - The role of CXCL12/CXCR4 chemoattraction axis”
- Ana Catarina Martins
Arguente principal
|
Ana Catarina Martins (Mestrado)
Universidade do Minho Escola de Medicina, Portugal
|
| 2015 | “Seeking new insights into IL-7Ra mutational activation in T-cell leukemia” - Joana Silva (Supervisor)
Orientador
|
Joana Silva (Mestrado)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal |
| 2015 | “Determining the prognostic significance of PI3K/Akt/mTOR and JAK/STAT5 signaling pathways in pediatric acute lymphoblastic
leukemia using single-cell analysis” - Mariana L. Oliveira (Supervisor)
Orientador
|
Mariana L. Oliveira (Mestrado)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal |
| 2015 | “The role of reciprocal regulation between TAL1 and miRNA expression in T-cell leukemia progression” - Nádia Correia (Supervisor)
Orientador
|
Nádia Correia (Doutoramento)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal |
| 2014 | “Long Non-coding RNAs at the Service of p53” - Carlos Melo
Arguente principal
|
Carlos Melo (Doutoramento)
Universidade de Coimbra Faculdade de Farmácia, Portugal
|
| 2014 | “Stochasticity and commitment in monoallelic gene activation” - Clara Pereira
Arguente
|
Clara Pereira (Doutoramento)
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
| 2014 | “The role of sphingosine kinase in IL-7-mediated signaling and T-cell acute lymphoblastic leukemia” - Joana Matos (Supervisor)
Orientador
|
Joana Matos (Mestrado)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Coimbra Faculdade de Medicina, Portugal |
| 2014 | “Maintaining the balance: Novel molecular mechanisms regulating Foxp3 function” - Xavier Cahu
(evaluated the thesis and wrote his formal evaluation of the thesis but did not participate in the thesis defense for health
reasons).
Arguente principal
|
Xavier Cahu (Doutoramento)
Université de Paris, França
|
| 2014 | “Maintaining the balance: Novel molecular mechanisms regulating Foxp3 function”. - Veerle Fleskens
Arguente principal
|
Veerle Fleskens (Doutoramento)
Universiteit Utrecht, Países Baixos
|
| 2014 | “Dissecting the signaling mechanisms of IL-7-mediated autophagy regulation in T-cell acute lymphoblastic leukemia” - Maria
Inês Felizardo Lopes (Supervisor)
Orientador
|
Maria Inês Felizardo Lopes (Mestrado)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal |
| 2014 | “On the reprogramming of the Krebs cycle in hypoxic and VHL-deficient cancer cells” - Paulo A. Gameiro
Arguente principal
|
Paulo A. Gameiro (Doutoramento)
Universidade de Coimbra Faculdade de Medicina, Portugal
|
| 2014 | “Resveratrol-induced activation of the Sirt1/AMPK axis in human CD4 T cells triggers replicative stress and na ATR-dependent
cell cycle arrest” - Marco Filipe Craveiro
Arguente principal
|
Marco Filipe Craveiro (Doutoramento)
Universidade de Coimbra Faculdade de Medicina, Portugal
|
| 2013 | “Autophagy and inflammasome: how are they related?” - Maria Inês Mahú
Arguente principal
|
Maria Inês Mahú (Doutoramento)
Universidade de Coimbra Faculdade de Medicina, Portugal
|
| 2013 | “HIF & CHIPs: A new autophagic pathway for the degradation of HIF-1a” - João Vasco Ferreira
Arguente principal
|
João Vasco Ferreira (Doutoramento)
Universidade de Coimbra Faculdade de Medicina, Portugal
|
| 2013 | “¿d T cell responses to tumours: recruitment, recognition and functions” - Telma Lança
Arguente
|
Telma Lança (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2012 | “B cells at the crossroad of immune responses: insights from primary B-cell immunodeficiencies” - Rita Barbosa
Arguente
|
Rita Barbosa (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2012 | “The T cell surface glycoprotein CD5: a regulatory hub in T cell signaling” - Ana Mafalda Santos
Arguente principal
|
Ana Mafalda Santos (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2012 | “The role of SETD2 in transcription and in DNA damage response” - Sílvia Carvalho
Arguente principal
|
Sílvia Carvalho (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
| 2012 | “Protein tyrosine kinase signaling in T-cell acute lymphoblastic leukemia”. - Michaël Porcu
Arguente principal
|
Michaël Porcu (Doutoramento)
Katholieke Universiteit Leuven Departement Cellulaire en Moleculaire Geneeskunde, Bélgica
|
| 2012 | “Modulating hematopoietic progenitor cell engraftment and T cell differentiation: Role of conditioning and route of administration”
- Stéphanie de Barros
Arguente principal
|
Stéphanie de Barros (Doutoramento)
Université de Montpellier, França
|
| 2012 | “CK2 as a potential novel therapeutic target in chronic lymphocytic leukemia” - Leila Martins (Supervisor)
Orientador
|
Leila Martins (Doutoramento)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal |
| 2012 | “HIV2 immunopathology: how the immune system deals with long-lasting infection” - Rita Tendeiro
Arguente
|
Rita Tendeiro (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2012 | “The transcriptome of the oncogenic HOXA9 homeoprotein in human glioblastomas: functional and clinical relevance” - Ana Xavier
Magalhães
Arguente principal
|
Ana Xavier Magalhães (Mestrado)
Universidade do Minho Escola de Ciências, Portugal
|
| 2012 | “The role of the delta-like 4 Notch ligand in tumor angiogenesis” - Dusan Djokovic
Arguente
|
Dusan Djokovic (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2012 | “Lentiviral target-specific strategy for molecular therapy” - Lídia Fonseca
Arguente
|
Lídia Fonseca (Doutoramento)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
| 2012 | “Molecular mechanisms of human ¿¿ T cell activation and tumor cell recognition” - Daniel Correia
Arguente
|
Daniel Correia (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2012 | “Identification of mechanisms controlling the transcriptional activity of nuclear factor kappa B (NF-kB) p65/RelA” - Nadja
Pejanovic
Arguente
|
Nadja Pejanovic (Doutoramento)
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
| 2011 | “IL-4 and TAL1 in T-cell acute lymphoblastic leukemia: studies on the participation of microenvironmental cues and cell-autonomous
alterations in leukemogenesis” - Bruno Cardoso (Supervisor)
Orientador
|
Bruno Cardoso (Doutoramento)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal |
| 2011 | “RTKs and MAPK pathway alterations in solid tumors: dissecting prognostic and therapeutic biomarkers” - Olga Martinho
Arguente principal
|
Olga Martinho (Doutoramento)
Universidade do Minho Escola de Ciências, Portugal
|
| 2011 | “Estudo da regulação da angiogénese tumoral pelo H2O2 in vivo [Study of tumor angiogenesis regulation by H2O2 in vivo]” -
Gonçalo Rodrigues
Arguente principal
|
Gonçalo Rodrigues (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
| 2010 | “The Role of Lymphotoxin-¿ Receptor Signaling in T-cell Acute Lymphoblastic Leukemia Development” - Mónica Fernandes
Arguente principal
|
Mónica Fernandes (Mestrado)
Universidade do Algarve - Campus de Gambelas, Portugal
|
| 2010 | “Development of regulatory T cells in human thymus: one step beyond” - Helena Cabaço
Arguente
|
Helena Cabaço (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2010 | “Analysis of PAX2 gene alterations in renal cell tumors” - Patrícia Patrício
Arguente principal
|
Patrícia Patrício (Mestrado)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
| 2010 | “Genetic dissection of antigen presentation pathways” - Catarina Ferreira Moita
Arguente
|
Catarina Ferreira Moita (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2010 | “Biochemical and functional analysis of the T cell growth and survival bioactivities of human red blood cells” - Ricardo Filipe
Antunes
Arguente principal
|
Ricardo Filipe Antunes (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2010 | “The regulation of interleukin 7 receptor alpha internalization, recycling and degradation by IL-7 – possible implications
in T-cell homeostasis, migration and leukaemogenesis” - Catarina Henriques (Supervisor)
Orientador
|
Catarina Henriques (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 2010 | “IL-7- and PI3K-Mediated Signaling in T-Cell Leukemia: The Role of External and Cell-Autonomous Signals in Tumorigenesis”
- Ana Silva (Supervisor)
Orientador
|
Ana Silva (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 2009 | “Studies on a human model and a murine model of immunodeficiency: HIV-2 infection and TACI deficiency”. - Catarina Cortesão
Arguente
|
Catarina Cortesão (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2009 | “The role and therapeutic potential of regulators and effectors of PI3K/Akt pathway in T-cell leukemia” - Daniel Ribeiro (Supervisor)
Orientador
|
Daniel Ribeiro (Mestrado)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Ciências, Portugal |
| 2009 | “Screening for RAG activity in haematopoietic tumours using a novel reporter strategy” - Inês Trancoso
Arguente principal
|
Inês Trancoso (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
| 2009 | “Targeted Gene Silencing Therapy in Small Cell Lung Cancer” - Adriana Oliveira dos Santos
Arguente principal
|
Adriana Oliveira dos Santos (Doutoramento)
Universidade de Coimbra Faculdade de Farmácia, Portugal
|
| 2009 | “Topoisomerase-II mediated DNA damage: role of BRCA1 and other chromatin structure regulators” - Inês Teles Alves
Arguente principal
|
Inês Teles Alves (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
| 2009 | “Genetic and functional analysis of IL-7 signalling in control of T cell homeostasis” - Claire Pearson
Arguente principal
|
Claire Pearson (Doutoramento)
National Institute for Medical Research, Reino Unido
|
| 2009 | “Signalling Pathways Activated by Red Blood Cells-Derived Factors in Normal T cells and Jurkat T cells” - Cláudia Brandão
Silva
Arguente principal
|
Cláudia Brandão Silva (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2008 | Ultrasound contrast agents in triggered drug and gene delivery” - Marta Aido
Arguente principal
|
Marta Aido (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal
|
| 2008 | “Lentiviral target-specific strategy for molecular therapy” - Lídia Fonseca (1st Year PhD Final Report)
Arguente principal
|
Lídia Fonseca (Outro)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
| 2008 | “Identification and Characterization of Novel Molecular Components of the mTOR Complexes”. - Maria Alexandra Frias
Arguente principal
|
Maria Alexandra Frias (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2008 | “Characterization of an In vitro 3D Multicellular Model of the Tumor Microenvironment” - Pedro Sampaio
Arguente principal
|
Pedro Sampaio (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
|
| 2008 | “Estudo do Efeito da Activação da Cascata de Sinalização JAK/STAT por IL-7 em Células T Malignas [Study of the effect of the
activation of JAK/STAT signaling pathway by IL-7 in malignant T cells]” - Cristina Santos (Supervisor)
Orientador
|
Cristina Santos (Mestrado)
Universidade da Beira Interior Faculdade de Ciências da Saúde, Portugal
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 2005 | “Clonagem dos genes tal1 e lmo2 num vector lentiviral para expressão em células T precursoras primárias [Cloning of tal1 and
lmo2 in a lentiviral vector for expression in primary precursor T cells]” - Bruno Cardoso (Supervisor)
Orientador
|
Bruno Cardoso - Bsc. student (Outro)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Ciências, Portugal |
| 2004 | “IL-7-mediated signaling in human thymocytes” - Luís Bicheiro (Supervisor)
Orientador
|
Luís Bicheiro - Bsc. student (Outro)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Ciências, Portugal |
| 2004 | “Efeito da Activação da Cascata de Sinalização Jak/STAT por IL-7 em Células T Leucémicas [Effect of IL-7-mediated Jak/STAT
pathway activation on leukemic T cells]” - Luís Vinagre (Supervisor)
Orientador
|
Luís Vinagre - Bsc. student (Outro)
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
Universidade de Lisboa Faculdade de Ciências, Portugal |
Arbitragem científica em conferência
| Nome da conferência | Local da conferência | |
|---|---|---|
| 2020/03/02 - 2020/03/04 | EACR-AACR Basic and Translational Research Conference in partnership with ASPIC: Tumor Microevironment | |
| 2019/10/18 - 2019/10/19 | SINAL 2019 - Xth Meeting on Signal Transduction | |
| 2017 - 2017 | YoungEHA Research Meeting on Molecular Aspects of Hematological Disorders, Madrid, Spain | European Hematology Association |
| 2014/11/25 - 2014/11/26 | 1st ASPIC International Congress | |
| 2013/12/06 - 2013/12/07 | SINAL 2013 – 7th National Meeting on Cell Signalling | |
| 2012/04/13 - 2012/04/14 | SINAL 2012 – 6th National Meeting on Cell Signaling | |
| 2011/04/28 - 2011/04/30 | SINAL 2011 – 5th Annual Meeting on Cell Signalling | |
| 2010/05/21 - 2010/05/22 | SINAL 2010 – 4th National Meeting on Signal Transduction |
Arbitragem científica em revista
| Nome da revista (ISSN) | Editora | |
|---|---|---|
| 2023 - Atual | Leukemia (1476-5551) | Springer Nature |
| 2022 - Atual | Tumor Discovery (2810-9775) | ACC Science Publishing |
| 2020 - Atual | Cancers (2072-6694) | MDPI AG |
| 2018/11 - Atual | Cells (2073-4409) | MDPI |
| 2016 - Atual | Cellular Signalling | |
| 2011/10 - Atual | American Journal of Cancer Research (2156-6976) | e-Century Publishing |
Comissão de avaliação
| Descrição da atividade Tipo de assessoria |
Instituição / Organização | Entidade financiadora | |
|---|---|---|---|
| 2019 - Atual | Reviewer/Evaluator of grant applications/research projects for INSERM.
Avaliador
|
INSERM, França | |
| 2023 - 2023 | Reviewer/Evaluator of grant applications/research projects for the Italian Association for Cancer Research ¿ AIRC (Italy).
Avaliador
|
Associazione Italiana per la Ricerca sul Cancro, Itália | |
| 2022 - 2022 | Reviewer/Evaluator of grant applications/research projects for the Italian Association for Cancer Research ¿ AIRC (Italy).
Avaliador
|
Associazione Italiana per la Ricerca sul Cancro, Itália | |
| 2021 - 2022 | Reviewer/Evaluator of grant applications/research projects for the Italian Association for Cancer Research - AIRC (Italy). | Associazione Italiana per la Ricerca sul Cancro, Itália | |
| 2021 - 2021 | Reviewer/Evaluator of grant applications/research projects for the Institut Pasteur. | Institut Pasteur, França | |
| 2021 - 2021 | Reviewer/Evaluator of grant applications/research projects for the Italian Association for Cancer Research ¿ AIRC (Italy).
Avaliador
|
Associazione Italiana per la Ricerca sul Cancro, Itália | |
| 2021 - 2021 | Reviewer/Evaluator of grant applications/research projects for Institute Pasteur
Avaliador
|
Institut Pasteur, França | |
| 2018 - 2018 | Reviewer/Evaluator of grant applications/research projects for European Hematology Association
Avaliador
|
European Hematology Association, Países Baixos | |
| 2018 - 2018 | Reviewer/Evaluator of grant applications/research projects for the KU Leuven (Belgium).
Avaliador
|
||
| 2014 - 2018 | Reviewer/Evaluator of grant applications/research projects for the Worldwide Cancer Research (WCR) (formerly known as Association
for International Cancer Research – AICR)
Avaliador
|
Worldwide Cancer Research, Reino Unido | |
| 2017/05/24 - 2017/05/26 | Member of the evaluation panel of Oral Sessions VI and VII, May 15; XI PhD CAML Students Meeting, iMM-Lisboa, Faculdade de
Medicina, Universidade de Lisboa, Portugal, 24-26 May.
Avaliador
|
||
| 2017 - 2017 | Reviewer/Evaluator of grant applications/research projects for the European Commission Research Executive Agency - ECREA (Marie
Sklodowska-Curie Individual Fellowships)
Avaliador
|
European Commission Research Executive Agency , Bélgica | |
| 2017 - 2017 | Reviewer/Evaluator of grant applications/research projects for the Dutch Arthritis Association (The Netherlands)
Avaliador
|
Dutch Arthritis Association , Países Baixos | |
| 2017 - 2017 | Reviewer/Evaluator of grant applications/research projects for the National Science Centre - NCN (Poland).
Avaliador
|
Narodowe Centrum Nauki, Polónia | |
| 2016/12/14 - 2016/12/14 | Member of the evaluation panel of the Poster Sessions; Research Day for Medical Students / 19th Workshop “Education through
Science”, Faculdade de Medicina, Universidade de Lisboa, Portugal, 14 December.
Avaliador
|
||
| 2016 - 2016 | Evaluator of grant applications/research projects for the European Research Council - ERC
Avaliador
|
European Research Council, Bélgica | |
| 2016 - 2016 | Reviewer/Evaluator of grant applications/research projects for the University Medical Center Utrecht (The Netherlands) | University Medical Center Utrecht (The Netherlands) , Países Baixos | |
| 2016 - 2016 | Reviewer/Evaluator of grant applications/research projects for the Flanders Research Foundation – FWO (Belgium).
Avaliador
|
||
| 2016 - 2016 | Reviewer/Evaluator of grant applications/research projects for the Ministry for Education, University and Research – MIUR
(Italy).
Avaliador
|
Ministero dell'Istruzione dell'Università e della Ricerca, Itália | |
| 2016 - 2016 | Reviewer/Evaluator of grant applications/research projects for the German Research Foundation/Deutsche Forschungsgemeinschaft
– DFG (Germany).
Avaliador
|
Deutsche Forschungsgemeinschaft, Alemanha | |
| 2011 - 2016 | Reviewer/Evaluator of grant applications/research projects for the Fundação para a Ciência e a Tecnologia - FCT (Portugal)
Avaliador
|
Fundação para a Ciência e a Tecnologia, Portugal | |
| 2015/12/16 - 2015/12/16 | Member of the evaluation panels of the Poster and Oral communication Sessions; Research Day for Medical Students / 18th Workshop
“Education through Science”, Faculdade de Medicina da Universidade de Lisboa, Portugal, 16 December.
Avaliador
|
||
| 2015/11/24 - 2015/11/24 | Member of the Evaluation Committee for the renewal of the Specialist Programme “Developmental origins, clonal evolution and
molecular targets in childhood acute lymphoblastic leukaemia” (PI: Tariq Enver) funded by Bloodwise (former Leukaemia & Lymphoma
Research), University College London, 24 November.
Membro
|
||
| 2015/09/25 - 2015/09/25 | Member of the Evaluation Committee for the best oral presentation, 3rd iMM Post-Doc Day, Lisboa, Portugal, 25 September.
Membro
|
||
| 2015 - 2015 | Reviewer/Evaluator of grant applications/research projects for the Italian Association for Cancer Research – AIRC (Italy).
Avaliador
|
Associazione Italiana per la Ricerca sul Cancro, Itália | |
| 2012 - 2015 | Reviewer/Evaluator of grant applications/research projects for the Bloodwise (formerly known as Leukaemia & Lymphoma Research
(UK).
Avaliador
|
Bloodwise, Reino Unido | |
| 2014 - 2014 | Reviewer/Evaluator of grant applications/research projects for the Foundation Against Cancer (Belgium).
Avaliador
|
Fondation contre le Cancer, Bélgica | |
| 2013/12/11 - 2013/12/11 | Member of the evaluation panel, Poster Session II; Research Day for Medical Students / 16th Workshop “Education through Science”,
Faculdade de Medicina da Universidade de Lisboa, Portugal, 11 December.
Avaliador
|
||
| 2013 - 2013 | Reviewer/Evaluator of grant applications/research projects for the KU Leuven (Belgium).
Avaliador
|
||
| 2013 - 2013 | Reviewer/Evaluator of grant applications/research projects for the Flemish League against Cancer – VLK (Belgium).
Avaliador
|
||
| 2013 - 2013 | Reviewer/Evaluator of grant applications/research projects for the Wellcome Trust/DBT India Alliance (India).
Avaliador
|
||
| 2012 - 2013 | Reviewer/Evaluator of grant applications/research projects for the National Agency for the Evaluation of Universities and
Research Institutes – ANVUR (Italy)
Avaliador
|
||
| 2012 - 2012 | Reviewer/Evaluator of grant applications/research projects for European Hematology Association.
Avaliador
|
European Hematology Association, Países Baixos | |
| 2012 - 2012 | Reviewer/Evaluator of grant applications/research projects for the Flanders Research Foundation – FWO (Belgium).
Avaliador
|
||
| 2012 - 2012 | Reviewer/Evaluator of grant applications/research projects for the Fondazione Cassa di Risparmio di Padova e Rovigo - CARIPARO.
Avaliador
|
Fondazione Cassa di Risparmio di Padova e Rovigo, Itália | |
| 2012 - 2012 | Reviewer/Evaluator of grant applications/research projects for the Italian Association for Cancer Research – AIRC (Italy).
Avaliador
|
Associazione Italiana per la Ricerca sul Cancro, Itália | |
| 2011/11/29 - 2011/11/30 | Member of the Jury for the selection of the best poster “Portrait of the Immune System: History and Perspective” XXXVII Annual
Meeting of the Portuguese Society of Immunology, Instituto Gulbenkian de Ciência, Oeiras, Portugal, 29-30 November.
Membro
|
Sociedade Portuguesa de Imunologia, Portugal | |
| 2011 - 2011 | Reviewer/Evaluator of grant applications/research projects for the Faculty of Medicine of the University of Coimbra (Portugal).
Avaliador
|
Universidade de Coimbra Faculdade de Medicina, Portugal | |
| 2010 - 2010 | Reviewer/Evaluator of grant applications/research projects for the Dutch Cancer Society (The Netherlands).
Avaliador
|
KWF Kankerbestrijding, Países Baixos | |
| 2010 - 2010 | Reviewer/Evaluator of grant applications/research projects for the Health Research Board (Ireland).
Avaliador
|
Health Research Board, Irlanda | |
| 2009/10/12 - 2009/10/13 | Member of the Jury for the selection of the best poster and oral communications, 3rd IMM PhD Students Meeting, IMM, Lisbon,
Portugal, 12-13 October.
Avaliador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal | |
| 2008 - 2008 | Reviewer/Evaluator of grant applications/research projects for Dutch Arthritis Association (The Netherlands).
Avaliador
|
Dutch Arthritis Association , Países Baixos | |
| 2008 - 2008 | Member of evaluation committees of the applications for the positions open under the protocol “Ciência 2008” at IPATIMUP,
Porto, Portugal, and Life and Health Science Research Institute (ICVS), School of Health Sciences, University of Minho, Braga,
Portugal.
Membro
|
Fundação para a Ciência e a Tecnologia, Portugal | |
| 2007 - 2007 | Reviewer/Evaluator of grant applications/research projects for the Centro Infantil Boldrini (Brazil).
Avaliador
|
Curso / Disciplina lecionado
| Disciplina | Curso (Tipo) | Instituição / Organização | |
|---|---|---|---|
| 2022/02/15 - Atual | Teacher of the Lab Seminar “Signaling in Cancer: an overview of our work”, LisbonBioMed PhD program, IMM, Faculty of Medicine of Lisbon University, Lisbon, Portugal, 15 February | ||
| 2021/10/26 - Atual | Teacher of the Seminar “Signal transduction in cancer: towards precision medicine”, Signal transduction and targeted therapy, Integrated Masters in Medicine (6th year) | Seminar “Signal transduction in cancer: towards precision medicine”, Integrated Masters in Medicine (6th year) (Mestrado integrado) | Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal |
| 2020 - Atual | Chair of the Oncobiology course for 3rd year medical students (Faculdade de Medicina, Universidade de Lisboa). | ||
| 2020 - Atual | Coordinator of the Masters in Oncobiology (Faculdade de Medicina, Universidade de Lisboa) | ||
| 2015 - Atual | Teacher (coordinator) of the “Signal Transduction in Cancer” Course of the Masters in Oncobiology, Faculty of Medicine of Lisbon University, Lisbon Academic Medical Center (CAML), Lisbon, Portugal, 14-17 January. | Universidade de Lisboa Faculdade de Medicina, Portugal | |
| 2014 - Atual | Teacher at the Oncobiology Course, Signal Transduction in Cancer, Integrated Masters in Medicine (3rd year students), Faculty of Medicine of Lisbon University, Lisbon, Portugal. | Universidade de Lisboa Faculdade de Medicina, Portugal | |
| 2014 - Atual | Teacher at and coordinator of (together with Sérgio Dias and Gonçalo Bernardes) the “Tissues and Tumors” week, LisbonBioMed International FCT PhD Program, IMM, Faculty of Medicine of Lisbon University, Lisbon, Portugal. | Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal Universidade de Lisboa Faculdade de Medicina, Portugal |
|
| 2022/03/26 - 2022/03/26 | Lecture at "Twists and turns of immune cells: Lymphoid leukemia and anti-leukemia immunotherapies", Curso de Imunologia e Imunoterapia [Immunology and Immunotherapy course], SPFCS - Sociedade Portuguesa dos Farmacêuticos dos Cuidados da Saúde, Tomar, Portugal, 26 March | Curso de Imunologia e Imunoterapia | |
| 2022/02/15 - 2022/02/15 | Teacher of the Lab Seminar “Signaling in Cancer: an overview of our work”, LisbonBioMed PhD program, IMM, Faculty of Medicine of Lisbon University, Lisbon, Portugal. | ||
| 2021/10/26 - 2021/10/26 | Teacher of the Seminar “Signal transduction in cancer: towards precision medicine”, Integrated Masters in Medicine (6th year students), Instituto de Investigação em Ciências da Vida e Saúde (ICVS), School of Health Sciences, University of Minho, Braga, Portugal. | ||
| 2021/07 - 2021/07 | Lecture at “Bridging – A integração da investigação básica na investigação clínica em Oncologia [Bridging – Integrating basic research into Clinical research in Oncology]”, 3ª Edição do Curso de Investigação em Oncologia [3rd Edition of the Course on Research in Oncology], organized by Núcleo de Internos e Jovens Especialistas da SPO [Group of Interns and Young Specialists of the Portuguese Society of Oncology] (Online course) | ||
| 2019 - 2019 | Teacher of the 'Signal Transduction in Cancer' seminar, Molecular and Cellular Biology of Cancer course, Masters in Molecular Biology and Genetics/ Masters in the Biology of Evolution and Development, Faculty of Sciences of the University of Lisbon, Portugal, 11 March. | Universidade de Lisboa Faculdade de Ciências, Portugal | |
| 2018 - 2018 | Teacher at the Advanced Course on “Fundamentals of Genetics, Development and Neoplasia” (October 22- November 9), International Postgraduate Programme, School of Health Sciences, University of Minho, Braga, Portugal, 23 October. | Universidade do Minho Escola de Ciências, Portugal | |
| 2017 - 2017 | Teacher at the Advanced Course on “Fundamentals of Genetics, Development and Neoplasia” (October 23- November 10), International Postgraduate Programme, School of Health Sciences, University of Minho, Braga, Portugal, 25 October. | Universidade do Minho Escola de Ciências, Portugal | |
| 2017 - 2017 | Teacher of the “Signal Transduction in Cancer” seminar, Molecular and Cellular Biology of Cancer course, Masters in Molecular Biology and Genetics/ Masters in the Biology of Evolution and Development, Faculty of Sciences of the University of Lisbon, Portugal, 6 March. | Universidade de Lisboa Faculdade de Ciências, Portugal | |
| 2016 - 2016 | Teacher at the Advanced Course on “Fundamentals of Genetics, Development and Neoplasia” (October 24- November 11), International Postgraduate Programme, School of Health Sciences, University of Minho, Braga, Portugal, 27 October. | Universidade do Minho Escola de Ciências, Portugal | |
| 2016 - 2016 | Teacher at the Curricular unit “From the clinics to molecular biology”, Signal transduction and targeted therapy, Integrated Masters in Medicine (6th year students), Instituto de Investigação em Ciências da Vida e Saúde (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, 27 October. | Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal | |
| 2015 - 2015 | Teacher at the Advanced Course on “Fundamentals of Genetics, Development and Neoplasia” (October 12-23), International Postgraduate Programme, School of Health Sciences, University of Minho, Braga, Portugal. | Universidade do Minho Escola de Ciências, Portugal | |
| 2014 - 2014 | Teacher at the Advanced Course on Molecular Oncology: Cancer Biology and Emerging Therapies. Lecture on “Cell cycle & checkpoints – I (G1/S)”. Instituto Português de Oncologia de Coimbra Francisco Gentil, Coimbra, Portugal. 24 October. | Instituto Português de Oncologia de Coimbra Francisco Gentil EPE, Portugal | |
| 2013 - 2013 | Teacher at the Advanced Course on “Fundamentals of Genetics, Development and Neoplasia” (4th Edition, January 14-25; and 5th Edition, October 14-25), International Postgraduate Programme, School of Health Sciences, University of Minho, Braga, Portugal. | Universidade do Minho Escola de Ciências, Portugal | |
| 2013 - 2013 | Teacher (coordinator) of the “Signal Transduction in Cancer” Course of the Masters in Oncobiology, Faculty of Medicine of Lisbon University, Lisbon Academic Medical Center (CAML), Lisbon, Portugal, 15-18 January. | Universidade de Lisboa Faculdade de Medicina, Portugal | |
| 2008 - 2013 | Teacher at the Advanced Course on Oncobiology of the BEB PhD Program of the Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal. | Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal | |
| 2012 - 2012 | Teacher at the Workshop on “Imunoterapia do Cancro: da Investigação Básica à Aplicação Clínica [Immunotherapy of Cancer: From Basic Research to Clinical Application]”, Center for Evidence-based Medical Studies (CEMBE), Faculty of Medicine of Lisbon University, Lisbon, Portugal, 24 March. | Universidade de Lisboa Faculdade de Medicina, Portugal | |
| 2010 - 2010 | Teacher at the Advanced Course on “Fundamentals of Genetics, Development and Neoplasia” (October 11-22), International Postgraduate Programme, School of Health Sciences, University of Minho, Braga, Portugal. | Universidade do Minho Escola de Ciências, Portugal | |
| 2010 - 2010 | Teacher of the Module of Cancer Immunotherapy (July 2-3), Curricular unit of Immunological Therapies, Masters in Molecular Therapies, CESPU, Gandra, Portugal. | Cooperativa de Ensino Superior Politécnico e Universitário, Portugal | |
| 2009 - 2010 | Teacher (and organizer) at the Cancer Course for the IMM International PhD Program. | Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal Universidade de Lisboa Faculdade de Medicina, Portugal |
|
| 2008 - 2008 | Teacher (coordinator) of the discipline “Cancerigenesis”, Masters in Medical Biochemistry, Molecular Biology and Genetics, and Human Molecular Biology, FCUL. | Universidade de Lisboa Faculdade de Ciências, Portugal | |
| 2002 - 2005 | Teacher of the Module “Tumors of the Immune System: Proliferation, Differentiation and Signal Transduction” Masters in Clinical Immunology, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal. | Universidade da Beira Interior Faculdade de Ciências da Saúde, Portugal |
Membro de associação
| Nome da associação | Tipo de participação | |
|---|---|---|
| 2015 - Atual | Associação Portuguesa de Investigação em Cancro (ASPIC) – Portuguese Association for Cancer Research | |
| 2010 - Atual | Sociedade Portuguesa de Imunologia (SPI) – Portuguese Society of Immunology | |
| 2006 - Atual | Sociedade Portuguesa de Ciências em Pequenos Animais de Laboratório (SPCAL) – Portuguese Society of Sciences in Small Laboratory Animals | |
| 2005 - Atual | European Association for Cancer Research (EACR) | |
| 2004 - Atual | Sociedade Portuguesa de Bioquímica (SPB) – Portuguese Society of Biochemistry | |
| 2001 - Atual | Society for Hematology and Stem Cells – former International Society for Experimental Hematology (ISEH) | |
| 1996 - Atual | Sociedade Portuguesa de Autores (SPA) – Portuguese Authors Society | |
| 1992 - Atual | Ordem dos Biólogos (Obio) – Order of the Portuguese Biologists | |
| 1998 - 2002 | Portuguese-American Post-graduate Society (PAPS) | |
| 1994 - 1995 | Co-director of the Marketing Section, Board of European Students of Technology, Coimbra, Portugal |
Membro de comissão
| Descrição da atividade Tipo de participação |
Instituição / Organização | |
|---|---|---|
| 2022 - Atual | Member of the LIFE SCIENCES 1 Evaluator Panel Committee for the “la Caixa” Foundation Postgraduate Abroad Fellowships Programme
2022, Spain
Membro
|
|
| 2022 - Atual | Member of the Reviewer Group for "Category 603 - Lymphoid Oncogenesis: Basic" of the 64th Annual Meeting of the American Society
of Hematology, USA
Membro
|
|
| 2022 - Atual | Member of the Jury for the Prémio GAPIC David Ferreira 2021/2022 Award for the best integrated Masters work done by final
year medical students in the Faculty of Medicine of Lisbon University, Portugal
Membro
|
|
| 2018 - Atual | Member of the Scientific Advisory Committee of Worldwide Cancer Research (formerly known as Association for International
Cancer Research), UK
Consultor
|
Worldwide Cancer Research, Reino Unido |
| 2021 - 2022 | Member of the Grant Evaluation Committee for the "Immunology & Infectious Diseases" program
Membro
|
Agence nationale de la recherche, França |
| 2020 - 2022 | Chairman of the General Assembly of the ASPIC (Portuguese Association for Cancer Research). | |
| 2018 - 2020 | Board Member, ASPIC (Portuguese Association for Cancer Research).
Membro
|
Associação Portuguesa de Investigação em Cancro, Portugal |
| 2018/05/23 - 2018/05/25 | Member of the Evaluation Committee for the best oral presentation, XII PhD Students Meetings - Lisbon Academic Medical Center,
Lisboa, Portugal, 23-25 May.
Membro
|
|
| 2018/05/10 - 2018/05/11 | Chairman of the Scientific Committee and co-chair of the EACR and ASEICA plenary lecture session, 3rd ASPIC International
Congress, Lisboa, Portugal, 10-11 May.
Presidente / Vice-presidente
|
|
| 2017 - 2018 | Oncobiology Thematic Line Coordinator for the FCT 2017-18 institutional plurennial funding national call (Avaliação de Unidades
I&D 2017/2018).
Coordenador
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 2016 - 2018 | Chairman of the General Assembly of the ASPIC (Portuguese Association for Cancer Research).
Presidente / Vice-presidente
|
|
| 2016 - 2018 | Researchers representative at the General Assembly of Instituto de Medicina Molecular.
Coordenador
|
|
| 2013 - 2013 | Member of the Selection Committee, LisbonBioMed International FCT PhD Program in Biomedicine and Clinical Research, IMM, Faculty
of Medicine of Lisbon University, Lisbon, Portugal.
Membro
|
|
| 2012 - 2013 | Member of the work group (Strategic Committee), together with Luísa Figueiredo and Henrique Veiga-Fernandes (chair), responsible
for the elaboration of the strategic plan in iMM’s application to the FCT 2013 institutional plurennial funding national call
(Avaliação de Unidades I&D 2013).
Membro
|
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal |
| 1992 - 1993 | Member of the National Committee of Students of Biology, Portugal
Membro
|
|
| 1992 - 1993 | Member of the Pedagogic Council, Faculty of Sciences and Technology, University of Coimbra, Portugal
Membro
|
Outro júri / avaliação
| Descrição da atividade | Instituição / Organização | |
|---|---|---|
| 2022 - Atual | Reviewer for the international journals Advances in Biological Regulation, British Journal of Haematology and Expert Opinion On Therapeutic Targets (2022). | |
| 2021 - Atual | Reviewer for the international journal Redox Biology and Review Commons | |
| 2019 - Atual | Guest Editor, Advances in Biological Regulation special issue on “T-cell acute lymphoblastic leukemia genetics, biology and therapeutics” (2019). | |
| 2016/09 - Atual | Editorial Board member of Cellular Signalling (from September 2016), Cells (from November 2018), and Cancers (from April 2020). Associate Editor of the American Journal of Cancer Research (from October 2011) and of Tumor Discovery (from September 2022). Ad Hoc Section Editor for Leukemia. | |
| 2012 - Atual | Reviewer for the international journals Molecular and Cellular Biology, Mediators of Inflammation, Molecular Pharmaceutics, Oncotarget, OncoTargets and Therapy, Pediatric Blood & Cancer, PLoS One, Scientific Reports, Seminars in Cell & Developmental Biology, Signals, Translational Oncology, and Tumor Biology. | |
| 2010 - Atual | Reviewer for the international journals Haematologica, HemaSphere, Immunology & Cell Biology, Inflammation Research, International Journal of Molecular Sciences, Journal of Immunological Methods, Journal of Immunology, Journal of Leukocyte Biology, Leukemia & Lymphoma and Leukemia Research, | |
| 2008 - Atual | Reviewer for the international journals Nature Medicine, Nature Communications, Science Translational Medicine, EMBO Molecular Medicine, Journal of Clinical Investigation, Blood, Leukemia, Oncogene, as well as: Advances in Hematology, African Journal of Biotechnology, Annals of Hematology, Archives of Medical Research, Biochemical Journal, Blood Cancer Journal, Cancers, Cells, Cell cycle, Cellular and Mollecular Immunology, Cellular Signalling, Cytokine, Drug Design, Development and Therapy, Experimental Hematology and Expert Review of Hematology |
Tutoria
| Tópico | Nome do aluno | |
|---|---|---|
| 2024 - Atual | Mentor/ Tutor of Margarida Paulo Pedro (Supervisors: Ana E. Sousa and Afonso Almeida) | Margarida Paulo Pedro |
| 2023 - Atual | Mentor/ Tutor of Carolina Pinto (Supervisor: Vera Martins) | Carolina Pinto |
| 2021 - Atual | Mentor/ Tutor of Raquel Sofia Cruz-Duarte (Supervisor: Marta Martins) | Raquel Sofia Cruz-Duarte |
| 2021 - Atual | Mentor/ Tutor of Ítala Silva (Supervisors: Sónia Gonçalves e Nuno Santos). | Ítala Silva |
| 2016 - Atual | Carlos Labão-Almeida (Supervisors: Gonçalo Bernardes & Karine Serre) | |
| 2014 - Atual | Rui Traquete (Supervisor: Gonçalo Bernardes) | |
| 2017 - 2022 | Marco Cavaco (Supervisor: Miguel Castanho) | |
| 2015 - 2022 | Mentor/ Tutor of Catarina Silveira (Supervisor: Maria Carmo-Fonseca) | Catarina Silveira |
| 2015 - 2018 | Vânia Cardoso (Supervisor: Henrique Veiga-Fernandes) | |
| 2014 - 2018 | Susana Lopes da Silva (Supervisor: Ana Espada Sousa) | |
| 2013 - 2018 | Neidy Rodrigues (Supervisors: Sérgio Dias e Bruno Silva-Santos) | |
| 2013 - 2018 | Rita Drago (Supervisor: Carmo-Fonseca) | |
| 2016 - 2017 | Yumie Tokunaga (Supervisor: Ana Espada Sousa - ENLIGHTEN) | |
| 2009 - 2017 | Pedro Didelet Pereira (Supervisor: João Ferreira) | |
| 2012 - 2016 | Diana Fontinha (Supervisor: Pedro Simas) | |
| 2012 - 2016 | Francisco Aresta Branco (Supervisor: Luísa Figueiredo) | |
| 2011 - 2015 | Mónica Fernandes (Supervisor: Nuno Rodrigues dos Santos – Universidade do Algarve) | |
| 2010 - 2015 | Catarina Moita Silva (Supervisor: Íris Caramalho) | |
| 2010 - 2014 | Vânia Batalha (Supervisor: Luísa Lopes) | |
| 2009 - 2014 | Carolina Moreira (Supervisor: Soren Prag) | |
| 2008 - 2013 | Diogo Pereira (Supervisor: Henrique Veiga-Fernandes) | |
| 2008 - 2013 | Leonor Miller Fleming (Supervisor: Tiago Outeiro) | |
| 2008 - 2012 | Sofia Azevedo (Supervisor: Leonor Saúde) | |
| 2007 - 2012 | Ana de Barros | |
| 2007 - 2012 | Ana de Barros (Supervisor: Bruno Silva-Santos) | |
| 2008 - 2011 | Olga Martinho (Supervisor: Rui Reis - Universidade do Minho) | |
| 2005 - 2011 | Inês Sofia Vala (Supervisor: Susana Constantino) |
Distinções
Prémio
| 2023 | Abstract Achievement Award - “Dependence of IL-7R-mediated signaling on sphingosine kinase activity in acute lymphoblastic
leukemia, but not healthy lymphoid cells, is an exploitable therapeutic vulnerability” to his PhD student Marta Fernandes
American Society of Hematology, Estados Unidos
|
| 2023 | Award for best PhD work in Oncology and Precision Medicine, for the work entitled ¿¿Sphingosine Kinases are essential positive
modulators of IL7/IL-7R signaling in Acute Lymphoblastic Leukemia¿¿ to his PhD student Marta Fernandes
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2023 | iMM Best Master Thesis Award, for the work entitled "Histone Deacetylase Inhibitors as therapeutic candidates against IL-7-responsive
Acute Lymphoblastic Leukemia" (by J. Fontela, J.T. Barata) to his Master Student João Fontela
Instituto de Medicina Molecular - João Lobo Antunes (iMM-JLA), Portugal
|
| 2022 | Award for best MSc work in Oncology and Precision Medicine - 'Exploring Exploring the role of HoxA9 in the role of HoxA9 in
IL7R-mediated B-Cell Leukemogenesis' (by S. Gama, M. Duque, J.T. Barata) to his Master student Sara Gama
Universidade de Lisboa Faculdade de Medicina, Portugal
|
| 2021 | Pfizer Award on Basic Research. Sociedade das Ciências Médicas de Lisboa. |
| 2019 | Best oral presentation award, for the work entitled “Sphingosine Kinases are key effectors of IL-7R-mediated signaling, viability,
growth and proliferation in T-cell Acute Lymphoblastic Leukemia” to his PhD student Marta B. Fernandes
Federation of European Biochemical Societies, Reino Unido
|
| 2019 | Best poster award, for the work entitled “Sphingosine Kinases are key effectors of IL-7R-mediated signaling, viability, growth
and proliferation in T-cell Acute Lymphoblastic Leukemia” to his PhD student Marta B. Fernandes,
SINAL - Signal Transdcution Network, Portugal
|
| 2018 | Best oral presentation award, for the work entitled “CASZ1 is overexpressed in T-cell acute lymphoblastic leukemia and promotes
cell transformation and tumor growth via PI3K-mTOR” to his Post-Doc Bruno A. Cardoso
Associação Portuguesa de Investigação em Cancro, Portugal
|
| 2014 | Pfizer Award on Clinical Research. Sociedade das Ciências Médicas de Lisboa.
Pfizer Portugal, Portugal
|
| 2013 | Silver Medal for Distinct Services from the Portuguese Ministry of Health.
Ministério da Saúde, Portugal
|
| 2011 | Pfizer Award on Clinical Research. Sociedade das Ciências Médicas de Lisboa.
Pfizer Portugal, Portugal
|
| 2009 | Pulido Valente Science Prize 2009 - Translational Molecular Oncology (Attributed to his student Ana Silva for the published
work: Silva, Yunes, Cardoso, Martins, Jotta, Abecasis, Nowill, Leslie, Cardoso & Barata (2008). PTEN Posttranslational Inactivation
Fundação para a Ciência e a Tecnologia, Portugal
Fundação Francisco Pulido Valente, Portugal |
| 2008 | Pfizer Award on Basic Research. Sociedade das Ciências Médicas de Lisboa.
Pfizer Portugal, Portugal
|
| 2005 | Prize “Programa de Apoio à Investigação em Onco-Hematologia”. Associação Portuguesa Contra a Leucemia
Associação Portuguesa Contra a Leucecmia, Portugal
|
| 2004 | Prize “Programa Gulbenkian de Estímulo à Investigação 2004”. Fundação Calouste Gulbenkian. (Attributed to his student Ana
Silva for her PhD project)
Fundação Calouste Gulbenkian, Portugal
|
| 2002 | LabMED Award – 3rd Place. LabMED Laboratories.
LabMED laboratories, Portugal
|
Outra distinção
| 2012 | Best Immunology Paper Award (Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nature
Genetics 43:932.).
Sociedade Portuguesa de Imunologia, Portugal
|
| 2011 | Vote of congratulations from the Portuguese Parliament recognizing the work conducted by João Barata’s research team.
Assembleia da República, Portugal
|
| 2010 | NRS/LPCC – “TERRY FOX” Grant/Prize for Research in Oncology
Liga Portuguesa Contra o Cancro Núcleo Regional do Sul, Portugal
|
| 2006 | Scholarship/travel award. European Commission’s Marie Curie Actions. 1st ESH - AACR Conference on Molecular Basis for Targeted
Therapy for Leukaemia (European School of Haematology).
EU Framework Programme for Research and Innovation Marie Sklodowska-Curie Actions, Bélgica
|
| 2006 | Scholarship/travel award. European Commission’s Marie Curie Actions. 6th ESH - UT MD Anderson Cancer Center Interdisciplinary
Euroconference on Mechanisms of Cell Death and Disease: Advances in Therapeutic Intervention and Drug Development.
EU Framework Programme for Research and Innovation Marie Sklodowska-Curie Actions, Bélgica
|
| 2005 | EMBO Short Term Fellowship – June – July
European Molecular Biology Laboratory, Alemanha
|
| 2003 | Post-Doctoral scholarship from Fundação para a Ciência e a Tecnologia (FCT), Portugal.
Fundação para a Ciência e a Tecnologia, Portugal
|
| 2002 | Travel Award. The International Society for Experimental Hematology. 31st ISEH Annual Meeting.
The International Society for Experimental Hematology, Estados Unidos
|
| 2002 | Travel Award. The American Society of Hematology. 44th ASH Annual Meeting.
The American Society of Hematology, Estados Unidos
|
| 2000 | Travel Award. The American Society of Hematology. 42nd ASH Annual Meeting.
The American Society of Hematology, Estados Unidos
|
| 1999 | Travel Award. The American Society of Hematology. 41st ASH Annual Meeting.
The American Society of Hematology, Estados Unidos
|
| 1998 | Ph.D. scholarship from FCT, Portugal.
Fundação para a Ciência e a Tecnologia, Portugal
|
| 1996 | M.Sc. scholarship (1st year of the Ph.D. Program on Basic and Applied Biology) from Junta Nacional para a Investigação Científica
e Tecnológica (JNICT), Portugal.
Junta Nacional para a Investigação Científica e Tecnológica , Portugal
|